ymc hplc columns applications notebook

HPLC ColumnsApplications

Notebook

WA30000

http://www.waters.com

http://www.waters.com/WatersDivision/promos/PRO_ymc/ymc_promo_2.html?WT.mc_id=Alias_ymc_CO

1

YMC™ HPLC Column Quality Assurance............................................................2

Guide to YMC™ Part Numbering System ...........................................................3

YMC™ Column Selection Guide ....................................................................4-7

HPLC Troubleshooting and Reference Guide..................................................8-14

List of Applications..................................................................................15-20

1. Vitamins .....................................................................................21

2. Carbohydrates ............................................................................32

3. Nucleic Acids .............................................................................43

4. Amino Acids, Peptides, Proteins ......................................................48

5. Organic Acids, Fatty Acid Derivatives .............................................60

6. Food Additives ............................................................................62

7. Natural Products ..........................................................................68

8. Steroids......................................................................................77

9. Drugs, Metabolites .......................................................................87

10. Antibiotics.................................................................................103

11. Pesticides, Environmental .............................................................114

12. Miscellaneous ...........................................................................119

Index of Analytes.......................................................................................128

Table of Contents

Click on the items below to go directly to that section of the notebook.To Start a new search, click on Table of Contents Bookmark to the left

2 © 2003 Waters Corporation.Waters is a trademark of Waters Corporation. YMC™ is a trademark of YMC™ , Co.,Ltd

YMC-Pack™ Pro C18™ columns come with a detailed Certificate ofAnalysis for reliability and traceability.

Waters Corporation announces worldwide distribution of the YMC™ HPLCanalytical and preparative column lines, a highly respected series of prod-ucts that Waters has distributed since 1997. In expanding the distributionof YMC™ columns globally, Waters maintains exclusive distribution rightsfor the YMC™ column product line in the Americas (North America, CentralAmerica, South America and the Caribbean Islands).

YMC...a Premium HPLC Packing ManufacturerYMC has built its reputation on the supply of consistent, premium qualityHPLC packing and columns. Control of the silica support is essential forproduct consistency and is of the highest priority to YMC. The silica sup-ports are then functionalized with the Company’s proprietary bonding andendcapping chemistries to yield rugged, reproducible, high performanceHPLC packings.

Consistent Production Methods Year to YearOnce a YMC product has been provided to customers for their chro-matography, the methods used to produce that product will not bechanged, as a matter of company policy. Even small changes in manu-facturing methods to “improve” a product can lead to selectivity changes inmethods for which that column is applied. Because YMC controls the pro-duction of its products from silica synthesis to packed column you can beassured that a method developed on a YMC™ column will be reproduciblefor as long as you conduct that method.

In-house manufacture gives YMC complete control over product quality andreproducibility. Proven procedures at every stage of manufacture guaran-tee consistency in silica purity, particle size, pore size, bonding and end-capping. Test chromatograms shipped with every column are merely thefinal demonstration of a rigorously controlled product.

A Product You Can Count OnYMC™ products must pass internal performance criteria as raw materials,as synthesized silica particles, after they are bonded, and finally when they are packed into a column. By setting tight standards, testing the rawmaterials and precise control of silica gel synthesis, low metal levels of puri-ty are achieved. Acceptance standards virtually eliminate problems withnonspecific adsorption caused by trace contaminants in the silica gel.

Waters Establishes Worldwide DistributionNetwork for YMC™ HPLC Columns

US Pharmacopeia HPLC "L1" (C18) Column DesignationSubclassification Testing by Brand Name*

Hydrophobicity Chelating Silanol Activity Shape SelectivityColumn Brand Name (k, Ethylbenzene) (Tailing Factor (TF), Quinizarin) (k, Amitriptyline) (TF, Amitriptyline) (Bonding Density, mmol/m2)

Pro C18™ 1.88 1.28 4.74 1.50 2.50

Hydrosphere™ C18 1.52 1.34 4.40 1.94 1.90

Pro C18™ RS 3.28 1.17 7.50 1.35 3.04

ODS-AL™ 1.79 1.52 13.59 2.81 2.56

ODS-A™ 1.89 1.53 5.00 2.40 2.66

ODS-AM™ 1.94 1.52 5.11 2.40 2.75

ODS-AQ™ 1.88 1.49 5.96 2.86 2.22

J’sphere™ ODS-H80 3.32 1.31 8.80 2.93 3.18

J'sphere™ ODS-M80 1.62 1.41 4.96 2.72 1.02

J’sphere™ ODS-L80 0.95 1.43 2.94 2.78 0.92

* For use in C18 Column Brand Name selection when referencing USP Monographs which specify the characteristics/performance of the C18 Column used in the method. Choose a brand as close as possibleto the referenced column values for the best chance of duplicating the analytical results of the method.

YMC™ HPLC Column Quality Assurance

© 2003 Waters Corporation.Waters is a trademark of Waters Corporation. YMC™ is a trademark of YMC™, Co.,Ltd. 3

The YMC™ part numbering system is designed to help identify the productbeing ordered. This system:

• embeds in the part number a description of the productthat can be read by the user;

• standardizes the YMC™ part numbers worldwide; and,

• simplifies computerized stocking and ordering.

The table below will enable you to “read” your part numbers, and confirmthat a part number you are about to use for ordering is exactly what youneed. This should reduce ordering errors that can delay delivery of the cor-rect column.

Gel Code & Hardware CodeThe part numbers are composed of a gel code, which describes the pack-ing in the HPLC column, and the hardware code, which describes the col-umn itself. The gel and hardware codes are further divided into short codesthat describe the chemistry, pore size, particle shape, particle size, column

length, and column inner diameter. These are followed by fitting codes forinternal use by Waters. The system is set out schematically below:

Example: a semipreparative column with the part number“OC12S052520WT” is in your stock. “Read” the part number asOC/12/S/05/25/20, and you can determine that this column is:

Please do not use this table to write your own part numbers. Certain attrib-utes that are available in some stationary phases are not available in others. If you are unsure of a part number, please check the catalog orprice list, ask your technical representative directly to confirm availability.

Octyl 12nm (120Å) Spherical 5 µm 25 cm 20 mm I.D.(C8) pores media particles long

Gel Code Hardware Code

Chemistry Pore Size in Particle Particle size Length InternalCode nm Shape in µm in mm diameter in mm

Guide to YMC™ Part Numbering System

Chemistry Code Pore Size in Angstroms Particle Shape Particle Size in µm Length in mm Internal Diameter in mm

ODS-A™: AAODS-AM™: AMODS-AQ™: AQODS-AL™: ALPolymerC18™: PCJ’sphere™ ODS-H80: JHJ’sphere™ ODS-M80: JMJ’sphere™ ODS-L80: JLYMCbasic™: BAOctyl (C8): OCPhenyl: PHButyl (C4): BUTMS (C1): TMCyano: CNAmino: NHPA-gel™: PAPolyamine II: PBSilica: SLPVA-Sil™: PVDiol (NP): DNDiol (SEC): DLProtein-RP™: PRPro C4 BSPro C8 OSPro C18™ ASCartenoid CTPro C18RS™ RSHydrosphere™ C18 HS

60Å: 0680Å: 08120Å: 12200Å: 20300Å: 301000Å A0Proprietary orunspecified: 99

Spherical: SIrregular: I

3 µm: 034 µm: 045 µm: 056 µm: 065/15 µm (10P): 1115 µm: 1510/20 µm: 1615/30 µm: 2130/50 µm: 4150 µm: 5075 µm: 75150 µm: A5350 µm: C5Undesignated: 99

Irregular:5/20 µm: 1210/25 µm: 1710/40 µm: 2525/40 µm: 3240/63 µm: 5263/210 µm: A4

10 mm: 0120 mm: 0223 mm: G330 mm: 0333 mm H350 mm: 0575 mm: L5100 mm: 10150 mm: 15250 mm: 25300 mm: 30500 mm: 501000 mm: A01500 mm: A52000 mm: B0

0.2 mm: G00.3 mm: H00.5 mm: J01.0 mm: 012.0 mm: 023.0 mm: 034.0 mm: 044.6 mm: 466.0 mm: 068.0 mm: 0810 mm: 1020 mm: 2030 mm: 3050 mm (1000psi): 5150 mm (2000psi): 5270 mm (1000psi): 7170 mm (2000psi): 72100 mm (1000psi): A1100 mm (2000psi): A2150 mm (1000psi): B1150 mm (2000psi): B2200 mm (1000psi): C1

200 mm (2000psi): C2

Guide to YMC™ Part Numbering System

4 © 2003 Waters Corporation.Waters is a trademark of Waters Corporation. YMC™ is a trademark of YMC™, Co.,Ltd

Choosing an HPLC ColumnYMC-Pack™ High Performance HPLC ColumnsYMC™ provides an extensive selection of packed columns to address yourseparation needs. Numerous specialty bonded phases are available tosolve the most difficult separation problems.

• Extensive selection of bonded phases availablein five different porosities

• Column diameters from microbore to process scale

• Column lengths from 10 to 2000 mm

• Available packed with 3 micron to350 micron spherical particles

• Columns individually tested for quality assurance

High Reproducibility:High purity synthetic spherical silica: YMC™ synthetic silica supports con-tain only trace levels of metal impurities and organic contaminants. Thisinert, chemically stable silica is the ideal support for YMC™ bonded phasechemistries and is an essential feature in YMC™ column reproducibility. Theultrapure YMC™ silica minimizes nonspecific adsorption and secondaryretention arising from silica contaminants.

Every lot scrutinized: Each lot of YMC*Gel™ is extensively tested for phys-ical and chemical properties. After acceptance, the silica lot is bonded andretested with a series of state-of-the-art chemical tests and specific chemicalprobes. These tests assure lot-to-lot reproducibility and confirm applicabilityfor the class of compounds for which the product is intended. The selectiv-ity and recovery of wide-pore bonded phases, for example, are batch-test-ed with peptides and proteins.

Every column tested: Each YMC™ column is chromatographically testedto assure that plate count, peak symmetry and general column perform-ance meet YMC™’s high standard of quality. The column performancereport supplied with every packed column fully documents the gel lot andtest results.

High Performance Silica SupportsSpherical packing for long column life: YMC™ spherical packing pro-vides high performance with long column lifetimes. Spherical particles packmore uniformly than “spheroidal” or irregular supports. The greater mechan-ical stability of the column bed eliminates premature voiding.

High surface area: The ultrapure YMC™ spherical supports have very highporosity, providing increased surface area for greater retention andincreased resolution. In preparative applications, increased surface areaalso means greater sample loading. The high sample loading, excellentresolution and long column life combine to provide higher productivity andeconomy in preparative separations.

State-of-the-Art Bonding and EndcappingMonomeric versus Polymeric Bonding: The bonding of ligands to the sil-ica surface is often referred to as either “monomeric” or “polymeric”. Withmonomeric bonding, the ligand has a single point of attachment via amonofunctional silane. The resulting surface provides superior efficiencyand resolution for smaller molecules.

With polymeric bonding, the ligands have multiple points of attachment viaa trifunctional silane. (Polymerically bonded silica packing should not beconfused with HPLC supports in which the support is a porous polymer.) Theselectivity differences between monomeric and polymeric bonding provideoptions in method development.

Unique Endcapping Technology: Silica supports are the foundation ofmost advanced HPLC packing, enabling these phases to tolerate the highpressures of modern HPLC. When a silica particle is bonded, "residualsilanols" (unbonded surface silanol sites: -SiOH) can interact with polar sam-ples and eluents. These interactions are desirable with some samples. Withbasic samples and aqueous eluents, however, residual silanols can causeproblems with peak symmetry and shorten column life. "End-capping" is aprocess by which residual silanols are bonded to minimize interaction withsolute molecules. The nature and completeness of the endcapping processgreatly influence the performance and quality of an HPLC column and, ulti-mately, the separation.

YMC™ Column Selection Guide

© 2003 Waters Corporation.Waters is a trademark of Waters Corporation. YMC™ is a trademark of YMC™, Co.,Ltd 5

Choosing an HPLC Column

Impact of Pore Size DifferencesYMC™ columns are available in five different pore sizes. Pore sizes are typ-ically matched to sample molecule sizes. Pore sizes can also be used toadjust ligand density and thus, retention of a bonded phase, since the sizeof the pores also affects the total packing surface area ina packed column.

60Å packing is available in bare silica for normal phase separations, andin diol-bonded phases for normal phase separations and aqueous sizeexclusion chromatography.

The 80Å J'sphere™ ODS and YMC-Pack™ Pro C18 RS™ pores and the120Å pores available in the rest of the YMC™ product line are useful for themajority of separations. These pore sizes are suited for most organic com-pounds and for peptides less than 20,000MW.

200Å pores, available in many YMC™ phases, can be used for virtuallyany size organic compound, as well as for peptides and smaller proteinsbetween 10 and 50 kD. The intermediate pore size provides access forbulkier molecules as well as higher surface area and higher preparativesample loading than 300Å media.

300Å columns are appropriate for the analysis of large biomolecules andof organic compounds with excessive retention on smaller pore materials.YMC offers 300Å porosity in a wide range of bonded phase chemistries.

Wide Range of Column SizesAnalytical Columns: To meet a range of HPLC situations, YMC™ offers ana-lytical columns in diameters of 1.0 mm, 2.0 mm, 3.0 mm, 4.6 mm and6.0 mm in a variety of lengths. These analytical columns are available inall YMC*Gel™ chemistries. Typically, 5 micron spherical supports are usedfor most analytical situations, although other supports are also available.

Semipreparative Columns: YMC™ offers three different semipreparativecolumn sizes (10, 20 and 30 mm I.D.) for scaling up separations to gramquantities. Semipreparative columns are typically packed with 5 or 10micron packings or with 15 micron high performance preparative media.YMC semiprep columns packed with 5 or 10 micron media provide ana-lytical grade separations at semiprep scale.

Preparative Columns: Using spherical packing in YMC™ preparativecolumns facilitates scale-up to preparative loads. High performance 10,15, 25 and 50 micron spherical particles are available to address anypreparative need. Scale-up from analytical through semiprep to prepara-tive column sizes is simplified by using the same bonded phasechemistries throughout.

Packing Size Matched to Column SizeSmaller particle packing performs best in smaller diameter columns, andlarger diameter packing excels in larger diameter columns. In general,3 micron packing performs best in columns up to 10 mm I.D.; 5 micronpacking is best suited to columns up to 30 mm I.D.; and 10 micron pack-ing is appropriate for columns up to 50 mm I.D. Columns of 100 mmI.D. or larger are generally packed with particles of 15 microns or larg-er in diameter.

*YMC-Pack™ Pro C18™ utilizes a novel Lewis-Acid-Lewis Base endcapping procedurewhich gives the maximum surface coverage and inertness.

USP Description

C18 bonded to 3-10 µm porous silica

5-10 µm porous silica


NH2 bonded to 10 µm porous silica

CN bonded to 3-10 µm porous silica

Phenyl bonded to 5-10 µm porous silica

Trimethylsilane bonded to 3-10 µm porous silica

Dihydroxypropane (Diol) bonded to 3-10 µm silica

32-63 µm semi-rigid hydrophilic vinyl polymer gel


30-50 µm porous silica

pH stable, silica-based GFC for 4-400KD proteins

C30 bonded to moderate-pore porous silica

C18 bonded to rigid porous polymethacrylate

Primary amines in polymer resin over porous silica

Secondary and tertiary amines in polymer resinover porous silica

USPDesignation

L1

L3

L7

L8

L10

L11

L13

L20

L24

L26

L27

L33

UnclassifiedYMC Phases

YMC, Inc. Phases

YMC-Pack™ Pro C18™

YMC-Pack™ Pro C18™RSYMC-Pack™ ODS-A™

YMC-Pack™ ODS-AM™

YMC-Pack™ ODS-AL™

YMC-Pack™ ODS-AQ™

J’sphere™ ODS seriesYMC-Pack™ Hydrosphere™

YMC-Pack™ Silica

YMC-Pack™ C8 (Octyl)YMCbasic™

YMC-Pack™ NH2 (Amino)

YMC-Pack™ CN (Cyano/Nitrile)

YMC-Pack™ Phenyl

YMC-Pack ™TMS

YMC-Pack™ Diol

YMC-Pack™ PVA-Sil

YMC C4 (Butyl)YMC-Pack™ Protein-RP

YMC-Pack™ Silica (S30/50)

YMC-Pack™ 200Å Diol

YMC30The Carotenoid Column

YMC-Pack™ PolymerC18™

YMC-Pack™ PA

YMC-Pack™ Polyamine II

USP Chromatography ColumnClassifications of YMC Columns


6 © 2003 Waters Corporation.Waters is a trademark of Waters Corporation. YMC™ is a trademark of YMC™, Co.,Ltd.

Characterization of Reversed-Phase Packings —a Tool for Column SelectionIt is clear that the final properties of a reversed-phase packing depend onmany different parameters of bonded-phase design and on the details ofthe manufacturing process of the different packings. To condense this largebody of data into information that is useful to the chromatographer, it isimportant to focus on the most relevant properties of reversed-phase pack-ings. There are two basic properties of a reversed-phase chromatographicpacking. One is the strength of the hydrophobic interaction which can eas-ily be measured by the retention factor of a purely hydrophobic analyte.The second property is the strength of the silanophilic interaction. This canbest be measured by using the relative retention between an analyte thatinteracts by hydrophobic and silanophilic interaction and an analyte thatinteracts by hydrophobic interaction only. This has been done for many ofthe packings that can be found in this catalogue as well as for some oth-ers, for which the relevant information was available.

A chromatographic test was developed so that all columns could be eval-uated under controlled conditions for these two chromatographic proper-ties. Two marker analytes were chosen. Acenaphthene as the hydropho-bic, neutral marker, and amitriptyline as the basic, silanophilic interactionmarker. The information is summarized clearly in the chart below. The x-axisrepresents the hydrophobicity of a packing, and the y-axis is the silanophilicinteraction of the packing.

The hydrophobicity increases fundamentally with the chain length. Forexample, you will find most C8 packings on the middle part of the chart,and most C18 packings on the right side of the chart. The silanophilic inter-action is measured at neutral pH (pH 7.0, which allows for the de-proto-nation of the silanol group creating a negatively charged-- cation exchangesurface). Packings based on high-purity silicas that are well endcappedshow a low silanol group activity and are found on the lower side of thegraph. Embedded polar group ligands are found there also because theyminimize silanol interaction. These are the packings that are preferentiallyused for basic analytes.

On the upper end of the y-axis, you find packings with a high silanol activ-ity. These are typically based on either lower purity silica and/or are notendcapped. These packings can be used to provide a different selectivitythan packings with a low silanol activity, but they usually exhibit tailing forbasic analytes at neutral mobile phase pH.

You can select the type of packing most suitable for your separation basedon this graph. If your analytes are basic and exhibit strong interactions withsurface silanols, select packings on the lower part of the graph. If you arelooking for a significant difference in polar selectivity, you should selectpackings that are located in different sections of the chart. If you are look-ing simply for differences in hydrophobicity, use packings that are far awayfrom each other on the hydrophobicity axis.

Note: The actual value obtained from the chromatographic evaluation isshown by the diamond symbol.

Selectivity Chart of Reversed-Phase Columns

-1

-0.5

0

0.5

1

1.5

2

2.5

3

3.5

4

-2.00 -1.00 0.00 1.00 2.00 3.00 4.00

Hydrophobicity (In K, Acenaphthene)

Sele

ctiv

ity(In

α, A

mitr

ipty

line/

Acen

apht

hene

)

Nova-Pak® CN HP

Waters Spherisorb® Phenyl

Waters Spherisorb® ODS-1

Waters Spherisorb® ODS-2

Waters Spherisorb® ODSB

YMC™ J'Sphere™ ODS L80

YMC™ J'Sphere™ ODS-H80

YMC-Pack™ ODS-AQ

YMC-Pack™ ODS-A™

YMC-Pack™ ProC18™ RS

YMC-Pack™ ProC18™



YMC™ Hydrosphere™ C18 YMC™ J'Sphere™ ODS-M80

Waters Spherisorb® CN

YMC™ PolymerC18™

YMC-Pack™ CN

Nova-Pak® C8

Nova-Pak® C18

Resolve™ C18

µBondapak™ C18

Atlantis™ dC18

Symmetry® C8

Symmetry® C18

YMCbasic™

Nova-Pak® Phenyl

XTerra® RP8

XTerra® MS C8XTerra® MS C18

XTerra® Phenyl

XTerra® RP18

SymmetryShield™ RP8

Symmetry300™ C18

Symmetry300™ C4

SymmetryShield™ RP18



Analyte Separation AnalyteSolubility Mechanism Class YMC-Pack™ Column

GENERAL...................................................................................Pro C18, Pro C18RS™, ODS-A™, ODS-AQ™, Octyl, Hydrosphere™

Acids, Organic............................................................................Pro C18™,Pro C18RS™, ODS-AQ™, Hydrosphere™

Acids, Amino (free) ....................................................................ODS-AQ™

Acids, Amino (derivatized) ..........................................................Pro C18™, Pro C18RS™, ODS-AQ™, YMCbasic™, ODS-A™, ODS-AM™, Hydrosphere™

Amines, Organic.........................................................................Pro C18™, Pro C18RS™, YMCbasic™, PolymerC18™

Amines, Quaternary (pH>7.5)....................................................PolymerC18™

Carbohydrates............................................................................Polyamine II, PA-gel™, AminoChelators...................................................................................Pro C18™, Pro C18RS™, PolymerC18™

Reversed- Drugs, Basic ..............................................................................Pro C18™, Pro C18RS™, YMCbasic™

Phase Dyes.........................................................................................ODS-A™, ODS-AM™

Explosives .................................................................................J’sphere™ ODS-H80Metabolites ...............................................................................ODS-AQ™, YMCbasic™, Pro C18™, Hydrosphere™

Nucleosides ...............................................................................ODS-AQ™, Hydrosphere™

Water- Nucleotides................................................................................ODS-AQ™, Hydrosphere™

Soluble Oligonucleotides.........................................................................ODS-AQ™, Hydrosphere™

Peptides....................................................................................Peptide Columns (ODS-AQ™, YMCbasic™), Hydrosphere™

Proteins.....................................................................................Protein-RP™, Wide-pore columns, ButylSugars ......................................................................................Polyamine II, PA-gel™, AminoTricyclic Antidepressants...............................................................Pro C18™, Pro C18RS™

Vitamins, Water Soluble .............................................................ODS-AQ™, Hydrosphere™

Size Oligosaccharides.........................................................................Diol

Exclusion Peptides....................................................................................DiolProteins.....................................................................................Diol

Ion-Pairing Acids, Organic............................................................................PolymerC18™, Pro C18™, Pro C18RS™, J’sphere™ ODS-H80Ion- Amines, Organic.........................................................................PolymerC18™, Pro C18™, Pro C18RS™, J’sphere™ ODS-H80Suppression

GENERAL...................................................................................Diol, PVA-Sil™, Silica

Normal Aflatoxins ..................................................................................Silica

Phase Steroids ....................................................................................Diol, PVA-Sil™

Triglycerides ...............................................................................Diol, PVA-Sil™

Vitamins, Fat Soluble .................................................................Diol, PVA-Sil™Non-Water

Aflatoxins ..................................................................................Octyl, J’sphere™ ODS-M80, L80 SolubleReversed- Carotenoids ...............................................................................YMC30 Carotenoid

Phase Fatty Acids ................................................................................Octyl, PhenylPolyaromatics (PAH) ..................................................................Phenyl, Octyl, YMC30Vitamins, Fat Soluble .................................................................ODS-A™

Choosing a YMC-Pack™ Column for Your SeparationThe following chart is a general guide for choosing a YMC-Pack™ column.Please contact our technical services for more in-depth recommendations.


8©

2003 Waters C

orporation.Waters is a tradem

ark of Waters C

orporation. YMC

™is a tradem

ark of YMC

™, Co.,Ltd.

Quick Reference Guide - YMC™ Liquid Chromatography Products

* Pro C18™

* ProC18 RS™

J’sphere™

ODS-AM

ODS-A

ODS-AL

*ODS-AQ™

*PolymerC18™

*YMCbasic™

C8 (Octyl)

C4 (Butyl)

Protein-RP

C18 bonded to ultrapure silicaw/Lewis acid-base endcapping

C18 with polymeric bonding toultrapure silica with Lewis

acid-base endcapping

C18 on ultrapure silica,well endcapped

C18super endcapped

Classic C18well endcapped

C18nonendcapped

C18 w/hydrophilicendcapping

C18-functionalizedpolymethacrylate

Alkylsilanes≤C8neutral silica

Octylsilanefully endcapped

Butylsilanefully endcapped

Butylsilane,fully end-capped

RP: partition,most inert C18

RP: partition, most inert C18with alternative selectivity

to Pro C18™

RP: partition,unique selectivity

RP: partition,very inert

RP: partition

RP: partition,mixed mode

RP: partition,most versatile C18

RP: partition,π interactions

RP: partition

RP: partition

RP: partition,

RP/Partitionlow pH stable

2-8

1-10

1.1-9.3(H)2-7(M,L)

2-7

2-7

2-6

2-6.3

2-12

2-7

2-7

2-7

1.5-7

3, 5, 10P, 15

5

4

3, 5, 10, 15

3, 5, 7, 10P, 1525, 30-50, 50, 75

5

3, 5, 7, 10P, 1525, 30-50, 50

6, 10, 50

3, 5, 10P, 15, 2530-50, 50

3, 5, 7, 10P, 15, 2530-50, 50

3, 5, 7, 10P, 15, 2530-50, 50

5, 15

120

80

80

120

120, 200, 300

120

120, 200

—

wide pore

120, 200, 300

120, 200, 300

wide pore

16

22

22, 14, 9(H, M, L)

17

17, 11, 7varies

17

14, 10varies

C18=10%

7

11, 7, 4varies

7, 5, 3

varies

3.5

Pharmaceuticals, organic amines,chelating compounds

Basic compounds, pharmaceuticals, an ideal compliment toPro C18™, when alternative selectivitiy or

aggressive pH conditions are required

Organic bases, peptides, steroids, PAHs; difficulthigh and low pH samples

Tailing compounds; organic acids, antibiotics, nonpolar peptides, fats, basic molecules

Pharmaceuticals, vitamins, amino acids, peptides;general purpose phase

Fat-soluble vitamins, steroids, fats

Separation of highly aqueous samples,mixed polarity peptides, amino acids

Phenols, anilines, peptides in high pH,pharmaceuticals, quaternary amines

Basic molecules w/o modifiers;pharmaceuticals, amino acids

Natural products; peptides, pharmaceuticalsproteins: general purpose phase

120Å: Non-polar peptides200/300Å: proteins/biopolymers

Protein separations especially at low pH

L1

L1

L1

L1

L1

L1

L1

—

L7

L7

L26

L26

Phase Principal USP pH Range Particle Size Pore Size CarbonProduct (silica unless Separation Class (room temp) (µm spherical) (Angstroms) LOAD Typical Applications

noted) Mechanism No. ** (%C)

HPLC

Troublesh

ootin

g a

nd R

eference G

uid

e

© 2003 W

aters Corporation.W

aters is a trademark of W

aters Corporation. YM

C™

is a trademark of YM

C™, C

o.,Ltd.9

C1 (TMS)

Phenyl

CN (Cyano)

*The CarotenoidColumn™

*PVA-Sil™

Diol

Aqueous GPC/SEC

Silica

NH2 (Amino)

*PA gel™

*Polyamine II™

(PBMN)

Hydrosphere™ C18

Trimethyl silane

Monomeric phenyl,endcapped

Monomeric CN,endcapped

C30

Polyvinyl alcoholbonded to silica

1, 2-dihydroxypropane

Diolphase

Spherical orirregular gel

Propylamine

Polyamine: 1°, 2°, 3°amine functionalities

Polyamine: 2° aminefunctionalities

C18 with hydrophilicendcapping

RP/NP:intermediate polarity

RP: partition,π interactions

RP: most polar,NP: silica alternative

RP: partition

NP: good alt to silica,H bonding

NP: good alt to silica,H bonding/adsorption

Aqueous sizeseparation

NP: adsorption,H bonding

NP: adsorption,H bonding, ion exchange

NP: adsorption,H bonding

NP:adsorption/H bonding

RP: partitionHigh purity silica

2-7

2-7

2-7

2-6

2-9.5

2-7

2-7

NA

2-7

2-9

2-9

2-8

5, 10P, 15, 2530-50, 50

3, 5, 7, 10P, 15, 2530-50, 50

3, 5, 7, 10, 10P, 1525, 30-50, 50

3, 5, 15

5

5, 10P, 15, 25, 50

5, 10, 15, 25, 50

3, 5, 7, 10P, 15, 25, 50, 75, 150, 350

3, 5, 7, 10, 10P, 15,25, 30-50, 50

5

5

3, 5

120, 200, 300

120, 300

120, 300

wide pore

120

60, 120, 200, 300

60, 120, 200, 300

60, 120, 200, 300

120, 300

120

120

120

4, 3.5, 3varies

9, 3varies

7, 3varies

20

N/A

—

—

—

3

—

—

12

Multifunctional compounds, nonpolar compoundswith NP solvents, vitamins

Aromatics, peptides and proteins, pharmaceuticals

RP/NP: phenols, pharmaceuticals, environmentalanalytes, carotenoids, metabolites

Polar and nonpolar geometric carotenoids isomers

Organic bases, lipids, retinoidsphospholipids, carotenoids; OK with polar solvents

Natural products, lipids, metabolites of pesticides

Aqueous size separations; biomolecules,pharmaceuticals

Small organic molecules to polymers, fat-solublevitamins, tocopherols

Sugars, saccharides, tocopherols, phenols, parafins, olefins, anions

More stable than amino over time;sugars, maltose and lactose

Sugars; very stable; high pH (<8.5) column washing OK

Separation of highly aqueous samples, mixedpolarity peptides, organic acids

L13

L11

L10

—

L24

L20

L33

L3

L8

—

—

L1

Phase Principal USP pH Range Particle Size Pore Size CarbonProduct (silica unless Separation Class (room temp) (µm spherical) (Angstroms) LOAD Typical Applications

noted) Mechanism No. ** (%C)

HPLC

Troublesh

ootin

g a

nd R

eference G

uid

e


Although there is no substitute for experience or consulting with an“expert,” here are some tips and tricks, some answers to the most com-monly-asked technical inquiries, and some key questions to ask to helpdiagnose your problem.

HPLC Troubleshooting

Poor Peak Shape, Loss of Resolution, or Peak SplittingProbable Causes: Mechanical fouling. Column void. Sample overload. Sample-mobile phase incompatibility. Dead volume

from improperly assembled fittings and connectors. Adsorption (active sites).

Key Questions: Are all peaks equally affected? Did the peak shape start out fine but degrade over time? Has the backpressure increased?

Be certain that…. The mobile phase is the proper pH for your analytes. Your analytes are soluble in the mobile phase. You arenot overloading the column with too much sample. Ensure that the sample solvent is not too strong for themobile phase. All connecting fittings are well-seated (see Column Hardware Section.

First Pass Solution: Make sure your column is properly connected with appropriate fittings for perfect, zero dead volume con-nections. Retest the column under our QA test procedure (shown on the report shipped with the column).

If the column looks fine, then the problem is specific to your analyte or system. If the column has poor per-formance, refer to the “Cleaning/regenerating columns” procedures at the end of this section.

High PressureProbable Causes: Restricted flow-path.

Be certain that…. All components in the mobile phase and sample are compatible with one another, filtered, and that precipitation can-not occur.

First Pass Solution: Replace column with a union and measure total system pressure. If pressure without the column is high, disconnectall connections starting at the end of the flow path until you’ve isolated the section giving high pressure. If pressurewithout the column is acceptable, attempt to remove particulate matter from the inlet frit by running the column inreverse with the outlet disconnected from the detector. If pressure is still high, refer to the “Cleaning/regeneratingcolumns” procedures at the end of this section. Use inline filters or improve your sample preparation procedure toremove particulates and contaminating matrix components.

Retention Time or Selectivity VariationProbable Causes: Variable pump flow, temperature variations, or solvent mixing. Mobile phase preparation technique.

Chemical variability in column.

Be certain that…. Comparisons are being made under identical system, mobile phase, and sample conditions. The columns are prop-erly equilibrated. Columns have not been exposed to conditions that could change them. Equilibration of columnsusing Ion-Pairing reagents has to be well controlled.

Key Questions: Is the void time consistent? Using the same sample and mobile phase bottle on the same day, how do the twocolumns in question compare?

First Pass Solution: Test the columns under our QA conditions to make sure they are still in good condition. Gather chromatograms fromthe columns in question, including details on mobile phase, system, and sample conditions, column serial number,and how they’ve been used in the past. Depending on use conditions, older columns can perform differently due tochemical changes to the packing material.

HPLC Troubleshooting and Reference Guide


Retention Time DriftProbable Causes: System not equilibrated. Adsorption (active sites). Temperature changing.

Be certain that…. All components in the mobile phase and sample are compatible with one another. The column is properly equili-brated. Drift is not caused by inconsistent column temperature or flow rate.

Key Questions: Is drift sample- or mobile phase-dependent? Do all peaks drift equally, or do certain ones drift more than others? Isthe void time stable? Is this a Normal Phase Method?

First Pass Solution: Retest after cleaning the column according to “Cleaning/regenerating columns” procedures at the end of this sec-tion, and re-equilibrating in fresh mobile phase.

For many Normal Phase applications, varying moisture levels in the mobile phase will cause the active packingmaterial to change. Control the moisture level.

Baseline Unstable or NoisyProbable Causes: Column not equilibrated in mobile phase. Pump delivering unstable flow. Leaks. Low detector lamp energy. Air bub-

ble, debris, or contamination in detector cell. Mobile phase not being mixed properly. Mobile phase contaminated.Purity of mobile phase components not high enough. Elution from column of strongly-adsorbed material.

Be certain that…. Pump is operating properly. Detector cell is clean. You are using HPLC-grade mobile phase components. Your wateris HPLC-grade and is fresh. Your mobile phase is properly degassed.

Key Questions: Does replacing the column solve the problem?

First Pass Solution: Clean the column according to “Cleaning/regenerating columns” procedures at the end of this section, andre-equilibrate in fresh mobile phase.

Poor Sensitivity Probable Causes: Detector lamp energy low. Wrong wavelength. Detector cell contaminated. Detector or integrator settings or cali-

bration incorrect. Analyte degraded or not in solution. Injection volume inconsistent. Too much extra-column volume.Adsorption (active sites).

Be certain that…. HPLC system (detector and injector) is clean, calibrated, and operating properly. All liquid connections are zero dead volume.

Key Questions: Does a similar column give better sensitivity?

First Pass Solution: If you can get good sensitivity from another similar column, adsorption may be occurring. Retest after cleaning thecolumn in question according to “Cleaning/regenerating columns” procedures at the end of this section.

Ghost PeaksProbable Causes: Carryover from prior injections. Contamination of column or system. Pump oil leaking into system. Late-eluting peak

from previous sample.

Be certain that…. The ghost peak is not electronic noise (test with pump turned off).

Key Questions: What samples have you previously injected onto the column? Does the peak diminish with each injection, stay thesame, or get larger? Does it occur only at low UV wavelengths (210nm) with Methanol?

First Pass Solution: Make several consecutive 0 µL injections (turn injector valve).

➜ If peak decreases with each injection, the contamination is from a previous sample injection. Clean the entire sys-tem (excluding the column) with isopropanol. On a separate system, clean the column according to“Cleaning/regenerating columns” procedures at the end of this section. Add a strong solvent flush at the end of therun to your analysis conditions to remove late eluting compounds.



Ghost Peaks (continued)➜ If peak stays the same size with each injection, the contamination is from the mobile phase. Ion-pair reagents andwater should be particularly suspect. Clean the system with isopropanol. On a separate system, clean the columnaccording to “Cleaning/regenerating columns” section below. Replace every component of your mobile phase,including glassware and solvent reservoirs, and check pump to make sure it isn’t leaking oil into the lines.

➜ If no peak is seen with a 0 µL injection, the ghost peak is in your sample. Add a strong solvent flush at the end of the run to your analysis conditions to remove late eluting compounds. Make sure sample is filtered and that allcomponents are soluble in the mobile phase and sample solvent.

If the peak disappears at 254 nm, then you have an oxygen-methanol complex which appears as a peak at210 nm. Because the mobile phase is degassed, there is no oxygen present until you inject your sample which hasoxygen dissolved in the injection solvent.

Negative Peaks (dip below the baseline)Probable Causes: Detector or integrator settings or calibration incorrect. Mobile phase has higher UV absorbance or greater

refractive index than analyte. Refractive index of sample solvent differs too much from the mobile phase. Ion pair-ing mobile phase.

Be certain that…. The negative peak is not electronic noise (test with pump turned off).

First Pass Solutions: 1. Make a 0 µL injection (turn injector valve). If the negative peak is seen, then it is due to the refractive index changecaused by the momentary stop in flow or increase in pressure when the valve switches.

2. Make injections of sample solvent only.

➜ If negative peak is seen, your sample solvent has less absorbance or a drastically different refractive index thanyour mobile phase. Change all of your mobile phase components, making sure they are fresh, HPLC grade (espe-cially ion-pair reagents and your water), and have no absorbance at your analysis wavelength.

➜ If you don’t see the negative peak, then there is a component in your sample that has less absorbance or a drastically different refractive index than your mobile phase. Adjust the detector wavelength. Change all of yourmobile phase components, making sure they are fresh, HPLC grade (especially ion-pair reagents and your water),and have no absorbance at your analysis wavelength.

Key Calculations

Parameter Units Equation

Resolution none R = 1/4 N 1/2 (α - 1) [k/(1+k)]R = 2(Tr2 – Tr1)/(w2 + w1)where Tr is retention time, and w is baseline peak width

Void volume (V0) mL V0 = (0.65)π(d/2)2L where d is column I.D. in cm, and L is column length in cm

Void time (T0) minutes T0 = V0 /Fwhere F is flow rate in mL/min

Capacity factor (k) none k = (Tr - T0)/ T0where Tr is retention time in minutes

Selectivity (α) none α = k2/k1

Efficiency (N) plates/column N = 16(Tr/w)2

where w is baseline peak width (Tr and w must have the same units)

Linear velocity (u) cm /sec u = L/T0where L is column length and T0 is void time in seconds



Physical Constants for Some Common HPLC Solvents

Solvent Formula Solubility in Boiling Density UV Cutoff Viscosity at Polaritywater (%w/w) Pt. (°C) (g/mL) (nm) 20 °C (cP) Index

Acetic acid CH3COOH fully soluble 117.9 1.0492 230 1.26 6.2Acetone CH3COCH3 fully soluble 56.2 0.7899 330 0.32 5.1Acetonitrile CH3CN fully soluble 81.6 0.9483 190 0.37 5.8Carbon tetrachloride CCl4 0.08 76.5 1.5940 263 0.97 1.6Chloroform CHCl3 0.82 61.7 1.4832 245 0.57 4.1Dichloromethane CH2Cl2 1.60 40 1.3266 235 0.44 3.11,4-Dioxane C4H8O2 fully soluble 101 1.0337 215 1.54 4.8Dimethylsulfoxide (DMSO) (CH3)2SO fully soluble 189 1.1014 268 2.00 7.2Ethanol CH3CH2OH fully soluble 78.5 0.7893 210 1.20 5.2Ethyl acetate CH3COOCH2CH3 8.70 77.1 0.9003 260 0.45 4.4Diethylether CH3CH2COCH2CH3 6.89 34.5 0.7138 220 0.32 2.8Heptane CH3(CH2)5CH3 <0.01 98.4 0.6837 200 0.39 0.0Hexane CH3(CH2)4CH3 <0.01 69 0.6603 200 0.33 0.0Methanol CH3OH fully soluble 65 0.7914 205 0.60 5.1Methyl-t-butyl ether (MTBE) CH3OC((CH2)3CH3)3 4.8 55.2 0.7404 210 0.27 2.5n-Propanol CH3CH2CH2OH fully soluble 97.4 0.8035 210 2.27 4.02-Propanol(Isopropanol) CH3CH2(OH)CH3 fully soluble 82.4 0.7855 210 2.30 3.9Tetrahydrofuran (THF)(Tetramethylene oxide) C4H8O fully soluble 66 0.8892 215 0.55 4.0Toluene (C6H5)CH3 0.05 110.6 0.8669 285 0.59 2.4Water H2O -- 100 1.00 -- 1.00 9.0

Viscosity Curves for Aqueous Eluent Mixtures

00

1

2

3

10 20 30 40 50 60 70 80 90 100

Ethanol

Tetrahydrofuran

Methanol

Acetone

Acetonitrile

Volume % Water

Visc

osity

at 2

0°

C (c

p)



Recommended Column Cleaning and Regenerating ProceduresUse the cleaning routine that matches the properties of the column and whatyou believe is contaminating it. Flush columns with 20 column volumes(e.g., 80 mL total for 4.6 x 250 mm column) of HPLC-grade solvents. Runcolumns in reverse flow direction, with the outlet disconnected from thedetector. Cleaning efficiency is increased by increasing mobile phase tem-perature to 35-55 °C. If the column performance is poor after regeneratingand cleaning, call us for additional support.

Polar Samples Non-polar Samples Proteinaceous Samples

1. water 1. isopropanol Option 1: Inject repeated aliquots of DMSO2. methanol 2. THF Option 2: gradient of 10 to 90% B where:3. THF 3. dichloromethane A = 0.1% TFA in water4. methanol 4. hexane B = 0.1% TFA in CH3CN5. water 5. isopropanol Option 3: Flush column with 7M guanidine HCl, or 7M urea6. mobile phase 6. mobile phase

Silica-based particles: Non-polar-bonded phases

Polar Samples Nonpolar Samples(aqueous mobile phases) (non-aqueous mobile phases)

1. water 1. chloroform2. methanol 2. methanol3. THF 3. dichloromethane 4. methanol 4. heptane or isooctane5. water 5. isopropanol6. mobile phase 6. mobile phase

Silica-based particles: Polar-bonded phases

1. Flush column with mobile phase but omit buffers or salts, for example, just organic and water, acetonitrile is preferable2. Run a gradient to 100% organic3. Flush with twenty column volumes of THF4. Flush with twenty column volumes of acetonitrile5. Run a gradient back to starting mobile phase conditions, omitting buffers and salts6. Re-equilibrate in mobile phase

Polymer-based particles



1. Vitamins

Oil-soluble vitamins................................................................................................................................ 21Vitamin A fatty acid ester.........................................................................................................................21Retinol................................................................................................................................................. 21Carotene ..............................................................................................................................................21β-Carotene ..........................................................................................................................................22Vitamin D ............................................................................................................................................22Tocopherols .................................................................................................................................... 23,24Tocopherol and tocopherol acetate .....................................................................................................24,25Vitamin K............................................................................................................................................. 25A drink including vitamins ....................................................................................................................... 26Water-soluble vitamins ....................................................................................................... 25,26,27,28,29Allantoin and water-soluble vitamins ..........................................................................................................29Thiamine and its modifide compounds ...................................................................................................... 30Riboflavin and related compounds ........................................................................................................... 30Nicotinic acid and derivatives................................................................................................................. 30Pantothenyl alcohol ............................................................................................................................... 30Coenzyme A and derivatives .................................................................................................................. 31L-Ascorbic acid and erythorbic acid ......................................................................................................... 312,4-Dinitrophenylhydrazone of L-ascorbic acid ........................................................................................... 31

2. Carbohydrates

Monosaccharides and disaccharides.........................................................................................................32Monosaccharides ................................................................................................................................. 32Unsaturated chondro-disaccharides .......................................................................................................... 33Sugar alcohols ..................................................................................................................................... 33Oligosaccharides ........................................................................................................................33,34,35Fructooligosaccharides........................................................................................................................... 34Oligosaccharides of soft drink ................................................................................................................. 34Maltooligosaccharides ..................................................................................................................35,36,37Cyclodextrins ...................................................................................................................................37,38Pyridylamino(PA)-Sugar chains..............................................................................................................38,39Polydextrose..........................................................................................................................................40Pullulans ..........................................................................................................................................40,41Chondroitin...........................................................................................................................................41Chondroitin sulfate A ..............................................................................................................................41Chondroitin sulfate B ..............................................................................................................................41Chondroitin sulfate C..............................................................................................................................42Hyaluronic acid .....................................................................................................................................42Heparin................................................................................................................................................42Heparan sulfate .....................................................................................................................................42

List of Applications

Click on the links below to go directly to that section of the notebook. To start a new search, click on List of Applications Bookmark to the left


3. Nucleic acids

Keratan sulfate.......................................................................................................................................43Keratan polysulfate .................................................................................................................................43Nucleosides and bases...........................................................................................................................43Nucleic acid bases ................................................................................................................................43Orotic acid ...........................................................................................................................................44Nucleotides ................................................................................................................................44,45,46Oligonucleotides....................................................................................................................................46Poly(A) .................................................................................................................................................46Sugar nucleotides..............................................................................................................................46,47Plasmid pBR322 restriction fragments.........................................................................................................47

4. Amino acids, Peptides, Proteins

Amino acids..........................................................................................................................................48Taurine in nutritious drink..........................................................................................................................48PTC-amino acids ....................................................................................................................................48PTH-amino acids ....................................................................................................................................48NBD-amino acids...................................................................................................................................49Peptides and proteins..............................................................................................................................49Glutathione, oxidized and reduced form ....................................................................................................49Angiotensins.....................................................................................................................................49,50Insulins ............................................................................................................................................50,51Peptides ......................................................................................................................51,52,53,55,56,59Human immunoglobulins.....................................................................................................................53,54Normal Human IgA................................................................................................................................54Cytochrome c........................................................................................................................................55Peptide fragments from myoglobin.............................................................................................................55Glycine oligomers ..................................................................................................................................56Casein .................................................................................................................................................56Proteins for molecular weight marker................................................................................................56,57,58Proteins ................................................................................................................................................58Human IgM(κ) myeloma protein ...............................................................................................................54

5. Organic acids, Fatty acid derivatives

Organic acids .......................................................................................................................................60Pyruvic acids .........................................................................................................................................60Unsaturated fatty acid methyl esters ...........................................................................................................61Methyl linolenate and methyl γ-linolenate ....................................................................................................61Triacylglycerols ......................................................................................................................................61





6. Food additives

Food preservatives ............................................................................................................................62,67p-Hydroxybenzoic acid esters..............................................................................................................62,63EDTA-chelates ........................................................................................................................................63Antioxidants ................................................................................................................................63,64,65Color additives ......................................................................................................................................65Annatto extract ......................................................................................................................................66Aspartame in a soft drink....................................................................................................................66,67Stevioside and rebaudioside A .................................................................................................................67Glycyrrhizic acid....................................................................................................................................67

7. Natural products

Purine Alkaloids .....................................................................................................................................68Alkaloids ..............................................................................................................................................68Chlorophyll a and b ...............................................................................................................................68Crude Drugs (Glycosides) ........................................................................................................................69Paeoniflorin...........................................................................................................................................69Paeoniflorin in Toki-shakuyaku-san..............................................................................................................70Saponins from roots of rubus suavissimus S.Lee............................................................................................70Saikosaponins .......................................................................................................................................70Ginsenosides ........................................................................................................................................71Flavonoids .......................................................................................................................................71,72Baicalin................................................................................................................................................72Flavanone glycosides.........................................................................................................................72,73Isoflavones from miso, fermented soybean paste ..........................................................................................73Catechins ........................................................................................................................................73,742-Phenylethyl glycosides ..........................................................................................................................74Sennosides ......................................................................................................................................74,75Arbutin and related compounds ................................................................................................................75Paeonol................................................................................................................................................76Aflatoxins..............................................................................................................................................76

8. Steroids

Steroids...........................................................................................................................................77,80Adrenocorticosteroids...............................................................................................................77,78,79,80Hydrocortisone and prednisone ................................................................................................................78Androgens ............................................................................................................................................81Synthetic androgens ..........................................................................................................................81,82Estrogens and progestins .........................................................................................................................82Estrogens.........................................................................................................................................82,83Norgestrel and ethinylestradiol .................................................................................................................83Phenacyl esters of bile acids from pig gall ..................................................................................................83

List of Applications To start a new search, click on List of Applications Bookmark to the leftClick on the links below to go directly to that section of the notebook.



8. Steroids (Cont.)

Ecdysones.............................................................................................................................................84Sterols ..................................................................................................................................................84Cardiac glycosides.................................................................................................................................85Steroids from toad venom ........................................................................................................................86

9. Drugs, Metabolites

Pain-killing drugs ...............................................................................................................................87,90Indometacin ..........................................................................................................................................87A cough/cold medication........................................................................................................................87Ingredients in a cough/cold medication ................................................................................................87,88Analgesics ............................................................................................................................................88Benzethonium chloride ............................................................................................................................89Benzalkonium chloride ............................................................................................................................89Ingredients in drug for rhinitis ....................................................................................................................89Ingredients in an eye drop .......................................................................................................................89Codeine ...............................................................................................................................................90Collunarium...........................................................................................................................................90Naphazoline hydrochloride and chlorpheniramine maleate............................................................................90Histamine antagonists .............................................................................................................................91Acidic non-steroidal anti-inflammatory drugs ...........................................................................................91,93Antipsychotic drugs.................................................................................................................................92Antiepileptics .........................................................................................................................................92Tricyclic antidepressants...........................................................................................................................93Calcium antagonists................................................................................................................................94Hypolipidemic drugs...............................................................................................................................95Lovastatin ..............................................................................................................................................95Antiarrhythmic drugs...........................................................................................................................94,97Local anesthetics ....................................................................................................................................97Diuretics ..........................................................................................................................................96,97Antineoplastic and related compounds .......................................................................................................96Folic acid and its antagonists ...................................................................................................................96Nicotinic acid analogues..................................................................................................................98,100Basic compounds ...................................................................................................................................98Disinfectants ..........................................................................................................................................98Acyclovir ..............................................................................................................................................99Carnitine chloride...................................................................................................................................99Xanthine oxidase inhibitor and related compounds .......................................................................................99Anti-human immunodeficiency virus (HIV) agents .........................................................................................100Acidic and Basic drugs .........................................................................................................................101Chlorhexidine ......................................................................................................................................101Purine catabolites .................................................................................................................................102Catecholamines ...................................................................................................................................102Hippuric and methylhippuric acids....................................................................................................101,102





10. Antibiotics

Antibacterial agents .............................................................................................................................104Sulfonamides ........................................................................................................................103,104,105Antibiotics ..........................................................................................................................................105Nalidixic acid antibiotics ...............................................................................................................105,106Cephalosporin antibiotics..........................................................................................106,107,108,109,110Cefoxitin sodium...........................................................................................................................111,112Penicillin antibiotics ..............................................................................................................................111Amoxicillin..........................................................................................................................................111Cephalosporin C.................................................................................................................................112Ceftriaxone ........................................................................................................................................112Erythromycin antibiotic drugs..................................................................................................................113Tetracycline antibiotics ..........................................................................................................................113Vancomycin ........................................................................................................................................113

11. Pesticides, Environmental

Copper 8-quinolinolate .........................................................................................................................114Herbicides .........................................................................................................................................114Atrazine derivatives..............................................................................................................................114Triazine herbicides ........................................................................................................................114,115Urea herbicides...................................................................................................................................115Acid amide herbicides .........................................................................................................................115Carbamate herbicides ..........................................................................................................................115Carbamate insecticides ........................................................................................................................116Fungicides..........................................................................................................................................116Imazalil..............................................................................................................................................1162,4-Dinitrophenylhydrazones of aldehydes and ketones ..............................................................................117Polyaromatic hydrocarbons.............................................................................................................117,118





12. Miscellaneous

Benzoic acid derivatives .................................................................................................................119,120Methoxybenzoic acid isomers .................................................................................................................119Chlorobenzoic acid isomers ............................................................................................................119,122Hydroxybenzoic acids ...........................................................................................................................120Resorcylic acid isomers ..........................................................................................................................120Phenol derivatives .................................................................................................................................121Cresol isomers ..............................................................................................................................121,124Polyphenols .........................................................................................................................................122Dimethylphenol isomers..........................................................................................................................122Aminoalcohols .....................................................................................................................................123Urea and related compounds .................................................................................................................123A nonionic detergent .............................................................................................................................123Polyethyleneglycols ...............................................................................................................................123Metal-PAN chelates...............................................................................................................................124Coordination compounds .......................................................................................................................124Hinokitiol.............................................................................................................................................124Phthalic acid isomers .............................................................................................................................125Chlorophenol isomers ............................................................................................................................125Chloracetophene isomers .......................................................................................................................125Fullerenes ............................................................................................................................................126Aromatic amines...................................................................................................................................126Terphenyl isomers..................................................................................................................................127




Vitamins1


Oil-soluble vitamins1. Menadione (Vitamin K3)2. Retinol (Vitamin A)3. Retinol acetate4. Menaquinone (Vitamin K2)5. δ −Tocopherol6. Ergocalciferol (Vitamin D2)7. Cholecalciferol (Vitamin D3)8. α−Tocopherol (Vitamin E)9. α−Tocopherol acetate10. Phylloquinone (Vitamin K1)

Column : YMC-Pack™ ODS-A™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AA12S051546WTEluent : acetonitrileFlow rate : 1.0 mL/minTemperature : 30˚CDetection : UV at 280 nm, 0.08 AUFSInjection : 15 µL (0.01~0.21 mg/mL)

Retinol

1. Retinol

Column : YMC-Pack™ Pro C18™ (5µm, 120Å)

150 x 4.6 mm I.D.Part number : AS12S051546WTEluent : methanol/water (92/8)Flow rate : 1.0 mL/minTemperature : 35 ˚CDetection : UV at 325 nm, 0.02 AUFSInjection : 20 µL (0.5 µg/mL)

Vitamin A fatty acid ester1. Retinol palmitate

(Vitamin A palmitate)

Column : YMC-Pack™ SIL (5µm, 120Å)150 x 4.6 mm I.D.

Part number : SL12S051546WTEluent : cyclohexane/dichloromethane/acetic acid (100/0.5/0.5)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 350 nm, 0.32 AUFSInjection : 5 µL (1.0 mg/mL)

Carotene

1. α - Carotene2. ß - Carotene

Column : YMC-Pack™ ODS-A™ (5µm, 120Å)150 x4.6 mm I.D.

Part number : AA12S051546WTEluent : acetonitrile/methanol/THF (50/45/5)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : VIS at 450 nm, 0.16 AUFSInjection : 5 µL (0.05 mg/mL)

(G910523T)(G910415B)

(A970708A) (G910523Q)

Vitamins1


ß-Carotene

1. ß - Carotene

Column: : YMC-Pack™ CN (5 µm, 120Å)250 x 4.6 mm I.D.

Part number : CN12S052546WTEluent: : acetonitrile/water/THF (35/35/30)Flow rate: : 1.0 mL/minTemperature : 30 ˚CDetection : VIS at 450nm, 0.32 AUFSInjection : 7 µL (0.125 mg/mL)

ß-Carotene

1. ß - Carotene

Column : YMC-Pack™ ODS-AL™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AL12S051546WTEluent : methanol/chloroform (96/4)Flow rate : 1.5 mL/minTemperature : 35 ˚CDetection : VIS at 455 nm, 0.04 AUFSInjection : 20 µL (4.0 µg/mL)

Vitamin D

1. Ergocalciferol (Vitamin D2)


Part number : SL12S052546WTEluent : hexane/2-propanol (99.6/0.4)Flow rate : 1.6 mL/minTemperature : ambient (28 ˚C)Detection : UV at 265 nm, 0.01 AUFSInjection : 100 µL (1.0 µg/mL)

Vitamin D

1. Cholecalciferol (Vitamin D3)

Column : YMC-Pack™ SIL (5µm, 120Å)250 x4.6 mm I.D.

Part number : SL12S052546WTEluent : hexane/2-propanol (99.6/0.4)Flow rate : 1.6 mL/minTemperature : ambient (28 ˚C)Detection : UV at 265 nm, 0.01 AUFSInjection : 100 µL (1.0 µg/mL)

(M910529A)

(C970808E) (C970808H)

(A970716K)

Vitamins1


Tocopherols

1. α --Tocopherol2. β -- Tocopherol3. γ −Tocopherol4. δ −Tocopherol

Column : YMC-Pack™ SIL (5µm, 120Å)150x 4.6 mm I.D.

Part number : SL12S051546WTEluent : hexane/THF/acetic acid (97/3/0.25)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.08 AUFSInjection : 10 µL (0.20 ~0.31 mg/mL)

Tocopherols

1. α -Tocopherol2. β -Tocopherol3. γ -Tocopherol4. δ -Tocopherol

Column : YMC-Pack™ Polyamine II™

250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : n-hexane/tetrahydrofuran/acetic acid/water (93/7/0.4/0.01)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.08 AUFSInjection : 7 µL (0.25 mg/mL)

Tocopherols

1. α -Tocopherol

2. β -Tocopherol

3. γ -Tocopherol

4. δ -Tocopherol


Part number : SL12S052546WTEluent : hexane/2-propanol/acetic acid (1000/6/5)Flow rate : 1.4 mL/minTemperature : 35 ˚CDetection : FLS at Ex 298 nm, Em 325 nmInjection : 20 µL (5~20µg/mL)

Tocopherols

1. α−Tocopherol

2. β−Tocopherol

3. γ−Tocopherol

4. δ− TocopherolText

Column: : YMC-Pack™ Polyamine II™

250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : hexane/ethyl acetate (70/30)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.08 AUFSInjection : 7 µL (0.25 mg/mL)

(S970702A)

(T920728E)(T910501A)

(G910523S)

Vitamins1


Tocopherols

1. α−Tocopherol

2. β−Tocopherol

3. γ−Tocopherol

4. δ−Tocopherol

Column : J’Sphere™ ODS-M80 (4µm, 80Å)250 x 4.6mm I.D.

Part number : JM08S042546WTEluent : 2-propanol/water (68/32)Flow rate : 0.5 mL/minTemperature : 30˚CDetection : UV at 295nm, 0.032 AUFSInjection : 7 µL (0.25mg/mL)

Tocopherols

1. α−Tocopherol

2. β−Tocopherol

3. γ−Tocopherol

4. δ−Tocopherol


Part number : AA12S05246WTEluent : 2-propanol/water (75/25)Flow rate : 0.3 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.08 AUFSInjection : 7 µL (0.25 mg/mL)Ref.) Y.Satomura, M. Kimura and Y. Itokawa, J.Chromatogr., 625, 372-376 (1992)

Tocopherols

1. α-Tocopherol

2. β-Tocopherol

3. γ-Tocopherol

4. δ-Tocopherol


Part number : AA12S051546WTEluent : 2-propanol/water (65/35)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.04 AUFSInjection : 7 µL (0.25 mg/mL)Ref.) Y.Satomura, M. Kimura and Y. Itokawa, J.Chromatogr., 625, 372-376 (1992)

Tocopherol and Tocopherol acetate

1. α−Tocopherol

2. α−Tocopherol acetate


Part number : AA12S051546WTEluent : 2-propanol/water (65/35)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 295 nm, 0.04 AUFSInjection : 7 µL (0.25 mg/mL)Ref.) Y.Satomura, M. Kimura and Y. Itokawa, J.Chromatogr., 625, 372-376 (1992

(S930726A)

(S921216C) (S970426E)

(S921217A)

Vitamins1


Tocopherol and Tocopherol acetate

1. α−Tocopherol

2. α−Tocopherol acetate


Part number : AA12S051546WTEluent : methanol/water (98/2)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 284 nm, 0.51 AUFSInjection : 20 µL (1 mg/mL)

(S970426C)

Vitamin K

1. Menaquinone (Vitamin K2)

2. Phylloquinone (Vitamin K1)

Column : YMC-Pack™ Pro C18™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AS12S051546WTEluent : methanol/ethanol (5/1)Flow rate : 0.8 mL/minTemperature : 40 ˚CDetection : FLS at Ex 320 nm, Em 430 nm

reduction column (platinum black, 10 x 4.0 mmI.D.)Injection : 20 µL (100 ng/mL)

(A970728B)

Water-soluble vitamins

1. L-Ascorbic acid (Vitamin C)

2. Nicotinic acid

3. Pyridoxine HCl (Vitamin B6)

4. Nicotinamide

5. Thiamine HCl (Vitamin B1)

6. Folic acid

7. Cyanocobalamin (Vitamin B12)

8. Riboflavin (Vitamin B2)


Part number : AA12S051546WTEluent : A)20mM KH2PO4 - K2HPO4 (pH 6.6)

B)20mM KH2PO4 - K2HPO4 (pH 6.6)/acetonitrile (80/20)0%B (0-5min), 0-100%B (5-20min, linear), 100%B (20-25min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 10 µL (0.04~0.31 mg/mL)

(G910415A)


1. Nicotinic acid2. Pantothenic acid (Na salt)3. Pyridoxine HCl (Vitamin B6)4. Nicotinamide5. Thiamine HCl (Vitamin B1)

Column : YMC-Pack™ ODS-AM™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AM12S051546WTEluent : 20mM NaH2PO4 - Na2HPO4 (pH 6.5)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.08 AUFSInjection : 5 µL (0.02~.58 mg/mL)

(G910523O)

Vitamins1



1. L-Ascorbic acid (Vitamin C)2. Pyridoxine HCl (Vitamin B6) 3. Nicotinamide4. Panthenol5. Caffeine6. Flavin mononucleotide sodium salt (Vitamin B2)

Column : Hydrosphere™ C18 (5µm, 120Å)150 x 4.6 mm I.D.

Part number : HS12S051546WTEluent : A)50mM KH2PO4-H3PO4(pH3.5)

B)50mM KH2PO4-H3PO4(pH3.5)/acetonitrile (80/20)0-60%B(0-20min), 60%B(20-30min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.32AUFSInjection : 5 µL (0.05 ~ 0.40 mg/mL

(F001004B)

A drink including vitamins

1. L-Ascorbic acid (Vitamin C)2. Pyridoxine HCl (Vitamin B6) 3. Nicotinamide4. Panthenol5. Caffeine6. Flavin mononucleotide sodium salt

(Vitamin B2)




Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.32AUFSInjection : 5 µL Sample : 5 times dilution with 5% metaphosphoric acid

(F001004A)


1. Thiamine HCl (Vitamin B1)2. Pyridoxine HCl (Vitamin B6) 3. Nicotinamide4. Caffeine5. Flavin mononucleotide sodium salt

(Vitamin B2)

(F001011A)

Column : Hydrosphere™ C18 (5µm, 120Å)150 x4.6 mm I.D.



Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32AUFSInjection : 15 µL Sample : 5 times dilution with water

A drink including vitamins1. Thiamine HCl (Vitamin B1)2. Pyridoxine HCl (Vitamin B6) 3. Nicotinamide4. Caffeine5. Flavin mononucleotide sodium salt

(Vitamin B2)




Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32AUFSInjection : 15 µL Sample : 5 times dilution with water

(F001011B)

Vitamins1



1. p-Aminobenzoic acid (PABA)2. Biotin (Vitamin H)3. Riboflavin (Vitamin B2)4. Cyanocobalamin (Vitamin B12)

Column : YMC-Pack™ Phenyl (5µm, 120Å)150 x 4.6 mm I.D.

Part number : PH12S051546WTEluent : acetonitrile/50mM NH4H2PO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 10 µL (0.02 ~ 0.30 mg/mL)

(M920212B)


1. p-Aminobenzoic acid (PABA)2. Biotin (Vitamin H)3. Cyanocobalamin (Vitamin B12)

4. Riboflavin (Vitamin B2)


Part number : AM12S051546WTEluent : acetonitrile/50mM NH4H2PO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 10 µL (0.02 ~ 0.30 mg/mL)

(M920212A)


1. p-Aminobenzoic acid (PABA)2. Biotin (Vitamin H)3. Riboflavin (Vitamin B2)4. Cyanocobalamin (Vitamin B12

Column : YMC-Pack™ TMS™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : TM12S051546WTEluent : acetonitrile/50mM NH4H2PO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 10 µL (0.02 ~ 0.30 mg/mL)

(M920212C)


1. p-Aminobenzoic acid (PABA)2. Biotin (Vitamin H)3. Cyanocobalamin (Vitamin B12)4. Riboflavin (Vitamin B2)

Column : YMC-Pack™ C4 (5µm, 120Å)150 x 4.6 mm I.D.

Part number : BU12S051546WTEluent : acetonitrile/50mM NH4H2PO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 10 µL (0.02 ~ 0.30 mg/mL)

(M920212D)

Vitamins1



1. L-Ascorbic acid (Vitamin C)2. Orotic acid (Vitamin B13)3. Pyrroloquinoline quinone(PQQ)4. Pyridoxine HCl (Vitamin B6)5. Nicotinamide


Part number : AM12S051546WTEluent : 100mM CH3COOH/100mM CH3COONH4 (30/70, pH 5.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.04 ~ 0.20 mg/mL)

(M920207B)


1. L-Ascorbic acid (Vitamin C)2. Orotic acid (Vitamin B13)3. Pyrroloquinoline quinone (PQQ)4. Pyridoxine HCl (Vitamin B6)5. Nicotinamide

Column : YMC-Pack™ TMS (5µm, 120Å)150 x 4.6 mm I.D.

Part number : TM12S051546WTEluent : 100mM CH3COOH/100mM CH3COONH4 (30/70, pH 5.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.04 ~ 0.20 mg/mL)

(M920207A)


1. Nicotinic acid2. Erythorbic acid3. L-Ascorbic acid


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/50mM NH4H2PO4 (70/30)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 250 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.1 mg/mL)

(T920525A)


1. Nicotinic acid2. Erythorbic acid3. L-Ascorbic acid

Column : YMC-Pack™ NH2 (5µm,120Å)250 x 4.6 mm I.D.

Part number : NH12S052546WTEluent : acetonitrile/50mM NH4H2PO4 (70/30)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 250 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.1 mg/mL)

(T920525B)

Vitamins1



1. Pyridoxine HCl (vitamin B6)2. Nicotinamide3. Benfotiamine4. Cyanocobalamin5. Riboflavin

Column : J’Sphere™ ODS-H80 (4µm, 80Å)150 x 4.6 mm I.D.

Part number : JH08S041546WTEluent : acetonitrile/50mM (NH4)2HPO4 (10/90)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.13 AUFSInjection : 5 µL (0.04 ~ 0.48 mg/mL)

(S930712E)


1. Xanthine(I.S.)

2. Pyridoxal HCl

3. Pyridoxine HCl

4. Nicotinamide

Column : YMC-Pack™ Pro C18™ (5µm,120Å)150 x 4.6 mm I.D.

Part number : AS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.13 AUFSInjection : 5 µL (0.05 ~ 0.2 mg/mL)

(S960912B)

1.

2.

3.

4.

5.

Pyridoxal HCl

Pyridoxine HCl

Nicotinamide

NCH3

CH2OHCH2OH

HO

NCH3

CH2OHCHO

HO

N

CONH2

ÅE HCl

ÅE HCl

N

COOH

Nicotinic acid

COOHH2N

2 4 60 min

1

2

3

4 5

-Aminobenzoic acidp



Part number : HS12S030502WTEluent : 10mM CH3COONH4Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.128 AUFSInjection : 2 µL (0.01 ~ 0.1 mg/mL)

(S010125A)

1.

2.

3.

4.

1

2

3 4

Allantoin

Pyridoxine HCl

Nicotinamide

NCH3

CH2OHCH2OH

HO

N

CONH2

ÅE HCl

N

N O

O

H

H

H2NCONH

N

N

N

O

O

NH

CH2CH CH CH CH2OH

OH OH OH

H3C

H3C

Riboflavin

0 5 10 15 20 min

Allantoin and water-soluble vitamins

Column : YMC-Pack™ NH2 (5µm, 120Å)250 x 4.6 mm I.D.

Part number : NH12S052546WTEluent : 50mM NH4H2PO4 - H3PO4 (pH 2.5) / acetonitrile (20/80) Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 8 µL (0.01 - 0.04 mg/mL)

(S971121D)

Vitamins1


Thiamine and its modified compounds

Thiamine HCl

Benfotiamine

Dicethiamine HCl

Bisbentiamine


Part number : JH08S04L546WTEluent : A)50mM (NH4)2HPO4

B)methanol/50mM (NH4)2HPO4 (60/40)10-100%B (0-15min, linear), 100%B (15-30min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.26 AUFSInjection : 10 µL (0.1~ 0.2 mg/mL)

(S940202D)

1.

2.

3.

4.

12 3

N

N

N

O

O

NH

CH2CH CH CH CH2OH

OH OH OH

H3C

H3C

Riboflavin

N

N

N

O

O

NH

CH2CH CH CH CH2O

OH OH OH

H3C

H3C

N

N

N

O

O

NH

CH2CH CH CH CH2O

OH OH OH

H3C

H3C

ONa

OH

P

O

O

P ONaO

O CH2O

OH

N

N N

N

NH2

OHP

O

ONa

Flavin sodium phosphate(Flavin mononucleotide sodium salt)

Flavin adenine dinucleotide disodium

1

2

3

10 200 min

Riboflavin and related compounds


Part number : HS12S051546WTEluent : 50mM KH2PO4 - K2HPO4 (pH 5.9) / acetonitrile (90/10)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 10 µL (0.1 mg/mL)

(S000803B)

Nicotinic acid and derivatives

1. Nicotinamide adenine dinucleotide phosphate oxidized form (NADP)

2. Nicotinic acid3. Nicotinamide adenine

dinucleotide phosphatereduced form (NADPH)

4. Nicotinamide5. β - Nicotinamide adenine

dinucleotide (NAD) 6. β - Nicotinamide adenine

dinucleotide reduced form (NADH)

Column : Hydrosphere™ C18 (5µm,120Å)150 x 4.6 mm I.D.

Part number : HS12S051546WTEluent : 20mM KH2PO4-K2HPO4(pH6.9)/acetonitrile (99/1) Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 6 µL (0.05 ~ 0.10 mg/mL)

(F000707B)

Pantothenyl alcohol

1. Pantothenyl alcohol

2. Resorcinol(I.S.)


Part number : AS12S051546WTEluent : acetonitrile/water (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.13 AUFSInjection : 5 µL (0.05 ~ 0.4 mg/mL)

(S961119B)

Vitamins1


Coenzyme A and derivatives1. Malonyl-CoA

2. Coenzyme A glutathione disulfide

3. Coenzyme A

4. Methylmalonyl-CoA

5. Su ccinyl-CoA

6. 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA)

7. Acetoacetyl-CoA

8. Acetyl-CoA

9. Coenzyme A oxidized

10. Propionyl-CoA

Column : J’Sphere™ ODS-M80 (4µm, 80Å)150 x 4.6 mm I.D.

Part number : JM08S041546WTEluent : A)methanol/50mM KH2PO4 (10/90)

B)methanol/50mM KH2PO4 (30/70)10%B (0-5min), 10-100%B (5-30min)

Flow rate : 0.7 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.016 AUFSInjection : 10 µL (16.7 nmol/mL)

Courtesy of Dr. Takamura, Ibaraki University (S940630E)

L-Ascorbic acid and erythorbic acid

1. Erythorbic acid2. L-Ascorbic acid (Vitamin C)


250 x 4.6 mm I.D.Part number : PB12S052546WTEleunt : acetonitrile/50mM NH4H2PO4 (70/30)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 250 nm, 0.16 AUFSInjection : 10 µL (0.1 mg/mL)

(T910425A)

L-Ascorbic acid and erythorbic acid

1. L-Ascorbic acid (Vitamin C)2. Erythorbic acid

Column : YMC-Pack™ ODS-AM™ (5µm,120Å)150 x 4.6 mm I.D.

Part number : AM12S051546WTEluent : 20mM CH3COONH4 in 5mM tetrabutylammonium bromideFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 250 nm, 0.08 AUFSInjection : 5 µL (0.05 mg/mL)

(G910523N)

2,4-Dinitrophenylhydrazone of L-ascorbic acid

1. L-Ascorbic acid 2,4-DNPH

Column : YMC-Pack™ SIL (5µm,120Å)150 x 6.0 mm I.D.

Part number : SL12S051506WTEluent : hexane/ethyl acetate/2-propanol/acetic acid (40/30/2/1)Flow rate : 1.5 mL/minTemperature : 35 ˚CDetection : VIS at 540 nm, 0.01 AUFSInjection : 20 µL (10 ~ g/mL)

(C970808K)

Carbohydrates 2


Monosaccharides and disaccharides

1. Fructose2. Glucose3. Sucrose4. Maltose5. Lactose


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (75/25)Flow rate : 1.0 mL/minTemperature : 26 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 5 µL (14.3 ~ 28.6 mg/mL)

(T910726A)




250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : ethanol/ethyl acetate/acetonitrile/water (30/40/5/25)Flow rate : 1.0 mL/minTemperature : 26˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 5 µL (14.3 ~ 28.6 mg/mL)

(T910723A)




250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : ethanol/ethyl acetate/acetonitrile/water (30/40/5/25)Flow rate : 1.0 mL/minTemperature : 35 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 5 µL (14.3 ~ 28.6 mg/mL)

(T910718E)

Monosaccharides

1. Rhamnose2. Fucose3. Xylose4. Fructose5. Mannose6. Glucose7. Galactose


250 x 4.6 mm I.D. x 2Part number : PB12S052546WTEluent : ethanol/ethyl acetate/acetonitrile/water (30/30/23/17)Flow rate : 1.0 mL/minTemperature : 26 ˚CDetection : RI, 16 x 10-6 RIU/FSInjection : 25 µL (0.65 ~ 115.6 mg/mL)

(T910718D)

Carbohydrates 2


Unsaturated chondro-disaccharides

1. ∆ Di-0S2. ∆ Di-6S3. ∆ Di-4S4. ∆ Di-diSD5. ∆ Di-diSE6. ∆ Di-triS


Part number : NH12S052546WTEluent : A) 0.01M NH4H2PO4 - (NH4)2HPO4(pH 6.7)

B) 0.5M NH4H2PO4 - (NH4)2HPO4(pH 6.7)0%B (0-5min), 0-100%B (5-30min,linear), 100%B (30-40min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 232 nm, 0.32 AUFSInjection : 9 µL (0.12 ~ 0.24 mg/mL)

(T910920A)

Sugar alcohols

1. Glycerol2. Erythritol3. Xylitol4. Ribitol5. Arabitol6. Sorbitol7. Mannitol8. Maltitol9. Inositol


250 4.6 mm I.D.Part number : PB12S052546WTEluent : ethanol/ethyl acetate/acetonitrile/water (30/30/25/15)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 15 µL (1.7 ~ 3.3 mg/mL)

(T910718B)

Oligosaccharides

1.2.


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (26˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 20 µL (4.0 mg/mL)

(A970625G)

Oligosaccharides

1.2.


Part number : NH12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (27 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 20 µL (4.0 mg/mL)

(A970701G)

Carbohydrates 2


1

2

3

4

10 20 300 min

Fructooligosaccharides

1. Fruƒβ 2→1 α Glc(Sucrose)

2. Frufƒβ 2→ 1Fruƒβ2 → 1 α Glc(1-Kestose)

3. Frufƒβ 2→[1Fruf β2]2 → 1 α Glc(Nystose)

4. Frufƒβ 2→[1Fruf β2]3→1 α Glc(1-Fructofuranosyl-D-nystose)


Part number : HS12S051546WTEluent : waterFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : RI, 64 x 10-6 RIU/FSInjection : 5 µL (10 mg/mL)

(F000725B)

Oligosaccharides

1.2.


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (26 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 20 µL (4.0 mg/mL)

(A970627F)

Oligosaccharides of soft drink

1.2.


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (27 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 10 µLSample : 10 times dilution with water

Oligosaccharides

(Lactosyl fructoside)


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (26 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 20 µL (4.0 mg/mL)

(A970630C) (A970628H)

1.

Carbohydrates 2


Oligosaccharides

(Lactosyl fructoside)


Part number : NH12S052546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : ambient (27 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 20 µL (4.0 mg/mL)

Maltooligosaccharides

1. Maltoundecaose (G11)2. Maltododecaose (G12)3. Maltotridecaose (G13)4. Maltotetradecaose (G14)5. Maltopentadecaose (G15)


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : acetonitrile/water (55/45)Flow rate : 1.0 mL/minTemperature : 26 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 200 µl (0.71 ~ 0.95 mg/mL)Sample : Manufactured by Nakano Vinegar Co., Ltd.,

Nakano Central Research Institute

(A970703A)

(T910718A)

1.


1. Glucose (G1)2. Maltose (G2)3. Maltotriose (G3)4. Maltotetraose (G4)5. Maltopentaose (G5)6. Maltohexaose (G6)7. Maltoheptaose (G7)

Column : Hydrosphere™ C18 (5µm,120Å)250x 4.6 mm I.D.

Part number : HS12S052546WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (26˚C)Detection : RI, 64 x 10-6 RIU/FSInjection : 10 µL (5.0 mg/mL)


1. Glucose(G1)2. Maltose(G2)3. Maltotriose (G3)4. Maltotetraose (G4)5. Maltopentaose (G5)6. Maltohexaose (G6)7. Maltoheptaose (G7)

Column : YMC-Pack™ ODS-AQ™ (5µm,120Å)250 x 10.0 mm I.D.

Part number : AQ12S052510WTEluent : waterFlow rate : 3.0 mL/minTemperature : ambient (25 ˚C)Detection : RI

(F000612D)Courtesy of Dr.Kimura and Dr.Chiba, Hokkaido University, Japan (Y910501A)

Carbohydrates 2




Column: : YMC-Pack™ ODS-A™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AA12S051546WTEluent : waterFlow rate : 1.0 mL/minTemperature : 20 ˚CDetection : RI, 8 x 10-6 RIU/FSInjection : 25 µL (1 mg/mL)Sample : Manufactured by Nakano Vinegar Co., Ltd.,


(M910604L)


1. Maltoundecaose (G11)

2. Maltododecaose (G12)3. Maltotridecaose (G13)4. Maltotetradecaose (G14)

5. Maltopentadecaose (G15)

Column : YMC-Pack™ ODS-A™ 5µm (300Å)250 x 4.6 mm I.D.

Part number : AA30S052546WTEluent : waterFlow rate : 1.0 mL/minTemperature : 20 ˚CDetection : RI, 8 x 10-6 RIU/FSInjection : 25 µl (1mg/mL)Sample : Manufactured by Nakano Vinegar Co., Ltd.,


(M910604K)



Column: : YMC-Pack™ ODS-AQ™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AQ12S051546WTEluent : methanol/water (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : RI, 8 x 10-6 RIU/FSInjection : 25 µL (1 mg/mL)Sample : Manufactured by Nakano Vinegar Co., Ltd.,


Maltooligosaccharides1. Maltoundecaose (G11)2. Maltododecaose (G12)3. Maltotridecaose (G13)4. Maltotetradecaose (G14)5. Maltopentadecaose (G15)

Column : YMC-Pack™ ODS-A™ (5µm,120Å)150 x 4.6 mm I.D.

Part number : AA12S05I546WTEluent : methanol/water (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : RI, 8 x 10-6 RIU/FSInjection : 25 µL (1 mg/mL)Sample : Manufactured by Nakano Vinegar Co., Ltd.,


(M910604M) (M910604N)

Carbohydrates 2



1. Maltopentadecaose (G15)2. Maltotridecaose (G13)3. Maltoundecaose (G11)4. Maltoheptaose (G7 )5. Maltopentaose (G5 )6. Maltotriose (G3 )7. Glucose (G1 )

Column : YMC-Pack™ Diol-60500 x 8.0 mm I.D.

Part number : DL06S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : RI, 64 x 10-6 RIU/FSInjection : 60 µL (0.60 ~ 0.75 mg/mL)

(G911216E)

Maltooligosaccharides1. Maltopentadecaose (G15)2. Maltotridecaose (G13)3. Maltoundecaose (G11)4. Maltoheptaose (G7 )5. Maltopentaose (G5 )6. Maltotriose (G3 )7. Glucose (G1 )

Column : YMC™-Pack Diol-120500 x 8.0 mm I.D.

Part number : DL12S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : RI, 64 x 10-6 RIU/FSInjection : 60 µL (0.60 ~ 0.75 mg/mL)

(G911216F)

Cyclodextrins

1. γ-Cyclodextrin2. α-Cyclodextrin3. β-Cyclodextrin

Column : YMC™-Pack ODS-AQ™ (5µm,120Å)150 x 4.6 mm I.D.

Part number : AQ12S051546WTEluent : methanol/water (7/93)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 8 µL (5~15 mg/mL)

(M910417B)

Cyclodextrins

1. γ-Cyclodextrin2. α-Cyclodextrin3. β-Cyclodextrin

Column : YMC™-Pack ODS-A™ (5µm,120Å)150 x 4.6 mm I.D.

Part number : AA12S051546WTEluent : methanol/water (7/93)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 8 µL (5~ 15 mg/mL)

(M910417A)

Carbohydrates 2


Cyclodextrins

1. γ-Cyclodextrin2. β-Cyclodextrin3. α-Cyclodextrin

Column : YMC-Pack™ Diol-60500x 8.0 mm I.D.

Part number : DL06S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : RI, 32 x 10-6 RIU/FSInjection : 30 µL (1.67 mg/mL)

(G911216I)

Cyclodextrins

1. γ-Cyclodextrin2. α-Cyclodextrin3. β-Cyclodextrin4. O-Dimethyl- β-cyclodextrin5. O-Trimethyl-β-cyclodextrin


Part number : AA12S051546WT Eluent : A) water

B) methanol2%B (0-5min), 2-30%B (5-15min, linear),30-100%B (15-20min, linear), 100%B (20-30min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection :Evaporative Mass Analyzer (ACS Ltd.)

Temp 150Time Constant 5PMT 3Attenuation 16Pressure 20 psi

Injection : 200 µL (1.5~15 mg/mL)

(M910423A)

Cyclodextrins

1. O-Dimethyl- β-cyclodextrin2. O-Trimethyl-β-cyclodextrin


Part number : AA12S051546WTEluent : methanol/water (80/20)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : RI, 32 x 10-6 RIU/FSInjection : 5 µL (15~20 mg/mL)

(M910417C)

Pyridylamino(PA)-Sugar chains1. PA-Sugar Chain 014

2. PA-Sugar Chain 001


Column : YMC-Pack™ ODS-AQ™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AQ12S051546WTEluent : methanol/20mM NH4H2PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : FLS at Ex.320 nm, Em. 400 nm, 8 mV/FSInjection : 2 µL (3.3 pmol/mL)Sample : PA-Sugar Chain Series, manufactured by TAKARA SHUZO CO., LTD.

(G910607C)

Carbohydrates 2






Part number : AA30S051546WTEluent : methanol/20mM NH4H2PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : FLS at Ex.320 nm, Em. 400 nm, 16 mV/FSInjection : 2 µL (3.3 pmol/mL)Sample : PA-Sugar Chain Series, manufactured by TAKARA SHUZO CO., LTD.

(G910607B)





Part number : AA12S051546WTEluent : methanol/20mM NH4H2PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : FLS at Ex.320 nm, Em. 400 nm, 16 mV/FSInjection : 2 µL (3.3 pmol/mL)Sample : PA-Sugar Chain Series, manufactured by TAKARA SHUZO CO., LTD.

(G910607A)

Pyridylamino(PA)-Sugar chains





150 x 4.6 mm I.D. Part number : PB12S051546WTEluent : acetonitrile/20mM NH4H2PO4 (60/40)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : FLS at Ex. 320 nm, Em. 400 nm, 8 mV/FSInjection : 5 µL (3.3 pmol/mL)Sample : PA-Sugar Chain Series, manufactured by TAKARA SHUZO CO., LTD.

(G910620B)

Pyridylamino(PA)-Sugar chains





150 x 4.6 mm I.D. Part number : PB12S051546WTEluent : methanol/20mM NH4H2PO4 (80/20)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : FLS at Ex.320 nm, Em. 400 nm, 4 mV/FSInjection : 3 µL (3.3 pmol/mL)Sample : PA-Sugar Chain Series, manufactured by TAKARA SHUZO CO., LTD.

(G910620A)

Carbohydrates 2


Polydextrose

1. Polydextrose


Part number : DL06S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : RI, 64 x 10-6 RIU/FSInjection : 40 µL (25 mg/mL)

(G911226A)

Pullulans

1. Pullulan P-800 (MW 853,000)2. Pullulan P-50 (MW 48,000)3. Pullulan P-20 (MW 23,700)4. Pullulan P-5 (MW 10,700)


Part number : DL06S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : RI, 16 x 10-6 RIU/FSInjection : 180 µL (0.25 mg/mL)Sample : Shodex STANDARD P-82, manufactured by SHOWA DENKO K.K.

(G911216A)

Pullulans




(G911216B)

Pullulans1. Pullulan P-800 (MW 853,000)2. Pullulan P-50 (MW 48,000)3. Pullulan P-20 (MW 23,700)4. Pullulan P-5 (MW 10,700)


Part number : DL20S055008WTEluent : waterFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : RI, 16 x 10-6 RIU/FSInjection : 180 µl (0.25 mg/mL)Sample : Shodex STANDARD P-82, manufactured by SHOWA DENKO K.K.

(G911216C)

Carbohydrates 2


Pullulans




(G911216D)

Chondroitin

1. Chondroitin, Na salt



(G920107A)

Chondroitin sulfate A

1. Chondroitin sulfate A, Na salt



(G920107C)

Chondroitin sulfate B

1. Chondroitin sulfate B, Na salt



(G920107E)

Carbohydrates 2


Chondroitin sulfate C

1. Chondroitin sulfate C, Na salt



(G920107D)

Hyaluronic acid

1. Hyaluronic acid, Na salt



(G920107B)

Heparin

1. Heparin, Na salt



(G920107I)

Heparan sulfate

1. Heparan sulfate, Na salt



(G920107F)

Nucleic Acids3


Keratan sulfate

1. Keratan sulfate, Na salt



(G920107G)

Keratan polysulfate

1. Keratan polysulfate, Na salt



(G920107H)

Nucleosides and bases

1. Cytocine2. Cytidine3. Uracil4. Deoxycytidine5. Guanine6. Adenine7. Hypoxanthine8. Uridine9. Xanthine10. Thymine11. Nosine12. Guanosine13. Deoxyinosine14. Deoxyguanosine15. Xanthosine16. Thymidine17. Adenosine18. Deoxyadenosine


Part number : AA12S052546WTEluent : A)20mM CH3COOH - CH3COONH4 (pH 3.5)

B)20mM CH3COOH - CH3COONH4 (pH 3.5)/methanol (90/10)30%B (0-5min), 30-100%B (5-13min,linear), 100%B (13-40min)


(T910404C) (S921217A)

Nucleosides and bases

1. Cytocine2. Cytidine3. Uracil4. Deoxycytidine5. Guanine6. Adenine7. Hypoxanthine8. Uridine9. Xanthine10. Thymine11. Inosine12. Guanosine13. Deoxyinosine14. Deoxyguanosine15. Xanthosine16. Thymidine17. Adenosine18. Deoxyadenosine


Part number : AQ12S052546WTEluent : A)20mM CH3COOH - CH3COONH4 (pH 3.5)

B)20mM CH3COOH - CH3COONH4 (pH 3.5)/methanol (90/10)30%B (0-5min), 30-100%B (5-13min,linear), 100%B (13-40min)


Nucleic Acids3


1

2

3

4

67

5

5 100 min

N

N

O

O

H

H

N

N

OH

NH2

N

N

O

O

H

H

CH3

N

NN

NO

HH

H2N

N

N

O

O

H

H

F

N

N

OH

NH2F

1.

Cytosine

2.

5-Fluorocytosine

3.

Uracil

4.

5-Fluorouracil

5.

Guanine

6.

Thymine

7.

Adenine

NH2

N

N

N

N

H

Nucleic acid bases


Part number : HS12S031046WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.128 AUFSInjection : 10 µL (0.01 - 0.02 mg/mL)

(J010209E)

Nucleic acid bases


Part number : HS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.064 AUFSInjection : 8 µL (0.01 - 0.02 mg/mL)

(S991029A)

Orotic acid


Part number : HS12S051546WTEluent : 20mM H3PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.256 AUFSInjection : 10 µL (0.015 - 0.1 mg/mL)

(A000711A)

Nucleotides


Part number : HS12S051546WTEluent : 20mM NH4H2PO4 - H3PO4 (pH 3.5) / methanol (92/8)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.064 AUFSInjection : 15 µL (5 - 15 µg/mL)

(A000802B)

Nucleic Acids3


Nucleotides

1. 5'-CMP2. 5'-UMP3. 5'-dCMP4. 5'-CDP5. 5'-GMP6. 5'-UDP7. 5'-IMP8. 5'-CTP9. 5'-UTP10. 5'-GDP11. 5'-TMP12. 5'-AMP13. 5'-dGMP14. 5'-GTP15. 5'-TDP16. 5'-ADP17. 5'-TTP18. 5'-dAMP19. 5'-ATP

Column : YMC-Pack™ ODS-AM™ (5µm,120Å)250 x 4.6 mm I.D.

Part number : AM12S052546WTEluent : A) 0.2M TEAA* (pH6.6)

B) 0.2M TEAA (pH6.6)/acetonitrile (95/5)4%B (0-10min), 4-100%B (10-35min, linear), 100%B (35-50min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 14 µL (0.029 ~ 0.16 mg/mL)* TEAA:triethylamine-acetic acid

(T910424A)

1

2

3

4

6

7

5

5 10 15 200 min

8

911

10

Nucleotides

1. 5'-UTP2. 5'-UDP3. 5'-CMP4. 5'-UMP5. 5'-dCMP6. 5'-GMP7. 5'-ATP8. 5'-IMP9. 5'-ADP

10. 5'-TMP11. 5'-AMP


Part number : HS12S051546WTEluent : 100mM KH2PO4 - K2HPO4 (pH 5.5)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.256 AUFSInjection : 10 µL (0.05 - 0.15 mg/mL)

(A000922A)

Nucleotides

1. 5'-CMP2. 5'-UMP3. 5'-GMP4. 5'-IMP5. 5'-TMP6. 5'-AMP


Part number : HS12S051546WTEluent : 100mM KH2PO4Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.256 AUFSInjection : 10 µL (0.1 - 0.3 mg/mL)

(A000912B)

Nucleotides

1. 5'-CMP2. 5'-AMP3. 5'-UMP4. 5'-IMP5. 5'-GMP


250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : 50mM KH2PO4 - H3PO4 (pH 3.5)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.1 mg/mL)

(T920525C)

Nucleic Acids3


Nucleotides

1. 5'-CMP2. 5'-AMP3. 5'-UMP4. 5'-IMP5. 5'-GMP


Part number : NH12S052546WTEluent : 50mM KH2PO4 - H3PO4 (pH 3.5)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.1 mg/mL)

(T920525D)

Oligonucleotides

1. c-Ha-ras/12 (20mer)GTGGGCGCC-AGC-GGTGTGGG

Ser2. c-Ha-ras/12 (20mer)

GTGGGCGCC-GCC-GGTGTGGGAla3. c-Ha-ras/12 (20mer)

GTGGGCGCC-GAC-GGTGTGGGAsp4. c-Ha-ras/12 (20mer)

GTGGGCGCC-GTC-GGTGTGGGVal5. c-Ha-ras/12 (20mer)

GTGGGCGCC-CGC-GGTGTGGGArg


Part number : AA30S051546WTEluent : A)100mM triethylamine - acetic acid (pH 6.5)/acetonitrile (94/6)

B)100mM triethylamine - acetic acid (pH 6.5)/acetonitrile (85/15)0-100%B (0-25min,linear)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm,0.01 AUFSInjection : 15 µL (2.0 pmol/µL )Sample : TAKARA ras Gene Probe set, manufacutured by TAKARA SHUZO CO., LTD.

(G910620C)

Poly(A)


Part number : AM12S051506WTEluent : A)0.1M phosophate buffer (pH 7)

B)0.1M phosophate buffer (pH 7) / acetonitrile (75/25)20-27%B (0-15min), 27-35%B (15-90min)

Flow rate : 1.0 mL/minTemperature : ambientDetection : UV at 260 nmInjection : 10 µL Sample : Poly(A)

Courtesy of Dr.Y.Baba, Kobe Women's College of Pharmacy (Y920608A)

Sugar nucleotides

1. CDP-D-glucose2. UDP-D-glucose3 UDP-N-acetyl-D-glucosamine4. GDP-D-mannose5. ADP-D-glucose


Part number : PH12S052546WTEluent : 100mM TEAA1) (pH 6.0)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.27 ~ 0.71 mg/mL)1) TEAA: triethylamine-acetic acid

(T911206D)

Nucleic Acids3


Sugar nucleotides



Part number : AA12S052546WTEluent : 20mM TEAA1) (pH 5.7)/acetonitrile (99/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.27~ 0.71 mg/mL)1) TEAA: triethylamine-acetic acid

(T911206B)

Sugar nucleotides


Column : YMC-Pack™ 0DS-A™ (5µm, 300Å)250 x 4.6 mm I.D.

Part number : AA30S052546WTEluent : 100mM TEAA1) (pH 6.0)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.27~0.71 mg/mL)1) TEAA: triethylamine-acetic acid

(T911206E)

Plasmid pBR322 restriction fragments

1. Plasmid pBR322 cleavedwith restriction endonucleaseMsp

Column : YMC-Pack™ Diol-300 + Diol-200500 x 8.0 mm I.D. x 2

Part number : DL30S055008WT , DL20S055008WT (x2)Eluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaClFlow rate : 0.7 mL/minTemperature : ambient (26 ˚C)Detection : UV at 260 nm, 0.01 AUFSInjection : 3 µL (0.49 mg/mL)Sample : Plasmid pBR322 cleaved with restriction endonuclease Msp I

(G920109B)

Amino Acids, Peptides, and Proteins4


Amino acids

1. L-Valine2. L-Tyrosine3. L-Phenylalanine4. L-Tryptophan


Part number : HS12S051546WTEluent : 20mM KH2PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 5 µL (0.05 - 1.6 mg/mL)

(A000419B)

Taurine in nutritious drink

1. Taurine


Part number : HS12S051546WTEluent : 10mM KH2PO4-K2HPO4(pH6.8)/acetonitrile (85/15)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : (A)FLS at Ex 345 nm, Em 450 nm

(B)UV at 254 nm, 0.32 AUFSInjection : 15 µLSample : OPA derivative

(F001115C)

PTC-amino acids

1. L-Aspartic acid2. L-Glutamic acid3. L-Serine

4. Glycine5. L-Histidine6. L-Arginine7. L-Threonine8. L-Alanine9. L-Proline10. NH311. L-Tyrosine12. L-Valine13. L-Methionine14. L-Cystine15. L-Isoleucine16. L-Leucine17. L-Phenylalanine18. L-Lysine


Part number : AM12S052546WTEluent : A) 60mM CH3COONa - CH3COOH (pH 6.6)/acetonitrile (94/6)

B) 60mM CH3COONa - CH3COOH (pH 6.6)/acetonitrile (40/60)0-55%B (0-20min, linear), 100%B (20-25min), 0%B (25-35min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 250 nm, 0.08 AUFSInjection : 5 µL (62.5 pmoL/µL )Sample : PTC derivatives

(G910523A)

PTH-amino acids

1. Asp2. His3. Arg4. Asn5. Glu6. Ser7. Gln8. Thr9. Gly10. Ala11. Tyr12. É¢-Thr13. Pro14. Met15. Val16. Trp17. Phe18. Lys19. Ile20. Leu


Part number : JH08S042502WTEluent : A)acetonitrile/THF/300mM TEAA* (pH 5.1) (10/4/90)

B)acetonitrile/THF/300mM TEAA (pH 5.1) (75/4/25)0-30%B (0-15min), 30-80%B (15-30min)

Flow rate : 0.2 mL/minTemperature : 50 ˚CDetection : UV at 270 nm, 0.08 AUFSInjection : 30 µL (25pmol/10µL)*TEAA: triethylamine-acetic acid

(K940331A)



NBD-amino acids 1. L-Aspartic acid2. L-Glutamic acid3. L-Asparagine 4. L-Serine5. L-Histidine 6. Glycine7. L-Arginine 8. L-Threonine9. Taurine

10. L-Alanine11. L-Proline12. L-Valine13. L-Cystine14. L-Methionine15. L-Isoleucine16. L-Leucine17. L-Phenylalanine18. L-Lysine 19. L-Tyrosine


Part number : HS12S5051546WTEluent : A)20mM KH2PO4-K2HPO4(pH6.5)

B)20mM KH2PO4-K2HPO4(pH6.5)/acetonitrile (50/50)15-25%B(0-25min), 25-40%B(25-30min),40-65%B(30-50min),65-100%B(50-55min), 100%B(55-60min)

Flow rate : 1.0 mL/min(0-25min), 1.5 mL/min(25-60min)Temperature : 30 ˚CDetection : FLS at Ex 470 nm, Em 530 nmInjection : 20 µLSample : NBD derivatives

(F001129E)

Peptides and proteins

1. Met-Enkephalin2. Leu-Enkephalin3. BSA4. α-Mating factor5. Insulin6. Ovalbumin

Column : YMC-Pack™ PolymerC18™ (6µm)150 x 4.6 mm I.D.

Part number : PC99S061546WTEluent : A)acetonitrile/water/TFA (20/80/0.05)

B)acetonitrile/water/TFA (45/55/0.05)0-100%B (0-30min,linear)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 30 µL

(S921217A)

Glutathione, oxidized and reduced form

1. Glutathione (GSH)2. Glutathione disulfide (GSSG)


Part number : AA12S051546WTEluent : 0.1M sodium perchlorate in A

A)acetonitrile/water/TFA (5/95/0.05)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm,0.64 AUFSInjection : 10 µL

Angiotensins

1. Angiotensin III2. Angiotensin II3. [Asn1,Val5] Angiotensin áT4. [Val5] Angiotensin I5. Angiotensin I


Part number : AM12S051546WTEluent : acetonitrile/20mM KH2PO4 (20/80)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm,0.08 AUFSInjection : 8 µL (0.05 ~ 0.15 mg/mL)

(H900710D)(G910520A)



Angiotensins

1. Angiotensin III2. Angiotensin II3. Angiotensin I

Column : YMC-Pack™ PolymerC18™ (6µm)250 x 4.6 mm I.D.

Part number : PC99S062546WTEluent : acetonitrile/water/TFA (18/82/0.05)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm,0.08 AUFSInjection : 10 µL

(H900723B)

Insulins

1. Insulin (Bovine)2. Insulin (Sheep)3. Insulin (Human)4. Insulin (Equine)5. Insulin (Porcine)


Part number : AM12S052546WTEluent : A)acetonitrile/water/TFA (30/70/0.1)

B)acetonitrile/water/TFA (32/68/0.1)0%B (0-3min), 0-100%B (3-25min,linear), 100%B (25-40min)

Flow rate : 0.6 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.16 AUFSInjection : 15 µL (0.2 mg/mL)

(G910522C)

Insulins





Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 220 nm,0.16 AUFSInjection : 15 µL (0.2 mg/mL)

(G910522B)

Insulins






(G910522A)



Insulins

1. Insulin (Bovine)2. Insulin (Sheep)3. Insulin (Human)4. Insulin (Porcine)


Part number : AM12S051506WTEluent : A)acetonitrile/0.01N HCl (28/72)

B)acetonitrile/0.01N HCl (35/65)0-100%B (0-60min,linear)


(G910522D)

Peptides

1. Bradykinin2. Dynorphin A (Human,1-13)3. Eledoisin related peptide4. Neurotensin5. Bombesin6. Substance P


Part number : AS12S03L546WTEluent : A) water / TFA (100/0.1)

B) acetonitrile / TFA (100/0.1)20-40%B (0-20min, linear)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 15 µL (0.05 - 0.15 mg/mL)

(A980827D)

Peptides

1. Oxytocin2. Met-Enkephalin3. Leu-Enkephalin4. Angiotensin I5. α−Mating factor6. Insulin


Part number : AS12S03L546WTEluent : A) water / TFA (100/0.1)

B) acetonitrile / TFA (100/0.1)20-40%B (0-20min, linear)


(A980827C)

1

23

4 6

7

5

0 5 10 15 20 min

Peptides

1. BAM-12P2. [D-Ala2,Met5]Enkephalinamide3. α-Endorphin4. Met-Enkephalin5. [D-Ala2,Met5]-Enkephalin6. γ-Endorphin7. β-Endorphin(Human)


Part number : HS12S051546WTEluent : A) water/TFA (100/0.1)

B) acetonitrile/TFA (100/0.1)20-40%B(0-15 min, linear),40%B(15-20 min)


(A000308B)



Peptides

1. Met-Enkephalin2. Bradykinin3. Angiotensin II4. Leu-Enkephalin5. CCK-Octapeptide6. Insulin Chain B


Part number : JH08S041546WTEluent : A)acetonitrile/water/TFA (5/95/0.1)

B)acetonitrile/water/TFA (40/60/0.1)20-100%B (0-40min, linear)


(S930909D)

Peptides

1. Bradykinin2. Met-Enkephalin3. Angiotensin III4. Leu-Enkephalin


Part number : JH08S041546WTEluent : acetonitrile/water/TFA (20/80/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 20 µL (34 ~ 65 µg/mL)

(O940804D)

Peptides



Part number : JH08S041502WTEluent : acetonitrile/water/TFA (20/80/0.1)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.08 AUFSInjection : 4 µL (34~65 µg/mL)

(O940804A)

Peptides



Part number : JH08S041501PFKEluent : acetonitrile/water/TFA (20/80/0.1)Flow rate : 0.1 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.08 AUFSInjection : 2 µL (34 ~ 65 µg/mL)

(O940804B)



Peptides



Part number : JH08S041501PFKEluent : acetonitrile/water/TFA (20/80/0.1)Flow rate : 0.05 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.08 AUFSInjection : 1 µL (34 ~ 65 É g/mL)

(O940804C)

Human immunoglobulins

1. Human IgM (κ),myeloma protein2. Normal human IgA3. Normal human IgG


Part number : DL30S055008WT, DL20S055008WT (x2)Eluent : 0.1M NaH2PO4 - Na2HPO4 (pH 6.8) containing 0.1M Na2SO4Flow rate : 0.7 mL/minTemperature : ambient (24 ˚C)Detection : UV at 280 nm, 0.04 AUFSInjection : 60 µL (0.33 mg/mL)

(G920108G)


1. Human IgM (É»),myeloma protein2. Normal human IgG


Part number : DL30S055008WTEluent : 0.1M NaH2PO4 - Na2HPO4 (pH 6.8) containing 0.1M Na2SO4Flow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : UV at 280 nm, 0.04 AUFSInjection : 40 µL (0.5 mg/mL)

(G920108F)


1. Human IgM (É»),myeloma protein2. Normal human IgA



(G920108E)



Human IgM(κ),myeloma protein

1. Normal human IgM (κ),myeloma protein



(G920108D)

Normal human IgA

1. Normal human IgA



(G920108C)

Human IgG(λ),myeloma protein

1. Human IgG (λ),myeloma protein



(G920108B)

Normal human IgG

1. Normal human IgG



(G920108A)



Cytochrome c

1. Cytochrome c (hexamer)2. Cytochrome c (tetramer)3. Cytochrome c (trimer)4. Cytochrome c (dimer)5. Cytochrome c (monomer)


Part number : DL20S055008WT, DL125055008WT (x2)Eluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaClFlow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : UV at 215 nm, 0.08 AUFSInjection : 30 µL (0.2 mg/mL)

(G911217D)

Peptide fragments from myoglobin

1. 1-153 (MW 17,000)2. 1-131 (MW 14,500)3. 56-153 (MW 10,700)4. 56-131 (MW 8,200)5. 1-55 (MW 6,300)6. 132-153 (MW 2,500)


Part number : DL12S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaCl/acetonitrile (70/30)Flow rate : 0.7 mL/minTemperature : ambient (25 ˚C)Detection : UV at 215 nm, 0.32 AUFSInjection : 20 µL (2.0 mg/mL)Sample : cyanogen bromide cleavages of horse heart myoglobim.

Molecular Weight Marker for proteins,manufactured byFluka Chemie AG.

(G911218A)

Peptides

1. Insulin (Bovine)2. Neurotensin3. Angiotensin II4. Glycine


Part number : DL06S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaCl/acetonitrile (70/30)Flow rate : 0.7 mL/minTemperature : ambient (25 ˚C)Detection : UV at 215 nm, 0.16 AUFSInjection : 25 µL (0.07~5.3 mg/mL)

(G911217A)

Peptides


Column : YMC-Pack™ Diol-120500 x 8.0 mm I.D. x 2

Part number : DL12S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaCl/acetonitrile (70/30)Flow rate : 0.7 mL/minTemperature : ambient (25 ˚C)Detection : UV at 215 nm, 0.16 AUFSInjection : 25 µL (0.07~5.3 mg/mL)

(G911217B)



Peptides



Part number : DL12S055008WT, DL06S055008WT (x2)Eluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0)

containing 0.2M NaCl/acetonitrile (70/30)Flow rate : 0.7 mL/minTemperature : ambient (25 ˚C)Detection : UV at 215 nm, 0.08 AUFSInjection : 25 µL (0.07~5.3 mg/mL)

(G911217C)

Glycine oligomers

1. Pentaglycine2. Triglycine3. Glycine


Part number : DL06S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0)/acetonitrile (70/30)Flow rate : 1.0 mL/minTemperature : ambient (24 ˚C)Detection : UV at 215 nm, 0.08 AUFSInjection : 20 µL (0.25 ~ 2.5 mg/mL)

(G911227B)

Casein1. Casein


Part number : DL30S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0)

containing 0.2M NaCl/acetonitrile (90/10)Flow rate : 1.0 mL/minTemperature : ambient (22 ˚C)Detection : UV at 215 nm, 0.16 AUFSInjection : 15 µL (1.0 mg/mL)

(G920123B)

Proteins for molecular weight marker

1. Glutamate dehydrogenase (MW 290,000)2. Lactate dehydrogenase (MW 142,000)3. Enolase (MW 67,000)4. Adenylate kinase (MW 32,000)5. Cytochrome c (MW 12,400)


Part number : DL30S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaClFlow rate : 0.7 mL/minTemperature : ambient (26 ˚C)Detection : UV at 280 nm, 0.08 AUFSInjection : 15 µL (100 µL/1 vial)Sample : MW-Marker(HPLC), manufactured by ORIENTAL YEAST CO.,LTD.

(G911213A)







(G911214A)





(S921217A)





(G911214B)




Part number : DL12S055008WT, DL30S055008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaClFlow rate : 0.7 mL/minTemperature : ambient (26 ˚C)Detection : UV at 280 nm, 0.08 AUFSInjection : 15 µL (100 µL/1 vial)Sample : MW-Marker(HPLC), manufactured by ORIENTAL YEAST CO.,LTD.

(G911214C)





Column : YMC-Pack™ Diol-200 + Diol-200500 x 8.0 mm I.D. + 300 x 8.0 mm I.D.

Part number : DL20S055008WT, DL20S053008WTEluent : 0.1M KH2PO4 - K2HPO4 (pH 7.0) containing 0.2M NaClFlow rate : 0.7 mL/minTemperature : ambient (26 ˚C)Detection : UV at 280 nm, 0.08 AUFSInjection : 15 µL (100 µL/1 vial)Sample : MW-Marker(HPLC), manufactured by ORIENTAL YEAST CO.,LTD.

(G911214H)

Proteins1. Ribonuclease A2. Cytochrome c3. Lysozyme5. Myoglobin

Column : YMC- Pack™ ODS-A™ (5µm, 300Å)150 x 4.6 mm I.D.

Part number : AA30S051546WTEluent : A) acetonitrile/water/TFA (5/95/0.1)

B) acetonitrile/water/TFA (60/40/0.1)30-90%B (0-20min, linear), 90%B (20-25min)

Flow rate : 1.0 mL/minTemperature : 37˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 16 µL (0.16 ~ 0.33 mg/mL)

(T931029A)

Proteins1. Ribonuclease A2. Cytochrome c3. Lysozyme4. Myoglobin

Column : YMC-Pack™ Butyl (5 µm, 300Å)150 x 4.6 mm I. D.

Part number : BU30S051546WTEluent : A) acetonitrile/water/TFA (5/95/0.1)

B) acetonitrile/water/TFA (60/40/0.1)30-90%B (0-20min, linear), 90%B (20-25min)

Flow rate : 1.0 mL/minTemperature : 37˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 16 µL (0.16 ~ 0.33 mg/mL)

(B931023A)

3.

OCH2CH3

COOH

OCH2CH2CH2CH3

COOH

OCH2CH2CH3

COOH

CHCH3CH3

COOH

CH3H3C C

COOH

CH3

p-Ethoxybenzoic acid

p-Propoxybenzoic acid

p-Buthoxybenzoic acid

p-Isopropylbenzoic acid(Cuminic acid)

p-tert-Butylbenzoic acid

4.

5.

5.00 10.00 15.00 20.00 min

5.00 10.00 15.00 20.00 min0.0

0.0

A) UV

B) MS

12

3

4

65

1

2 3

4

65

Peptides1. [Arg8]- Vasopressin2. Bradykinin3. Angiotensin4. Oxytocin5. Angiotensin6. Leu-Enkephalin

Column : YMC-Pack™ Pro C18 RS™ (5 µm, 80Å)150 x 2.0 mm I. D.

Part number : RS08S051502WTEluent : A) water/TFA (100/0.01)

B) acetonitrile/TFA (60/40/0.1)10-35%B (0-15min), 10%B (15-20min)

Flow rate : 0.2 mL/minTemperature : 37˚CDetection : A) UV at 220 nm, 0.32 AUFS

B) ESI positive-modeInjection : 4 µL ( 0.05 mg/mL)

(A020808A)



1

2

3

4 6

5

2.

3.

OCH2CH3

COOH

OCH2CH2CH2CH3

COOH

OCH2CH2CH3

COOH

CHCH3CH3

COOH

CH3H3C C

COOH

CH3

p-Ethoxybenzoic acid

p-Propoxybenzoic acid

p-Buthoxybenzoic acid

p-Isopropylbenzoic acid(Cuminic acid)

p-tert-Butylbenzoic acid

4.

5.

1.

5 10 150 min

Peptides1. [Arg8]- Vasopressin2. Oxytocin3. Bradykinin4. Angiotensin5. Leu-Enkephalin6. Angiotensin

Column : YMC-Pack™ Pro C18 RS™ (5 µm, 80Å)150 x 4.6 mm I. D.

Part number : RS08S051546WTEluent : A) water/TFA (100/0.1)

B) acetonitrile/TFA (100/0.1)15-35%B (0-15min)

Flow rate : 1.0 mL/minTemperature : 37˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 20 µL (0.05 mg/mL)

(A010821A)

Organic Acids5


Organic acids1. Glycolic acid2. L-Malic acid3. Malonic acid4. Lactic acid5. Acetic acid6. Maleic acid7. Citric acid8. Fumaric acid9. Succinic acid

10. Propionic acid


Part number : AQ12S051546WTEluent : 20mM H3PO4 - NaH2PO4 (pH 2.8)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.08 AUFSInjection : 10 µL (0.007~1.8 mg/mL)

(T910226A)

Organic acids

1. Tartaric acid2. L-Malic acid3. Lactic acid4. Acetic acid5. Citric acid6. Succinic acid


Part number : HS12S051546WTEluent : 20mM NaH2PO4 - H3PO4(pH 2.8)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.064 AUFSInjection : 10 µL (0.25 - 2.0 mg/mL)

(A001218A)

Organic acids1. L-Malic acid2. Lactic acid3. Acetic acid4. Maleic acid5. Succinic acid6. Propionic acid7. Fumaric acid

Column : YMC-Pack™ PolymerC18™

250 x 4.6 mm I.D.Part number : PC99S062546WTEluent : 0.1% TFAFlow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.08 AUFSInjection : 10 µL (0.016~2.2 mg/mL)

(Y910209)

Pyruvic acids

Phosphoenolpyruvic acidmonopotassium salt

Pyruvic acid


250 x 4.6 mm I.D.Part number : PC99S062546WTEluent : 100mM H3PO4 (pH 1.7)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.64 AUFSInjection : 5 µL (0.7, 20 mg/mL)

(S921217A)

1.

2.

Organic Acids5


Unsaturated fatty acid methyl esters

1. Eicosapentaenoic acid

2. É¡-Linolenic acid

3. Docosahexaenoic acid

4. Arachidonic acid

5. Linoleic acid

6. Eicosatrienoic acid


Part number : AM12S052546WTEluent : acetonitrile/water (81/19)Flow rate : 1.5 mL/minTemperature : ambientDetection : UV at 190 nm, 0.128 AUFSInjection : 20 µL (0.165 mg/mL)

(K930323A)

Methyl linolenate and methyl λ-linolenate

1. Methyl linolenate

2. Methyl λ-linolenate


Part number : JH08S042546WTEluent : acetonitrile/THF/water (35/30/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.26 AUFSInjection : 2 µL (2.5 µL/mL)

(S921217A)

Unsaturated fatty acid methyl esters

1 .Methyl linolenate

2. MethylÉ¡-linolenate

3. Methyl linoleate

4. Methyl oleate


Part number : JH08S041546WTEluent : A)acetonitrile/THF/water (10/30/60)

B)acetonitrile/THF/water(65/30/5)20-100%B (0-40min, linear)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.51 AUFSInjection : 18 µL (0.25~4 µL/mL)

(S931012C)

Triacylglycerols1. LLL2. LLO3. POL4. PPL5. OOO6. OOP7. PPO

L: linoleic acidO: oleic acidP: palmitic acid


Part number : JH08S042546WTEluent : acetonitrile/2-propanol (55/45)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.08 AUFSInjection : 30 µL (0.08~1.66 mg/mL)

(O940914F)

Food Additives6


Food preservatives

1. Saccharin sodium

2. Dehydroacetic acid

3. Sorbic acid

4. Benzoic acid


Part number : JH08S04L546WTEluent : THF/water/TFA (20/80/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 2 µL (0.13~0.32 mg/mL)Text

(O940819A)

Food preservatives


2. Sorbic acid

3. Benzoic acid


Part number : JM08S04L546WTEluent : THF/water/acetic acid (20/80/0.5)Flow rate : 2.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.08 AUFSInjection : 4 µL (56 µg/mL)

(O940802I)

Food Preservatives


2. Sorbic acid

3. Benzoic acid


Part number : JM08S04L502WTEluent : THF/water/acetic acid (20/80/0.5)Flow rate : 0.37 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.08 AUFSInjection : 0.8 µL (56 µg/mL

(0940802H)

p-Hydroxybenzoic acid esters

1. Methyl p-hydroxybenzoate

2. Ethyl p-hydroxybenzoate

3. Isopropyl p-hydroxybenzoate

4. Propyl p-hydroxybenzoate

5. Isobutyl p-hydroxybenzoate

6. Butyl p-hydroxybenzoate


Part number : JH08S04L546WTEluent : methanol/water (55/45)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.26 AUFSInjection : 4 µL (0.1 mg/mL)

(S930716D)

Food Additives6


p-Hydroxybenzoic acid esters


2. Ethyl p-hydroxybenzoate




Part number : JM08S04L546WTEluent : acetonitrile/water (50/50)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.26 AUFSInjection : 3 µL (0.1 mg/mL)

(S930716H)

EDTA-chelates

1. Fe (III)-EDTA

2. Cu (II)-EDTA


Part number : JH08S041546WTEluent : 50mM CH3COONa - CH3COOH (pH 4.6) containing

20mM tetrabutylammonium bromideFlow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.04 AUFSInjection : 10 µL (0.017~0.13 mg/mL)

(T940208A)

EDTE: Ethylenediamine-tetraacetic acid

Antioxidants

1. n-Propyl gallate(PG)

2. 2,4,5-Trihydroxybutyrophenone(THBP)

3. tert-Butylhydroquinone(TBHQ)

4. Nordihydroguaiaretic acid(NDGA)


Part number : AS12S051546WTEluent : A)acetonitrile/methanol/5% acetic acid (20/20/60)

B)acetonitrile/methanol/5% acetic acid (45/45/10)0-100%B (0-10min), 100%B (10-20min)


(A970524B)

5. 4-Hydroxymethyl-2,6-di-tert-butylphenol

(HMBP)

6. n-Octyl gallate(OG)

7. n-Dodecyl gallate(DG)

Antioxidants


2. 2,4,5-Trihydroxy butyrophenone

(THBP)


4. Nordihydroguaiareticacid(NDGA)


Part number : AS12S05L546WTEluent : A)acetonitrile/methanol/5% acetic acid (20/20/60)

B)acetonitrile/methanol/5% acetic acid (45/45/10)0-100%B (0-5min), 100%B (5-15min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 9 µL (0.05~0.6 mg/mL)Text

(A970526C)

5. 4-Hydroxymethyl2,6-di-tert-butylphe-

nol (HMBP)

6. n-Octylgallate(OG)

7. n-Dodecyl gal-late(DG)

Food Additives6


Antioxidants





Part number : AS12S051546WTEluent : acetonitrile/methanol/5% acetic acid (20/20/60)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 10 µL (0.05~0.2 mg/mL)

Antioxidants





Part number : AQ12S051546WTEluent : acetonitrile/methanol/5% acetic acid (20/20/60)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 10 µL (0.05 ~ 0.2 mg/mL

(A970522D)(A970522B)


Part number : HS12S030546WTEluent : acetonitrile / methanol / 5% acetic acid (35/35/30)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 10 µL (0.05 - 0.5 mg/mL)

(J010215B)

Antioxidants

1. Nordihydroguaiaretic acid(NDGA)

2. 4-Hydroxymethyl-2,6-di-tert-butylphenol(HMBP)

3. n-Dodecyl gallate(DG)


Part number : AS12S051546WTEluent : acetonitrile/methanol/5% acetic acid (35/35/30)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 10 µL (0.1~0.6 mg/mL)

(A970521B)

Antioxidants

Food Additives6


Antioxidants

1. Butyl hydroxyanisol (BHA)

2. Dibutyl hydroxytoluene (BHT)


Part number : JH08S04L546WTEluent : methanol/water (95/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.16 AUFSInjection : 1 µL (0.5 mg/mL)

(O940810D

Color additives 1. Tartrazine(FD&C Yellow No.5, C.I.19140, Y-4)

2. Amaranth(C.I.16185, R-2)

3. Indigo Carmine(FD&C Blue No.2, C.I.73015, B-2)

4. New Coccine(C.I.16255, R-102)

5. Sunset Yellow FCF(FD&C Yellow No.6, C.I.15985, Y-5)

6. Fast Green FCF(FD&C Green No.3, C.I.42053, G-3)

7. Brilliant Blue FCF(FD&C Blue No.1, C.I.42090, B-1)

8. Erythrosine(FD&C Red No.3, C.I.45430, R-3)

9. Acid Red(C.I.45100, R-106)

10. Phloxine(C.I.45410, R-104)

11. Rose Bengale(C.I.45440, R-105)


Part number : AA12S051546WTEluent : A) 10mM NH4H2PO4 - (NH4)2HPO4 (pH 6.0)/methanol (90/10)

B) 10mM NH4H2PO4 - (NH4)2HPO4 (pH 6.0)/methanol (20/80)0-100%B (0-40min, linear), 100%B (40-60min)

Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 100 µL (5 µg/mL)

(M910427A)

Color additives

1. Fast Green FCF(FD&C Green NO.3, C.I.42053, G-3)

2. Brilliant Blue FCF(FD&C Blue No.1, C.I.42090, B-1)

3. Erythrosine(FD&C Red No.3, C.I.45430, R-3)

4. Acid Red(C.I.45100, R-106)

5. Phloxine(C.I.45410, R-104)

6. Rose Bengale(C.I.45440, R-105)


Part number : AA12S051546WTEluent : acetonitrile/10mM CH3COONH4 (25/75)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 10 µL (35~140 µg/mL)

(M910430C)

Color additives1. Tartrazine

(FD&C Yellow No.5, C.I.19140,Y-4)2. Amaranth

(C.I.16185, R-2)3. Indigo Carmine

(FD&C Blue No.2, C.I.73015, B-2)4. New Coccine

(C.I.16255, R-102)5. Sunset Yellow FCF

(FD&C Yellow No.6, C.I.15985, Y-5)

Column :YMC-Pack™ ODS-A™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AA12S051546WTEluent : acetonitrile/10mM CH3COONH4 (8/92)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 5 µL (25~200 µg/mL)

(M910430A)

Food Additives6


Annatto extract1. Annatto pigment


Part number : AM12S051546WTEluent : acetonitrile/water/acetic acid (65/34/1)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : VIS at 454 nm, 0.16 AUFSInjection : 5 µL (2 mg/mL)Sample : Annatto pigment

Aspartame in a soft drink1. Benzoic acid2. Caffeine3. Aspartame


Part number : PHI2S051546WTEluent : 50mM KH2PO4/acetonitrile/methanol (84/3/13)Flow rate : 1.5 mL/minTemperature : 30 ˚CDetection : UV at 214 nm, 0.64 AUFSInjection : 10 µL

(T910123)(M910430E)

Aspartame in a soft drink

1. Caffeine2. Aspartame3. Benzoic acid


150 x 4.6 mm I.D.Part number : PC99S061546WTEluent : acetonitrile/water/TFA (15/85/0.05)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.64 AUFSInjection : 5 µL

(H900710B)

Aspartame in a soft drink1. Caffeine2. Aspartame3. Benzoic acid


Part number : AA12S051546WTEluent : acetonitrile/water/TFA (15/85/0.05)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.64 AUFSInjection : 5 µL

(H900710A)

Food Additives6


Stevioside and rebaudioside A

1. Stevioside2. Rebaudioside A


Part number : AQ12S051506WTEluent : acetonitrile/water (35/65)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 205 nm, 0.32 AUFSInjection : 7 µL

Aspartame in a soft drink

1. Caffeine2. Aspartame3. Benzoic acid

Column : YMC™-Pack CN (5µm, 120Å)250 x 4.6 mm I.D.

Part number : CN12S052546WTEluent : acetonitrile/water/TFA (15/85/0.05)Flow rate : 0.5 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.64 AUFSInjection : 5 µL

(H900710C) (G900727B)

Glycyrrhizic acid

1. Glycyrrhizic acid



Part number : AA12S051546WTEluent : acetonitrile/water/acetic acid (40/56/4)Flow rate : 0.6 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 1.0 AUFSInjection : 10 µL (0.1~0.5 mg/mL)

(S960306E)

1

23

1.

2.

3.

5 10 150 min

Sorbic acid

Benzoic acid

COOH

Dehydroacetic acid

CH3CH CHCH CHCOOH

O

O

O

COCH3

H3C

Food preservatives

Column : YMC-Pack™ Pro C18 RS™ (5µm, 80Å)150 x 4.6 mm I.D.

Part number : RS08S051546WTEluent : 20mM CH3COONa - CH3COOH (pH 4.3)/ acetonitrile (80/20)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.26 AUFSInjection : 10 µL (0,02 mg/mL)

(J011213F)

Natural Products7


Alkaloids

1. Hordenine sulfate2. Pilocarpine chloride3. Scopolamine bromide4. Atropine sulfate5. Cinchonine6. Sparteine sulfate7. Quinine8. Papaverine chloride9. Narcotine chloride


Part number : AM12S051546WTEluent : acetonitrile/20mM KH2PO4(20/80)Flow rate : 1.0 mL/minTemperature : 30˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 5 µL (0.05~2.19 mg/mL)

Alkaloids

1. Hordenine sulfate2. Pilocarpine chloride3. Scopolamine bromide4. Atropine sulfate5. Cinchonine6. Sparteine sulfate7. Quinine8. Papaverine chloride9. Narcotine chloride


Part number : AM12S051506WTEluent : A)acetonitrile/20mM KH2PO4 (17/83)

B)acetonitrile/20mM KH2PO4 (40/60)0-100%B (0-30min, linear), 100%B (30-40min)


(G910523J)

(G910523K)

Purine alkaloids

1. Trigonerlline2. Theobromine3. Theophylline4. Caffeine5. Phenol


Part number : AQ12S051546WTEluent : acetonitrile/water (8/92)Flow rate : 1.0 mL/minTemperature : 20 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 5 µL (0.3 ~ 4.5 mg/mL)

(M910612C)

Chlorophyll a and b

1. Chlorophyll b

2. Chlorophyll a


Part number : AA12S051506WTEluent : methanolFlow rate : 1.0 mL/minTemperature : ambientDetection : VIS at 450 nm, 1 AUFSInjection : 100 µL Sample : extract of Spinacia with acetone/water (90/10)

Courtesy of Dr. Toyoaki Aoki, University of Osaka Pref. (K940228A)

Natural Products7


Crude drugs(Glycosides)1. Arbutin2. Salicin3. Esculine4. G-Strophanthin (Ouabain)5. Baicalin6. Barbaloin7. Glycyrrhizin8. Digitoxin


Part number : AQ12S052546WTEluent : A)methanol/20mM NH4H2PO4 (5/95)

B)methanol/20mM NH4H2PO4 (80/20)0-100%B (0-20min, linear), 100%B (20-40min)


(G910607E)

Crude drugs(Glycosides)

1. Arbutin2. Salicin3. Esculine4. G-Strophanthin (Ouabain)5. Baicalin6. Barbaloin7. Glycyrrhizin8. Digitoxin


Part number : AA12S052546WTEluent : A)methanol/20mM NH4H2PO4 (5/95)

B)methanol/20mM NH4H2PO4 (80/20)0-100%B (0-20min, linear), 100%B (20-40min)


(G910607D)

Paeoniflorin

1. Albiflorin2. Paeoniflorin3. p-Hydroxyacetophenone(I.S.)


Part number : AS12S051546WTEluent : acetonitrile/water/acetic acid (20/80/1)Flow rate : 0.4 mL/minTemperature : 25 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 10 µL (48 - 56 µg/mL)

Paeoniflorin

1. Paeoniflorin

2. p-Hydroxyacetophenone(I.S.)


Part number : JH08S04L546WTEluent : THF/50mM (NH4)2HPO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 3 µL (0.67, 0.33 mg/mL)

(O941121M)(A980818A)

Natural Products7


Paeoniflorin in Toki-shakuyaku-san

1. Paeoniflorin


Part number : JH08S041546WTEluent : THF/50mM (NH4)2HPO4 (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 3 µL Sample : water extract from Toki-shakuyaku-san

(O941121I)

Saponins from roots of rubus suavissimus S. Lee

Column : YMC-Pack™ PolymerC18™ and YMC-Pack™ ODS-AM™ (5µm, 120Å)150 x4.6 mm I.D.

Part number : PC99S061546WT, AM12S051546WTEluent : methanol/water (45/55) for PolymerC18

methanol/water (50/50) for ODS-AM™

Flow rate : 0.8 mL/minTemperature : 50 ˚CDetection : UV at 210 nm, 0.32 AUFSSample : 1) β-D-Glucopyranosyl 2α, 3, β,23-trihydroxyurs-

12,18-dien-28-oate2) β -D-Glucopyranosyl 2α, 3, β,23-trihydroxyurs-

12,19-dine-28-oate

Courtesy of Dr.Ohtani,Hiroshima University,Japan (Y910123)

1.

2.

Saikosaponins

Column : J’Sphere™ ODS-L80 (4µm, 80Å)150 x 4.6 mm I.D.

Part number : JL08S041546WTEluent : acetonitrile/water (38/62)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.26 AUFSInjection : 8 µL (0.5~0.75 mg/mL)

Saikosaponins

1. Saikosaponin c

2. Saikosaponin a

3. Saikosaponin b2

4. Saikosaponin d


Part number : JM08S041546WTEluent : acetonitrile/water (38/62)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.26 AUFSInjection : 8 µL (0.5 ~ 0.75 mg/mL)

(S931210C)(S931210D)

1. Saikosaponin c

2. Saikosaponin a

3. Saikosaponin b2

4. Saikosaponin d

Natural Products7


Ginsenosides

1. Ginsenoside-Rg1

2. Ginsenoside-Rb1


Part number : AQ12S051546WTEluent : acetonitrile/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 203 nm, 0.16 AUFSInjection : 10 µL (0.125, 0.5 mg/mL)

Flavonoids

1. Myricetin

2. Quercetin

3. Kaempferol


Part number : AS12S051546WTEluent : acetonitrile/10mM H3PO4 (30/70)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 260 nm, 0.064 AUFSInjection : 2 µL (0.05 mg/mL)

Ginsenosides

1. Ginsenoside-Rg1

2. Ginsenoside-Rb1

Column : YMC-Pack™ Pro C18™ (5µm, 120Å)150 x3.0 mm I.D.

Part number : AS12S051503WTEluent : A)acetonitrile/water (20/80)

B)acetonitrile/water (40/60)0-100%B (0-10min), 100%B (10-20min)

Flow rate : 0.4 mL/minTemperature : 37 ˚CDetection : UV at 203 nm, 0.32 AUFSInjection : 4 µL (0.125, 0.5 mg/mL)

(A971120C)

(A971121D)

(D960722A)

Ginsenosides

1. Ginsenoside-Rg1

2. Ginsenoside-Rb1

Column : YMC-Pack™ Pro C18™ (5µm, 120Å)150 4.6 mm I.D.

Part number : AS12S051546WTEluent : acetonitrile/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 203 nm, 0.16 AUFSInjection : 10 µL (0.125, 0.5 mg/mL)

(S921217A)

Natural Products7


Flavonoids


Part number : AQ12S051546WTEluent : acetonitrile/10mM H3PO4 (35/65)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.13 AUFSInjection : 5 µL (0.05 mg/mL)

Baicalin

1. Baicalin



Part number : AS12S050546WTEluent : acetonitrile/10mM H3PO4 (30/70)Flow rate : 0.7 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.064 AUFSInjection : 10 µL (0.01, 0.02 mg/mL)

Flavanone glycosides

1. Narirutin

2. Naringin

3. Hesperidin

4. Neohesperidin



(S961111B)

(A970430A)(S961105C)

1. Luteolin

2. Apigenin

3. Chrysoeriol

4. Baicalein

5. Chrysin

6. Acacetin

Flavonoids



(S961107C)

1. Luteolin

2. Apigenin

3. Chrysoeriol

4. Baicalein

5. Chrysin

6. Acacetin

Natural Products7


Isoflavones from miso,fermented soybean paste


Part number : HS12S051546WTEluent : A)water/acetic acid (100/1)

B)acetonitrile/water/acetic acid (50/50/1)30%B(0-5min), 30-70%B(5-35min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.08AUFSInjection : 7 µLSample : methanol extract of miso

Catechins


Part number : JH08S041546WTEluent : 20mM KH2PO4 - H3PO4 (pH 2.4)/methanol (75/25)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.13 AUFSInjection : 8 µL (0.1~0.4 mg/mL)

Catechins


Part number : AA12S051546WTEluent : acetonitrile/ethyl acetate/water/TFA (9/3/88/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 7 µL (0.2 - 0.8 mg/mL)

(F001025B)

(F000828A) (S940124A)

1. (-)-Epigallocatechin

2. (+)-Catechin

3. (-)-Epigallocatehin gallate

4. (-)-Epicatechin

5. (-)-Epicatechin gallate

Flavanone glycosides

1. Narirutin

2. Naringin

3. Hesperidin

4. Neohesperidin


Part number :JH08S041546WTEluent : acetonitrile/10mM H3PO4 (20/80)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.04 AUFSInjection : 7 µL (0.025 mg/mL)

(A970506A)

Natural Products7


2-Phenylethyl glycosides

Sennosides

1. Sennoside B

2. Sennoside A


Part number : AS12S051546WTEluent : methanol/water/acetic acid (30/65/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 340 nm, 0.16 AUFSInjection : 10 µL (0.1 mg/mL)

Sennosides

1. Sennoside B

2. Sennoside A


Part number : JH08S041546WTEluent : methanol/water/acetic acid (30/65/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 340 nm, 0.16 AUFSInjection : 10 µL (0.1 mg/mL)

(F000911A)

(A961126B)(A961126C)


Part number :HS12S052546WTEluent : acetonitrile/methanol/water (8/4/88)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 5 µL (0.2 mg/mL)

Catechins

1. (-)-Epigallocatechin

2. (+)-Catechin

3. (-)-Epigallocatehin gallate

4. (-)-Epicatechin

5. (-)-Epicatechin gallate


Part number : JM08S041546WTEluent : 20mM KH2PO4 - H3PO4 (pH 2.4)/methanol (75/25)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.13 AUFSInjection : 8 µL (0.1~0.4 mg/mL)

(S940122D)

Natural Products7


Arbutin and related compounds

1. Arbutin

2. Hydroquinone

3. Gallic acid


Part number : AS12S051546WTEluent : methanol/10mM H3PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 5 µL (0.2~0.5 mg/mL)



Part number : AS12S03L502WTEluent : methanol / water / TFA (5/95/0.05)Flow rate : 0.2 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.16 AUFSInjection : 1 µL (0.2 - 0.5 mg/mL)


1. Arbutin

2. Hydroquinone

3. Gallic acid


Part number : AQ12S051546WTEluent : methanol/10mM H3PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 280 nm, 0.32 AUFSInjection : 5 µL (0.2 ~ 0.5 mg/mL)

(A970514D)

(A970514B) (A980831L)

Sennosides

1. Sennoside B

2. Sennoside A


Part number : JM08S041546WTEluent : methanol/water/acetic acid (30/65/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 340 nm, 0.16 AUFSInjection : 10 µL (0.1 mg/mL

(A961126D)

Natural Products7


Paeonol

1. Paeonol



Part number : AQ12S051546WTEluent : acetonitrile/water/acetic acid (35/65/2)Flow rate : 1.0 mL/minTemperature : ambient (22 ˚C)Detection : UV at 274 nm, 0.26 AUFSInjection : 10 µL (0.04, 0.2 mg/mL)

Aflatoxins

1. Aflatoxin G2

2. Aflatoxin G1

3. Aflatoxin B2

4. Aflatoxin B1


Part number : JM08S041546WTEluent : methanol/water (40/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 365 nm, 0.04 AUFSInjection : 10 µL (7~10 ppm)

Aflatoxins

1. Aflatoxin G2

2. Aflatoxin G1

3. Aflatoxin B2

4. Aflatoxin B1


Part number : JL08S041546WTEluent : methanol/water (40/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 365 nm, 0.04 AUFSInjection : 10 µL (7 ~ 10 ppm)

(S971107A)

(K931125A)(K931124B)

Paeonol

1. Paeonol



Part number : AS12S051546WTEluent : acetonitrile/water/acetic acid (35/65/2)Flow rate : 1.0 mL/minTemperature : ambient (22 ˚C)Detection : UV at 274 nm, 0.26 AUFSInjection : 10 µL (0.04, 0.2 mg/mL)

(S971106D)

Steroids 8


Steroids

1. Hydrocortisone

2. Corticosterone

3. Deoxycorticosterone

4. Progesterone

Column : YMC-Pack™ CN (5µm, 120Å)250 x 4.6 mm I.D.

Part number : CN12S052546WTEluent : acetonitrile/water (40/60)Flow rate : 0.6 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 3 µL (0.25 mg/mL)

Adrenocorticosteroids

4. Hydrocortisone

5. Corticosterone

6. Methylprednisolone


Part number : JH08S041546WTEluent : THF/water (20/80)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 8 µL (0.1 mg/mL)

Steroids

1. Progesterone


3. Corticosterone

4. Hydrocortisone

Column : YMC-Pack™ CN (5µm, 120Å)250 x 4.6 mm I.D.

Part number : CN12S052546WTEluent : hexane/methanol/dichloromethane (75/20/5)Flow rate : 0.6 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 3 µL (0.25 mg/mL)


6. Hydrocortisone acetate

7. Cortisone acetate


9. Corticosterone acetate

10. Benzene


Part number : JM08S041546WTEluent : acetonitrile/water (35/65)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 7 µL (0.07 mg/mL)

(S930322B) (S930319D)

(S940222C)(S940308B)

1. Prednisone

2. Cortisone

3. Prednisolone

1. Prednisolone

2. Hydrocortisone

3. Cortisone

4. Corticosterone

5. Fluocinolone acetonide

Steroids 8



5. Dexamethasone

6. Corticosterone

7. Beclomethasone

8. Triamcinolone acetonide

Column : J’Sphere™ ODS-H80 (4 µm, 80Å)150 x 4.6 mm I.D.

Part number : JH08S041546WTEluent : acetonitrile/water (27/73)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 10 µL (0.08 mg/mL


1. Hydrocortisone

2. Cortisone


4. Betamethasone



Hydrocortisone and prednisone

1. Prednisone

2. Hydrocortisone


Part number : SL12S051546WTEluent : chloroform/2-propanol/acetic acid (95/5/1)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 250 nm, 0.32 AUFSInjection : 10 µL (0.25 mg/mL)



2. Prednisolone acetate


4. Fluocinonide



(S940310E)

(K940530C)

(S940310F)

(O940408A)

1. Hydrocortisone

2. Cortisone


4. Betamethasone

5. Dexamethasone

6. Corticosterone

7. Beclomethasone


Steroids 8




2. Prednisolone acetate


4. Fluocinonide


Part number : AA12S051546WTEluent : acetonitrile/water (45/55)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 5 µL (0.1 mg/mL)


1. Triamcinolone

2. Prednisolone



Part number : JM08S041546WTEluent : acetonitrile/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 4 µL (0.1 ~ 0.2 mg/mL)


1. Triamcinolone

2. Prednisolone



Part number : JH08S041546WTEluent : acetonitrile/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 4 µL (0.1~ 0.2 mg/mL)


1. Prednisolone succinate

2. Hydrocortisone succinate


Part number : JH08S041546WTEluent : acetonitrile/water/acetic acid (30/70/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.064 AUFSInjection : 5 µL (0.1 mg/mL)

(O940408C) (S940420B)

(S940414A)(S940420C)

Steroids 8



1. Prednisone2. Cortisone3. Prednisolone4. Hydrocortisone5. Methylprednisolone6. Corticosterone7. Betamethasone8. Dexamethasone9. Triamcinolone acetonide10. Beclomethasone11. Fluocinolone acetonide12. Prednisolone acetate13. Hydrocortisone acetate14. Cortisone acetate15. Deoxycorticosterone16. Corticosterone acetate17. Fluocinonide18. Betamethasone valerate19. Deoxycorticosterone acetate20. Beclomethasone dipropionate21. Ethylbenzene


Part number : JH08S041546WTEluent : A)acetonitrile/THF/water (15/10/75)

B)acetonitrile/water (75/25)0-50%B (0-30min, linear), 50-100%B (30-50min)



1. Prednisone2. Cortisone3. Prednisolone4. Hydrocortisone5. Methylprednisolone6. Corticosterone7. Betamethasone8. Dexamethasone9. Triamcinolone acetonide10. Beclomethasone11. Fluocinolone acetonide12. Prednisolone acetate13. Hydrocortisone acetate14. Cortisone acetate15. Deoxycorticosterone16. Corticosterone acetate17. Fluocinonide18. Betamethasone valerate19. Deoxycorticosterone acetate20. Beclomethasone dipropionate21. Ethylbenzene


Part number : JM08S041546WTEluent : A)acetonitrile/THF/water (15/10/75)



Adrenocorticosteroids1. Prednisone2. Cortisone3. Prednisolone4. Hydrocortisone5. Methylprednisolone6. Corticosterone7. Betamethasone8. Dexamethasone9. Triamcinolone acetonide10. Beclomethasone11. Fluocinolone acetonide12. Prednisolone acetate13. Hydrocortisone acetate14. Cortisone acetate15. Deoxycorticosterone16. Corticosterone acetate17. Fluocinonide18. Betamethasone valerate19. Deoxycorticosterone acetate20. Beclomethasone dipropionate21. Ethylbenzene


Part number : JL08S041546WTEluent : A)acetonitrile/THF/water (15/10/75)



Steroids

1. Fluoxymesterone


3. Prednisolone

Column : YMC-Pack™ SIL-60A (5µm, 6Å)250 x 4.6 mm I.D.

Part number : SL06S052546WTEluent : hexane/THF/acetic acid (60/40/1)Flow rate : 1.5 mL/minTemperature : 30 ˚CDetection : UV at 250 nm, 0.16 AUFSInjection : 10 µL (0.25 mg/mL)

(S940303D)

(S940303C)

(S940303B)

(K940602B)

Steroids 8


Androgens

1. Fluoxymesterone

2. Testosterone

3. Dehydroisoandrosterone


Part number : JH08S041546WTEluent : methanol/acetonitrile/water (45/15/40)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 10 µL (0.1 ~ 2.0 mg/mL)

Androgens

1. Fluoxymesterone

2. Testosterone



Part number : JL08S041546WTEluent : methanol/acetonitrile/water (45/15/40)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 10 µL (0.1 ~ 2.0 mg/mL)

Androgens

1. Fluoxymesterone

2. Testosterone



Part number : JM08S041546WTEluent : methanol/acetonitrile/water (45/15/40)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 10 µL (0.1 ~ 2.0 mg/mL)

Synthetic androgens

1. Testosterone

2. Testosterone propionate

3. Testosterone enanthate


Part number : JL08S04L546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 5 µL (0.1 ~ 0.25 mg/mL)

(S930707D) (S930707C)

(S940412B)(S930706G)

4. Methyltestosterone

5. trans -Androsterone

6. Androsterone



6. Androsterone



6. Androsterone

Steroids 8


Synthetic androgens

1. Testosterone

2. Testosterone propionate

3. Testosterone enanthate


Part number : JM08S04L546WTEluent : acetonitrile/water (70/30)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 5 µL (0.1 ~ 0.25 mg/mL)

Estrogens and progestins

1. Estriol

2. β-Estradiol

3. Norethisterone

4. Ethinylestradiol


Part number : AA12S052546WTEluent : acetonitrile/THF/water (46/4/50)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 7 µL (0.1 mg/mL)

Estrogens and progestins

1. Estriol

2. β-Estradiol

3. Norethisterone

4. Ethinylestradiol


Part number : OC12S052546WTEluent : acetonitrile/THF/water (46/4/50)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 7 µL (0.1 mg/mL)

Estrogens

1. β-Estradiol

2. Estradiol benzoate

3. Estradiol dipropionate


Part number : JL08S041546WTEluent : acetonitrile/water (65/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.13 AUFSInjection : 6 µL (0.08 ~ 0.5 mg/mL)

(S940412C)

(S930312C)

(S930311D)

(S940428E)

5. Estrone

6. Progesterone

7. Medroxyprogesterone acetate

8. Mestranol

5. Estrone

6. Progesterone

7. Medroxyprogesterone acetate

8. Mestranol

Steroids 8


Estrogens

1. β-Estradiol

2. Estradiol benzoate

3. Estradiol dipropionate


Part number : JM08S04L546WTEluent : acetonitrile/water (65/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.13 AUFSInjection : 6 µL (0.08 ~ 0.5 mg/mL)

Norgestrel and ethinylestradiol

1. Ethinylestradiol

2. Norgestrel

3. Diphenyl(I.S


Part number : JM08S04L546WTEluent : acetonitrile/water (50/50)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.13 AUFSInjection : 6 µL (0.05 ~ 0.1 mg/mL

Norgestrel and ethinylestradiol

1. Ethinylestradiol

2. Norgestrel

3. Diphenyl(I.S.)


Part number : JL08S04L546WTEluent : acetonitrile/water (50/50)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.13 AUFSInjection : 6 µL (0.05 ~ 0.1 mg/mL)

Phenacyl esters of bile acids from pig gall

1. Cholic acid (CA)2. Hyodeoxycholic acid (HDCA)3. Chenodeoxycholic acid (CDAC)


Part number :AL12S052546WTEluent : acetonitrile/water (60/40)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 240 nm, 0.04 AUFSSample : extract of pig gall were derivatized with phenacyl bromideInjection : 5 µL

(S940428F) (S940427B)

(G900417B)(S940426A)

Steroids 8


Ecdysones1. β --Ecdysone2. α -Ecdysone


Part number : AM12S051546WTEluent : acetonitrile/methanol/water(5/50/45)Flow rate : 0.5 mL/minTemperature : ambientDetection : UV at 254 nm, 0.04 AUFSInjection : 5 µL (0.04 mg/mL)

Sterols

4. Stigmasterol

5. Campesterol

6. β-Sitosterol

Column : YMC-Pack™ ODS-AL™ (5µm, 120Å) x 3 + J’Sphere™ ODS-M80 (4µm, 80Å)(250 x 4.6 mm I.D.) x 4

Part number : AL12S052546WT, JM08S042546WTEluent : methanol/water (100/2)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 10 µL (0.4 ~ 1 mg/mL)

Sterols


Part number : JM08S042546WTEluent : methanol/water (100/2)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.64 AUFSInjection : 10 µL (0.4 ~ 1 mg/mL)

Sterols

1. Brassicasterol

2. Cholesterol

3. Fucosterol

4. Stigmasterol

5. Campesterol

6. β-Sitosterol


Part number : AL12S052546WTEluent : methanol/water (100/2)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.32 AUFSInjection : 10 µL (0.4 ~ 1 mg/mL)

Courtesy of Dr.Furusawa, Kyoto Institute of Technology, Japan (G910523H)

(O940706H)

(O940701C)

(O940706C)

1. Brassicasterol

2. Cholesterol

3. Fucosterol

1. Brassicasterol

2. Cholesterol

3. Fucosterol

4. Stigmasterol

5. Campesterol

6. β-Sitosterol

Steroids 8


Cardiac glycosides


Part number : AS12S051546WTEluent : acetonitrile/water (35/65)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.13 AUFSInjection : 4 µL (0.05 ~ 0.2 mg/mL)

Cardiac glycosides

1. Lanatoside C

2. Proscillaridin A

3. Lanatoside B


Part number : AS12S05L546WTEluent : acetonitrile/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.13 AUFSInjection : 8 µL (0.1 ~ 0.2 mg/mL)

Cardiac glycosides


Part number : JL08S041546WTEluent : acetonitrile/water (35/65)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.13 AUFSInjection : 4 µL (0.05 ~ 0.2 mg/mL)

Cardiac glycosides

1. Ouabagenin

2. G-Strophanthin(Ouabain)


Part number : AS12S5L546WTEluent : acetonitrile/water (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.26 AUFSInjection : 5 µL (0.2, 0.4 mg/mL)

(S961125B) (S961126F)

(S921217A)(S961129G)

1.

2.

3.

4.

5.

1.

2.

3.

4.

5.

Steroids 8


Bufalin

HO

H3C

OH

H3C

O O

H

Cinobufagin

HO

H3C

H3C

O O

H�

O

OCCH3O

Resibufogenin

HO

H3C

H3C

O O

H�

O

N

H3COCH2COOH

CH3

CO Cl

Indomethacin (I.S.)�@

1.

2.

3.

4.

10 200 min

1

23

4

Steroids from toad venom

Column : YMC-Pack™ ODS-AL™ ( 5µm,120Å)150 x 4.6 mm I.D.

Part number : AL12S051546WTEluent : acetonitrile/0.1% phosphoric acid (45/55)Flow rate : 1.0 mL/minTemperature : 40 ˚CPressure : 7.2 MPaDetection : UV at 300 nm, 0.08 AUFSInjection : 10 µL (0.4 ~ 0.08 mg/mL)

(S010806A)

Drugs and Metabolites9


Pain-killing drug1. Acetaminophen2. Caffeine3. Ethenzamide4. Bromovalerylurea


Part number : AA12S051546WTEluent : acetonitrile/0.1% phosphoric acid (3/17)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 5 µL

Indometacin

1. p-Chlorobenzoic acid2. p-Hydroxybenzoic acid n-butyl ester3. Indometacin


Part number : AA12S051546WTEluent : methanol/0.1% phosphoric acid (70/30)Flow rate : 1.3 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.64 AUFSInjection : 20 µL

A cough/cold medication1. Caffeine2. Chlorpheniramine maleate3. Narcotine4. Ethenzamide5. Bucetine

Column : YMC-Pack™ ODS-AM™ (5µm, 120Å)250 x4.6 mm I.D.

Part number : AM12S052546WTEluent : acetonitrile/methanol/0.1% phosphoric acid (18/15/77)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 3 µL (10 mg/mL)Sample : an extract from a commercially available cough/cold preparation

Ingredients in a cough/cold medication


Part number : AM12S052546WTEluent : acetonitrile/methanol/0.1% phosphoric acid (18/15/77)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 10 µL (0.02 ~ 0.22 mg/mL)

(G900727D)

(G910523U)

(G900727F)

(G910523E)

2.

3.

1.

1. Acetaminophen2. Caffeine3. Chloropheniramine malate4. Narcotine5. Ethenzamide6. Bucetine






Part number : AM12S052506WTEluent : acetonitrile/methanol/0.1% phosphoric acid (18/15/77)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 17 µL (0.02 ~ 0.22 mg/mL)

Analgesics

1. Acetaminophen

2. Caffeine

3. Ethenzamide

4. Apronalide


Part number : AA12S051546WTEluent : methanol/water (40/60)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.51 AUFSInjection : 5 µL (0.2 ~ 2.0 mg/mL)




Part number : AA12S051506WTEluent : acetonitrile/methanol/0.1% phosphoric acid (18/15/77)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 17 µL (0.02 ~ 0.22 mg/mL)

Analgesics

1. Acetaminophen

2. Caffeine

3. Ethenzamide

4. Apronalide


Part number : OC12S051546WTEluent : methanol/water (40/60)Flow rate : 0.7 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.51 AUFSInjection : 5 µL (0.2 ~ 2.0 mg/mL)

(G910523F) (G910523G)

(S930422G)(S921217A)



Benzethonium chloride1. Benzethonium chloride


Part number : AM12S051506WTEluent : acetonitrile/water/NH4SCN (70/30/0.5, v/v/w)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.16 AUFSInjection : 10 µL (1.0 mg/mL)

·

·

Ingredients in a drug for rhinitis


Part number : HS12S030546WTEluent : A)20mM KH2PO4 - H3PO4 (pH 2.5)

B)acetonitrile0-40%B(0-10min)


Benzalkonium chloride

1. Benzalkonium chloride R=-C12H25

2. Benzalkonium chloride R=-C14H29


Part number : AM12S051506WTEluent : acetonitrile/water/NH4SCN (70/30/0.5, v/v/w)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.02 AUFSInjection : 10 µL (1.0 mg/mL benzalkonium chloride)

·

Ingredients in an eye drop


Part number : HS12S030546WTEluent : A)20mM KH2PO4 - H3PO4 (pH 2.5)

B)acetonitrile0-60%B(0-10min), 60%B(10-15min)


Courtesy of NIHON ARUTU PHARMACEUTICAL CO.,LTD. (T920527A) Courtesy of NIHON ARUTU PHARMACEUTICAL CO.,LTD. (T920529D)

(J010406A)(J010418B)



Pain-killing drugs

Column : YMC-Pack™ Pro C4™, Pro C8™ and Pro C18™ (5µm,120Å) 150 x 4.6 mm I.D.

Part number : AS12S051546WT, OS12S051546WT, BS12S051546WTEluent : methanol/20mM H3PO4 (60/40)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 10 µL (0.01 - 2.0 mg/mL)

Codeine

1. Codeine

Column : YMC-Pack™ Pro C18™ (5µm,120Å) 150 x 4.6 mm I.D.

Part number : AS12S051546WTEluent : acetonitrile/0.05% TFA (10/90)Flow rate : 1.5 mL/minDetection : UV at 210 nmInjection : 5 µL (0.1 mg/mL)

Collunarium


Part number : PH12S051546WTEluent : acetonitrile/water/NH4SCN (48/52/0.5, v/v/w)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 2.56 AUFSInjection : 10 µL (0.2 ~ 5 mg/mL)Sample : collunarium

Naphazoline hydrochloride and chlorpheniramine maleate

1. Naphazoline hydrochloride2. Chlorpheniramine maleate


Part number : AM12S051506WTEluent : acetonitrile/water/NH4SCN (35/65/0.5, v/v/w)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 10 µL (0.125 mg/mL)

(A001019B)

Courtesy of NIHON ARUTU PHARMACEUTICAL CO.,LTD. (Y920610A)

(J010528A)

Courtesy of NIHON ARUTU PHARMACEUTICAL CO.,LTD. (T920526A)

1. Naphazoline hydrochloride

2. Chlorpheniramine maleate

3. Benzethonium chloride



·

·

Histamine antagonists


Part number : AS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) / methanol (35/65)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.13 AUFSInjection : 5 µL (0.05 - 2.0 mg/mL)

·

·

Histamine antagonists


Part number : AS12S03L502WTEluent : acetonitrile / 50mM CH3COONH4 (40/60)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 2 µL (0.05 - 2.0 mg/mL)

Acidic non-steroidal anti-inflammatory drugs

1. Piroxicam

2. Sulindac

3. Tolmetin sodium dihydrate

4. Ketoprofen

5. Naproxen


Part number : AM12S051546WTEluent : 1-propanol/water/acetic acid (30/70/1)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.04 AUFSInjection : 3 µL (20 µg/mL)


1. Piroxicam

2. Sulindac

3. Tolmetin sodium dihydrate

4. Ketoprofen

5. Naproxen


Part number : JH08S04L546WTEluent : 2-propanol/water/acetic acid (25/75/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.04 AUFSInjection : 5 µL (20µg/mL)

(J010619A)

(O950126A)

(A980723A)

(O950124A)



Tricyclic antidepressants

1. Desipramine hydrochloride

2. Acenaphthene (I.S.)

3. Imipramine hydrochloride

4. Amitriptyline hydrochloride


Part number : AM12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9)/methanol (25/75)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 5 µL (0.1 ~ 0.5 mg/mL)

·

·

·



Part number : AS12S03L546WTEluent : methanol / 20mM CH3COONH4 (75/25)Flow rate : 1.0 mL/minTemperature : 37˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 5 µL (0.1-0.5 mg/mL)

Antipsychotic drugs 1. Perphenazine

2. Prochlorperazine maleate

3. Promazine hydrochloride

4. Fluphenazine hydrochloride

5. Trifluoperazine hydrochloride

6. Ethopropazine hydrochloride

7. (Profenamine hydrochloride)

8. Chlorpromazine hydrochloride


Part number : JH08S04L546WTEluent : acetonitrile/water/TFA (30/70/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.064 AUFSInjection : 5 µL (0.02 mg/mL)

Antiepileptics

1. Ethosuximide

2. Primidone

3. Phenobarbital sodium salt

4. Phenytoin

5. Carbamazepine


Part number : AS12S051546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.7)/methanol (50/50)Flow rate : 0.7 mL/minTemperature : 37 ˚CDetection : UV at 215 nm, 0.32 AUFSInjection : 8 µL (0.035 ~ 0.7 mg/mL)

(A961016B)

(O950627B)

(S921217A)

(S960723A)




1. Fenoprofen calcium dihydrate

2. Flurbiprofen

3. Ibuprofen


Part number : JH08S04L546WTEluent : methanol/water/acetic acid (65/35/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.04 AUFSInjection : 7 µL (160, 16, 820 µg/mL)


1. Doxepin hydrochloride





Part number : AS12S051546WTEluent : acetonitrile/50mM NH4H2PO4 (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 215 nm, 0.13 AUFSInjection : 2 µL (0.125 mg/mL)


1. Ketoprofen

2. Fenoprofen calcium dihydrate

3. Flurbiprofen

4. Ibuprofen


Part number : AA12S051546WTEluent : methanol/water/acetic acid (65/35/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.032 AUFSInjection : 7 µL (6 ~ 820 µg/mL)



2. Acenaphthene (I.S.)




Part number : AS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9)/methanol (25/75)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 5 µL (0.1 ~ 0.5 mg/mL)

(O950125C) (A970321A)

(A961015G)(D960724A)



Calcium antagonists

5. Prenylamine lactate

6. Bepridil HCl

7. Niguldipine HCl

8. Nifedipine


Part number : JH08S041546WTEluent : 20mM KH2PO4 - H3PO4 (pH 3.0)/acetonitrile/THF/TBA•Br

(75/15/10/0.5, v/v/v/w)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.064 AUFSInjection : 8 µL (0.05 ~ 1.4 mg/mL)

Calcium antagonists


6. Bepridil HCl

7. Niguldipine HCl

8. Nifedipine


Part number : JM08S041546WTEluent : 20mM KH2PO4 - H3PO4 (pH 3.0)/acetonitrile/THF/TBA•Br

(70/20/10/0.35, v/v/v/w)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.064 AUFSInjection : 8 µL (0.05 ~ 1.4 mg/mL)Text

Calcium antagonists


6. Bepridil HCl

7. Niguldipine HCl

8. Nifedipine


Part number : JL08S041546WTEluent : 20mM KH2PO4 - H3PO4 (pH 3.0)/acetonitrile/THF/TBA•Br

(70/20/10/0.35, v/v/v/w)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.064 AUFSInjection : 8 µL (0.05 ~ 1.4 mg/mL)

·

·

·

·

Antiarrhythmic drugs


Part number : AS12S052546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) / methanol (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.26 AUFSInjection : 5 µL (0.05 - 0.1 mg/mL)

(S930702C)

(S930702A)

(S930701D)

(S990819B)

1. Diltiazem HCl

2. Verapamil HCl

3. Methoxyverapamil HCl

4. Nicardipine HCl

1. Diltiazem HCl

2. Verapamil HCl


4. Nicardipine HCl

1. Diltiazem HCl

2. Verapamil HCl


4. Nicardipine HCl



Hypolipidemic drugs

1. Bezafibrate

2. Gemfibrozil

3. Clofibrate

4. Fenofibrate


Part number : JH08S041546WTEluent : acetonitrile/water/acetic acid(60/40/1)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 275 nm, 0.064 AUFSInjection : 8 µL (0.05~0.25 mg/mL)

Hypolipidemic drugs

1. Bezafibrate

2. Gemfibrozil

3. Clofibrate

4. Fenofibrate


Part number : JL08S041546WTEluent : acetonitrile/water/acetic acid(60/40/1)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 275 nm, 0.064 AUFSInjection : 8 µL (0.05 ~ 0.25 mg/mL)

Hypolipidemic drugs

1. Bezafibrate

2. Gemfibrozil

3. Clofibrate

4. Fenofibrate


Part number : JM08S041546WTEluent : acetonitrile/water/acetic acid(60/40/1)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 275 nm, 0.064 AUFSInjection : 8 µL (0.05 ~ 0.25 mg/mL)

Lovastatin

1. Lovastatin


Part number : AS12S051546WTEluent : acetonitrile/0.05% formic acid (30/70)Flow rate : 1.5 mL/minDetection : UV at 240 nmInjection : 5 µL (0.1 mg/mL)

(S930706E) (S930706C)

(J010528B)(S930706B)



Diuretics


Part number : AS12S03L502WTEluent : methanol / 1% acetic acid (40/60)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.08 AUFSInjection : 3 µL (0.015 - 0.2 mg/mL)

Antineoplastic and related compounds

1. Uracil

2. 5-Fluorouracil

3. Deoxyuridine

4. 5-Fluoro-2'-deoxyuridine


Part number : AA12S051546WTEluent : 10mM NH4H2PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.025 ~ 0.2 mg/mL)

Antineoplastic and related compounds

1. Uracil

2. 5-Fluorouracil

3. Deoxyuridine

4. 5-Fluoro-2'-deoxyuridine


Part number : AQ12S051546WTEluent : 10mM NH4H2PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.025 ~ 0.2 mg/mL)

Folic acid and its antagonists

1. Aminopterin

2. Methotrexate

3. Folic acid


Part number : JM08S04L546WTEluent : methanol/water/acetic acid (20/80/1)Flow rate : 1.0 mL/minTemperature : ambient(25 ˚C)Detection : UV at 300 nm, 0.04 AUFSInjection : 5 µL (16 µg/mL)

(A980716A)

(T920924G)

(T920924E)

(S921217A)



·

·

·

·

Antiarrhythmic drugs


Part number : BS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) / methanol (40/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.26 AUFSInjection : 5 µL (0.05 - 0.1 mg/mL

Diuretics

1. Hydrochlorothiazide

2. Chlorthalidone

3. Furosemide


Part number : AS12S051546WTEluent : 20mM NH4H2PO4 - H3PO4(pH 3.2)/methanol (60/40)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.16 AUFSInjection : 15 µL (0.015 ~ 0.2mg/mL)

12

3

4

6

5

1.

2.

3.

4.

6.

5.

5 10 150 min

Lidocaine

CH3)2N(CH2NHCCH2

OCH3

CH3

H2N

O

COCH2CH3

Benzocaine(Ethyl 4-aminobenzoate)

H2N

O

COCH2CH2N(CH2CH3)2

Procaine HCl·HCl

O

COCH2CH2N(CH3)2

·HCl

NHCH2CH2CH2CH3

Tetracaine HCl

H2N

O

COCH2CH2CH2N(C4H9)2

Butacaine

N

CH2 CH

CHON

H

Cinchonine

H

H

Local anesthetics


Part number : HS12S03L546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) / methanol (40/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.02 - 0.5 mg/mL)

Diuretics

1. Hydrochlorothiazide

2. Chlorthalidone

3. Furosemide


Part number : AQ12S051546WTEluent : 20mM NH4H2PO4 - H3PO4(pH 3.2)/methanol (60/40)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.16 AUFSInjection : 15 µL (0.015 ~ 0.2mg/mL)

(S990817C) (J010302E)

(A970426D)(A970425C)



Nicotinic acid analogues

1. Isonicotinic acid

2. Nicotinic acid

3. Isonicotinic acid hydrazide

4. Nicotinamide

5. N' -Methylnicotinamide


Part number : OC12S051546WTEluent : acetonitrile/20mM KH2PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.64 AUFSInjection : 13 µL (0.2 mg/mL)

Basic compounds

1. Uracil

2. Procainamide

3. N-Acetylprocainamide

4. 4'-Hydroxyacetophenone


Part number : AM12S051546WTEluent : 20mM K2HPO4 - KH2PO4 (pH 6.9)/acetonitrile (92/8)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 10 µL (30 ~ 300 É g/mL)

Basic compounds

1. Uracil

2. Procainamide

3. N-Acetylprocainamide

4. 4'-Hydroxyacetophenone


150 x 4.6 mm I.D.Part number : PC99S061546WTEluent : 20mM K2HPO4 - KH2PO4 (pH 6.9)/acetonitrile (92/8)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.32 AUFSInjection : 10 µL (30 ~ 300 É g/mL)

Disinfectants

1. Benzoic acid

2. Salicylic acid

3. Theophylline (I.S.)

4. Phenol


Part number : AL12S051546WTEluent : 100mM KH2PO4 - Na2HPO4 (pH 7.0)/methanol (75/25)Flow rate : 0.8 mL/minTemperature : 30 ˚CDetection : UV at 270 nm, 0.13 AUFSInjection : 3 µL (0.1 ~ 0.8 mg/mL)

(K940125K)

(T931217B)

(S921217A)

(S930617D)



Acyclovir

1. Acyclovir


Part number : AS12S051546WTEluent : acetonitrile / 0.05% formic acid (3 / 97)Flow rate : 1.5 mL/minDetection : UV at 254 nmInjection : 5 µL (0.1 mg/mL)

Xanthine oxidase inhibitor and related compounds

1. Uric acid

2. Hypoxanthine

3. Xanthine

4. Oxipurinol

5. Allopurinol


Part number : JM08S041546WTEluent : 50mM NH4H2PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.51 AUFSInjection : 8 µL (0.05 ~ 0.2 mg/mL)

5 10 15 200 min

12

L-Histidine hydrochloride

Carnitine chloride

Cl-(CH3)3N+CH2CHCH2COOH

OH

N

N

H

CH2CHCOOHNH2

·HCl

1.

2.

Carnitine chloride

Column : Hydrosphere™ C18 (5µm, 120Å)150 X 4.6 mm I.D.

Part number : HS12S051546WTEluent : 50mM NaH2PO4-H3PO4(pH2.6)

containing 15mM 1-pentanesulfonic acid sodium saltFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 210 nm, 0.064 AUFSInjection : 4 µL (0.2 ~ 20 mg/mL)

Xanthine oxidase inhibitor and related compounds

1. Uric acid

2. Hypoxanthine

3. Xanthine

4. Oxipurinol

5. Allopurinol


Part number : JL08S041546WTEluent : 50mM NH4H2PO4Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.51 AUFSInjection : 8 µL (0.05 ~ 0.2 mg/mL)

(J010528C)

(F000629A)

(S930729B)(S930728J)



Anti-human immunodeficiency virus (HIV) agents


Part number : AA12S051546WTEluent : methanol/10mM KH2PO4 (10/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 7 µL (0.125 mg/mL)


1. DDC

2. DDI

3. D4T

4. AZT


Part number : BU12S051546WTEluent : methanol/10mM KH2PO4 (10/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 7 µL (0.125 mg/mL


1. DDC

2. DDI

3. D4T

4. AZT


Part number : OC12S051546WTEluent : methanol/10mM KH2PO4 (10/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 7 µL (0.125 mg/mL)

Nicotinic acid analogues

1. Isonicotinic acid

2. Nicotinic acid

3. Isonicotinic acid hydrazide

4. Nicotinamide

5. N' -Methylnicotinamide


Part number : AA12S051546WTEluent : acetonitrile/20mM KH2PO4 (5/95)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 260 nm, 0.64 AUFSInjection : 13 µL (0.2 mg/mL)

(K930311C) (K930311A)

(K940125I)(K930311F)

1. DDC

2. DDI

3. D4T

4. AZT



Hippuric and methylhippuric acids

1. Mandelic acid

2. Hippuric acid

3. o-Methylhippuric acid

4. m-Methylhippuric acid

5. p-Methylhippuric acid


Part number : JM08S041546WTEluent : 20mM NH4H2PO4 - H3PO4 (pH 3.2)/methanol (80/20)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 225 nm, 0.16 AUFSInjection : 10 µL (0.04 ~ 0.07 mg/mL)

(A961119A)

1

2

3

4

5

10 20 300 min

CHCOOH

CH3

FFlurbiprofen

COOCH3

Methyl benzoate

Lidocaine

CH3)2N(CH2NHCCH2

OCH3

CH3

Diltiazem HCl

OCH3

ON

OCOCH3S

CH2CH2N(CH3)2

·HCl

Verapamil HCl

H3CO C

OCH3

CH(CH3)2

CN

(CH2)3NCH2CH2

CH3H3CO

OCH3

·HCl

1.

2.

3.

4.

5.

Acidic and basic drugs

Column : YMC-Pack™ Pro C18 RS™ (5µm, 80Å)150 x 4.6 mm I.D.

Part number : RS08S051546WTEluent : 20mM CH3COONH4(ph 6.8) / methanol (40/60)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 220 nm, 0.64 AUFSInjection : 10 µL (0.1mg/mL, 0.036 mg/mL)

(C020517A)

1

2

3

4

5

CHCOOH

CH3

FFlurbiprofen

COOCH3

Methyl benzoate

Lidocaine

CH3)2N(CH2NHCCH2

OCH3

CH3

Diltiazem HCl

OCH3

ON

OCOCH3S

CH2CH2N(CH3)2

·HCl

Verapamil HCl

H3CO C

OCH3

CH(CH3)2

CN

(CH2)3NCH2CH2

CH3H3CO

OCH3

·HCl

1.

2.

3.

4.

5.

10 20 300 min

Acidic and basic drugs


Part number : JM08S041546WTEluent : 20mM CH3COONH4-NH3 (pH8.9) /methanol (35/65)Flow rate : 1.0 mL/minTemperature : 30 ˚CPressure : 13.1 MPaDetection : UV at 220 nm, 0.64 AUFSInjection : 10 µL (0.1 mg/mL, 0.036µL/mL)

(C020425A)

2.

1

2

1.

10 200 min

COOCH3

NHCNHCNH(CH2)6NHCNHCNHCl ClNH NH NH NH

�E2HClChlorhexidine�E2HCl

Methyl benzoate

Chlorhexidine


Part number : AS12S051546WTEluent : acetonitrile/water/TFA (30/70/0.1)Flow rate : 1.0 mL/minTemperature : 30 ˚CPressure : 8.0 MPaDetection : UV at 220 nm, 0.16 AUFSInjection : 10 µL (0.1mg/mL )

(A020117C)



Purine catabolites1. Allantoin2. Allantoic acid3. Uric acid


Part number : AM12S051506WTEluent : 10mM CH3COOHFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 200 nm, 0.16 AUFSInjection : 4 µL (0.10 ~ 0.71 mg/mL)

Purine catabolites1. Allantoin2. Allantoic acid3. Uric acid


Part number : AQ12S051506WTEluent : 10mM CH3COOHFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 200 nm, 0.16 AUFSInjection : 4 µL (0.10 ~ 0.71 mg/mL)

10 20 30 400 min

1

2

3

4

5

67

8

9

Catecholamines

1. Norepinephrine hydrochloride2. Epinephrine3. 3,4-Dihydroxyphenylalanine

(DOPA)4. Dopamine hydrochloride5. 4-Hydroxy-3-methoxymandelic acid6. 3-Methoxytyramine hydrochloride7. 4-Hydroxy-3-methoxyphenylglycol8. 3,4-Dihydroxyphenylacetic acid9. Homovanilic acid


Part number : HS12S051546WTEluent : A)50mM KH2PO4-H3PO4(pH 3.1)

B)50mM KH2PO4-H3PO4(pH 3.1)/acetonitrile (90/10)0%B (0-5min), 0-100%B (5-25min,linear), 100%B (25-35min)


Hippuric and methylhippuric acids

1. Mandelic acid

2. Hippuric acid

3. o-Methylhippuric acid

4. m-Methylhippuric acid

5. p-Methylhippuric acid


Part number : AS12S051546WTEluent : 20mM NH4H2PO4 - H3PO4 (pH 3.2)/methanol (80/20)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 225 nm, 0.16 AUFSInjection : 10 µL (0.04 ~ 0.07 mg/mL)

(G910607G)

(F000817A)

(G910618A)

(A961114A)

Antibiotics 10


Sulfonamides

6. Sulfathiazole

7. Trimethoprim

8. Sulfapyridine

9. Sulfamerazine

10. Sulfamethoxypyridazine

11. Sulfamethazine

Column : J’Sphere™ ODS-H80 (4µm, 80Å)250 x4.6 mm I.D.

Part number : JH08S042546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.2)/THF (90/10)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 10 µL (18 µg/mL)

Sulfonamides

6. Sulfamonomethoxine hydrate

7. Sulfadoxine

8. Sulfamethoxazole

9. Sulfadimethoxine

10. Sulfaquinoxaline sodium


Part number : JM08S04L546WTEluent : THF/acetonitrile/50mM NH4H2PO4 (15/5/80)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 3 µL (50 µg/mL)

Sulfonamides1. Sulfamethazine

2. Sulfadoxine

3. Sulfamonomethoxine hydrate

4. Sulfisoxazole

5. Sulfamethoxazole

6. Sulfachloropyridazine

7. Sulfadimethoxine

8. Sulfaquinoxaline sodium


Part number : AA12S052546WTEluent : THF/water/acetic acid (30/70/1)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 5 µL (42 µg/mL)

1

2

3

4

6

75

Sulfathiazole

2.

3.

Sulfamerazine

4.

Sulfadimidine

5.1.

Sulfisomidine Sulfamonomethoxine

6.

Sulfamethoxazole

7.

Sulfadimethoxine

5 10 15 200 min

NH2 SO2NHN

N

CH3

CH3

N

S

N

N

CH3

CH3

CH3

NN

OCH3

ONCH3

OCH3

OCH3

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

N

N

NN

Sulfonamides


Part number : HS12S030546WTEluent : 10mM CH3COOH - CH3COONH4 (pH 4.6) / acetonitrile

(85/15)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 10 µL (0.01 - 0.04 mg/mL)

(O950324L) (O950302C)

(J010321F)(O950217D)

1. Sulfaguanidine

2. Sulfamethizole

3. Sulfanilamide

4. Sulfisomidine

5. Sulfadiazine

1. Sulfisomidine

2. Sulfathiazole

3. Sulfadiazine

4. Sulfamerazine

5. Sulfamethazine

Antibiotics 10


Antibacterial agents1. Olaquindox2. Carbadox3. Thiamphenicol4. Sulfamerazine5. Sulfadimidine6. Sulfamonomethoxine7. Furazolidone8. Oxolinic acid9. Sulfaquinoxaline

10. Sulfadimethoxine11. Nalidixic acid12. Piromidic acid


Part number : AA12S052546WTEluent : A)acetonitrile/50mM NH4H2PO4 (10/90)

B)acetonitrile/50mM NH4H2PO4 (80/20)25%B (0-5min), 25-100%B (5-15min), 100%B (15-20min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 240 nm, 0.32 AUFSInjection : 10 µL (0.05 mg/mL

Antibacterial agents

1. Olaquindox2. Carbadox3. Thiamphenicol4. Sulfamerazine5. Sulfadimidine6. Sulfamonomethoxine7. Furazolidone8. Oxolinic acid9. Sulfaquinoxaline

10. Sulfadimethoxine11. Nalidixic acid12. Piromidic acid


Part number : JL08S042546WTEluent : A)acetonitrile/50mM NH4H2PO4 (10/90)

B)acetonitrile/50mM NH4H2PO4 (80/20)25%B (0-5min), 25-100%B (5-15min), 100%B (15-20min)


Antibacterial agents

1. Diaveridine

2. Trimethoprim

3. Pyrimethamine


Part number : JM08S04L546WTEluent : acetonitrile/50mM NH4H2PO4 (15/85)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 5 µL (20 µg/mL)

Sulfonamides

6. Sulfapyridine

7. Sulfamerazine

8. Sulfamethizole

9. Sulfamethoxypyridazine

10. Sulfamethazine


Part number : JM08S042546WTEluent : THF/50mM NH4H2PO4 (10/90)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 3 µL (50 µg/mL)

(K940614B)

(O950320G)

(K940615C)

(O950306E)

1. Sulfaguanidine

2. Sulfanilamide

3. Sulfisomidine

4. Sulfathiazole

5. Sulfadiazine

Antibiotics 10


1

2

3

4

6

5

N

NNH2 SO2NH

Sulfathiazole

2.

3.

Sulfamerazine

4.

Sulfadimidine

5.1.

Sulfadiazine Sulfamonomethoxine

6.

Sulfamethoxazole

N

S

N

N

CH3

CH3

CH3

NN

OCH3

ONCH3

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

NH2 SO2NH

N

N

5 100 min

Sulfonamides


Part number : HS12S03L502WTEluent : 10mM CH3COOH - CH3COONH4 (pH 4.6) / acetonitrile

(85/15)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 275 nm, 0.16 AUFSInjection : 2 µL (0.02 mg/mL)

Antibiotics


Part number : AM12S051546WTEluent : A)acetonitrile/50mM NH4H2PO4 (10/90)

B)acetonitrile/50mM NH4H2PO4 (50/50)0-55%B (0-30min,linear), 55%B (30-40min)


Nalidixic acid antibiotics1. Pipemidic acid

2. Enoxacin

3. Cinoxacin

4. Norfloxacin

5. Ofloxacin

6. Nalidixic acid

7. Oxolinic acid

8. Piromidic acid


Part number : JH08S041546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.7)/tetrahydrofuran (90/10)

containing 20mM TBA•BrFlow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 260 nm, 0.32 AUFSInjection : 5 µL (0.03 mg/mL)

Nalidixic acid antibiotics


Part number : AM12S051546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.7)/tetrahydrofuran (90/10)

containing 20mM TBA•BrFlow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 260 nm, 0.32 AUFSInjection : 5 µL (0.03 mg/mL)

(J010130D)

(O950428A)

(G910523M)

(O950428D)

1. Ampicillin2. Cephalexin3. Oxytetracycline hydrochloride4. Tetracycline5. Chlorotetracycline6. Chloramphenichol7. Oxolinic acid8. Doxorubicin hydrochloride9. Nalidixic acid

1. Pipemidic acid

2. Enoxacin

3. Cinoxacin

4. Norfloxacin

5. Ofloxacin

6. Nalidixic acid

7. Oxolinic acid

8. Piromidic acid

Antibiotics 10



Part number : HS12S030502WTEluent : acetonitrile / 50mM NaH2PO4 (25/75)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.128 AUFSInjection : 1 µL (0.02 - 0.1 mg/mL)

Cephalosporin antibiotics1. Cefsulodin sodium2. Cephalexin hydrate3. Cefaclor4. Cephradine5. Cephaloglycin6. Cephapirin sodium7. Cefotaxime sodium8. Cephaloridine9. Cefazolin sodium

10. Cefuroxime sodium11. Cefoxitin sodium


Part number : JH08S042546WTEluent : acetonitrile/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.12 ~ 0.35 mg/mL)



Part number : HS12S030502WTEluent : 10mM CH3COOH - CH3COONH4(pH 4.3) / acetonitrile

(75/25)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.128 AUFSInjection : 1 µL (0.02 - 0.1 mg/mL)




Part number : JM08S042546WTEluent : acetonitrile/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.12 ~ 0.35 mg/mL)

(A010324C) (A010324A)

(O940715F)(O940719A)


Antibiotics 10


Cephalosporin antibiotics

1. Cefadroxil

2. Cephalosporin C potassium

3. Cefatrizine propylene glycol

4. Cephalexin hydrate

5. Cephaloridine


Part number : AQ12S051546WTEluent : methanol/water/acetic acid (10/85/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.2 mg/mL)


1. Cefoperazone sodium

2. Cephalothin sodium

3. Cefamandole sodium


Part number : JH08S04L546WTEluent : THF/50mM NH4H2PO4 (15/85)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.17 mg/mL)


1. Cefadroxil




5. Cephaloridine


Part number : AM12S051546WTEluent : methanol/water/acetic acid (10/85/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.2 mg/mL)






Part number : JM08S04L546WTEluent : THF/50mM NH4H2PO4 (15/85)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.17 mg/mL)

(O940927G) (O941025E)

(O940928Q)(O940928P)

Antibiotics 10




Column : J’Sphere™ ODS-L80 (4µ m, 80Å)250 x 4.6 mm I.D.

Part number : JL08S042546WTEluent : acetonitrile/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.12 ~ 0.35 mg/mL)


1. Cefadroxil




5. Cephaloridine


Part number : JH08S041546WTEluent : methanol/water/acetic acid (10/85/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.2 mg/mL)

(O940718B) (O940927B)


1. Cefadroxil




5. Cephaloridine


Part number : JM08S04156WTEluent : methanol/water/acetic acid (10/85/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.2 mg/mL)


1. Cefadroxil




5. Cephaloridine


Part number : JL08S041546WTEluent : methanol/water/acetic acid (10/85/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.2 mg/mL)

(O940927C) (O940927I)

Antibiotics 10



1. Ceftriaxone sodium

2. Cefotaxime sodium


Part number : JM08S04L546WTEluent : methanol/50mM NH4H2PO4 (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.08, 0.16 mg/mL)





Part number : JH08S04L502WTEluent : methanol/50mM NH4H

2PO4 (30/70)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 3 µL (0.08, 0.16 mg/mL)

(O940928F) (O940929K)


1. Cephaloglycin


3. Cephapirin sodium


Part number : JM08S04L546WTEluent : acetonitrile/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.64 AUFSInjection : 5 µL (0.5 mg/mL)

1

23

4

5 10 15 200 min

CH

CH3

S

N

NHCO

NH2COOH

CH

CH2OCOCH3

S

N

NHCO

NH2COOH

Cephalexin

Cephaloglycin

CH

Cl

S

N

NHCO

NH2COOH

Cefaclor

COS CH2

CH2

S

NO

NH

COOHCephaloridine

O

O

O

1

2

3

4

+N



Part number : HS12S051546WTEluent : acetonitrile/20mM KH2PO4 (10/90) Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 15 µL (0.1 ~ 0.2 mg/mL)

(S000717B)(O940720A)

Antibiotics 10







Part number : JL08S04L546WTEluent : THF/50mM NH4H2PO4 (15/85)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.17 mg/mL)






Part number : JH08S04L502WTEluent : THF/50mM NH4H2PO4 (15/85)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 3 µL (0.17 mg/mL)

(O940928R) (O940929D)






Part number : AA12S030546WTEluent : THF/50mM NH4H2PO4 (15/85)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 6 µL (0.17 mg/mL)





Part number : JH08S04L546WTEluent : methanol/50mM NH4H2PO4 (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 5 µL (0.08, 0.16 mg/mL)

(O940928S) (O940928G)

Antibiotics 10


Cefoxitin sodium

1. Caffeine (I.S.)

2. Cefoxitin sodium


Part number : JH08S041502WTEluent : acetonitrile/50mM KH2PO4 (20/80)Flow rate : 0.34 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 1.2 µL (1.6, 2.4 mg/mL)

Penicillin antibiotics1. Bacampicillin hydrocloride

2. Methicillin sodium

3. Penicillin G potassium

(Benzylpenicillin potassium)

4. Penicillin V potassium(Phenoxymethylpenicillin potassium)

5. Phenethicillin potassium(Phenoxyethylpenicillin potassium)

6. Cloxacillin sodium

7. Propicillin potassium

8. Dicloxacillin sodium


Part number : JH08S041546WTEluent : 50mM NaH2PO4 - H3PO4 (pH 2.3)/acetonitrile (67/33)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.26 AUFSInjection : 8 µL (0.13 mg/mL)

(O940729A) (O950908A)

Penicillin antibiotics

1. Amoxicillin hydrate

2. Ampicillin anhydrous


Part number : JH08S04L546WTEluent : 50mM NaH2PO4 - H3PO4 (pH 2.3)/acetonitrile (80/20)

containing 20mM sodium 1-heptanesulfonateFlow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.13 AUFSInjection : 2 µL (0.3, 0.7 mg/mL)

1.

2.

5 10 150 min

CH

COOH

CH3CH3

S

NO

NHCO

NH2

HO

Amoxicillin

N

NN

NO

O

Caffeine

CH3

H3CCH3

1

2

Amoxicillin


Part number : HS12S051546WTEluent : acetonitrile / water / TFA (10/90/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 10 µL (0.2, 0.1 mg/mL)

(S000622D)(O950920C)

Antibiotics 10


1

2

1.

2.

CH

CH2

S

N

(CH2)3OCNH

COCH3COOK

O O

OH

Cephalosporin C potassium

ResorcinolOH

HOOC

5 10 150 min

H2N

Cephalosporin C


Part number : HS12S051546WTEluent : acetonitrile/20mM KH2PO4 (5/95) Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 10 µL (0.2 mg/mL)

1

2

5 10 150 min

C

CH2S

S

N

NHCO

NOCH3COONa

O N

NN

O

OHS

N

OH

Ceftriaxone sodium

Phenol (I.S.)

1.

2.

H2N H3C

Ceftriaxone


Part number : HS12S051546WTEluent : methanol / 10mM H3PO4 (25/75)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 10 µL (0.1, 0.4 mg/mL)

(S000714B) (S000726B)

Cefoxitin sodium

1. Caffeine (I.S.)

2. Cefoxitin sodium


Part number : JH08S04L546WTEluent : acetonitrile/50mM KH2PO4 (20/80)Flow rate : 1.8 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 1.2 µL (8, 12 mg/mL)

Cefoxitin sodium

1. Caffeine (I.S.)

2. Cefoxitin sodium


Part number : JH08S04L502WTEluent : acetonitrile/50mM KH2PO4 (20/80)Flow rate : 0.34 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.32 AUFSInjection : 1.2 µL (1.6, 2.4 mg/mL)

(O940728M) (O940728P)

Antibiotics 10


Erythromycin antibiotic drugs

1. Erythromycin2. Erythromycin ethylsuccinate3. Erythromycin estolate


Part number : JH08S041546WTEluent : acetonitrile/methanol/100mM (NH4)2HPO4(45/15/40)Flow rate : 1.0 mL/minTemperature : 45 ˚CDetection : UV at 210 nm, 0.26 AUFSInjection : 15 µL (2.5 mg/mL)

Tetracycline antibiotics

1. Oxytetracycline hydrochlo-ride

2. Tetracycline hydrochloride


Part number : AS12S051546WTEluent : acetonitrile/10mM oxalic acid (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.13 AUFSInjection : 6 µL (0.2 mg/mL)

(S930910B) (S970524D)

Tetracycline antibiotics

1. Oxytetracycline hydrochloride

2. Tetracycline hydrochloride


Part number : JH08S041546WTEluent : acetonitrile/10mM oxalic acid (10/90)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 280 nm, 0.13 AUFSInjection : 4 µL (0.2 mg/mL)

10 200 min

1

2

OH

NH2

H

O

O

HO

H

H

H

HHHO

OH H

CH3

CH3

O

CH2OH

Cl

O

NH

O

CH3

H3C

NH

CH3

OHN

CNH2

ONH

O

O

NH

HN

OCl

HO

O NH

CO2H

OH

OHOH

Vancomycin hydrochloride

4'-Hydroxyacetophenone

OH

O

CO CH3

OH

1.

2.

HCl

Vancomycin


Part number : HS12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH 6.9) / acetonitrile

(88/12)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 220 nm, 0.32 AUFSInjection : 10 µL (0.1 mg/mL

(S921217A) (S000728B)


Pesticides, Environmental11

Copper 8-quinolinolate1. Copper 8-quinolinolate


Part number : HS12S051502WTEluent : acetonitrile/20mM H3PO4 (5/95)Flow rate : 0.2 mL/minTemperature : 37 ˚CDetection : UV at 250 nm, 0.32 AUFSInjection : 2 µL (0.02 mg/mL)

Herbicides1. Atrazine-desisopropyl2. Atrazine-dsethyl3. Crimidine4. Hexazinone5. Metoxuron6. Simazine7. Cyanazine8. Atraton9. Atrazine

10 Isoproturon11. Diuron12. Prometon13. Metobromuron14. Terbumeton15. Metazachlor16. Ametryn17. Sebuthylazine18. Propazine19. Terbuthylazine20. Linuron21. Prometryn22. Terbutryn23. Metolachlor


Part number :JH08S042546WTEluent : A)acetonitrile/50mM NH4H2PO4 (20/80)

B)acetonitrile/50mM NH4H2PO4 (65/35)0-100%B (0-60min, linear)


(A010717A)

(O941020H)

Atrazine derivatives

1. Atrazine-2-hydroxy

2. Atrazine-dsisopropyl

3. Atrazine-deethyl

4. Atrazine


Part number : JH08S04L546WTEluent : acetonitrile/water/TFA (25/75/0.1)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.16 AUFSInjection : 5 µL (0.04 mg/mL)

Triazine herbicides1. Cyanazine2. Simazine3. Atraton4. Atrazine5. Prometon6. Terbumeton7. Sebuthylazine8. Propazine9. Terbuthylazine

10. Prometryn11. Terbutryn


Part number : JH08S041546WTEluent : acetonitrile/50mM NH4H2PO4 (45/55)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.32 AUFSInjection : 5 µL (0.05 mg/mL)

(O941102F)(O941020H)



Triazine herbicides

5. Sebuthylazine

6. Propazine

7. Terbuthylazine

8. Prometryn

9. Terbutryn


Part number : AS12S052546WTEluent : acetonitrile/50mM NH4H2PO4 (45/55)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.32 AUFSInjection : 5 µL (0.05 mg/mL)

(A970210B)

1. Simazine

2. Atrazine

3. Prometon

4. Terbumeton

Urea herbicides

1. Metoxuron

2. Isoproturon

3. Diuron

4. Metobromuron

5. Linuron


Part number : JH08S04L546WTEluent : THF/water (30/70)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.16 AUFSInjection : 4 µL (0.2 mg/mL)

(O941028B)

Acid amide herbicides

1. Metazachlor

2. Metolachlor

3. Alachlor

4. Butachlor


Part number : JM08S04L546WTEluent : 2-propanol/THF/water (25/15/60)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 210 nm, 0.16 AUFSInjection : 8 µL (0.05 mg/mL)Text

(O941108C)

Carbamate herbicides

1. Propham

2. Swep

3. Chloropropham


Part number : JL08S04L546WTEluent : acetonitrile/water (45/55)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 240 nm, 0.16 AUFSInjection : 5 µL (0.08 mg/mL)

(O941124G)



1

2

3

4

5

1.

2.

3.

4.

5.

5 100 min

(CH3)2NC C

O

SCH3

O

NOCNHCH3

Oxamyl

CH3S

O

NOCNHCH3

Aldicarb

C(CH3)2CH

O

OCNHCH3O

O

CH3

CH3

Bendiocarb

O

OCNHCH3CH2SC2H5

Ethiofencarb

CH3H3C

N(CH3)2

Pirimicarb

NN(CH3)2NCO

O

Carbamate insecticides


Part number : HS12S03L546WTEluent : methanol / 20mM KH2PO4 (45/55)Flow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 240 nm, 0.64 AUFSInjection : 5 µL (0.1 - 1.5 mg/mL)

Fungicides

1. Thiabendazole

2. o-Phenylphenol

3. Imazalil

4. Diphenyl


Part number : AS12S05L546WTEluent : methanol/20mM NH4H2PO4 (70/30)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.32 AUFSInjection : 10 µL (0.02 ~ 0.20 mg/mL)

(J010220D) (A970217A)

Fungicides


Part number : AA12S05L546WTEluent : methanol/20mM NH4H2PO4 (70/30)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.32 AUFSInjection : 10 µL (0.02 ~ 0.20 mg/mL)

Imazalil1. Imazalil


Part number : JM08S041546WTEluent : acetonitrile/20mM NH4H2PO4 (50/50)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.04 AUFSInjection : 10 µL (0.05 mg/mL)

(B931007A)(A970219A)

1. Thiabendazole

2. o-Phenylphenol

3. Imazalil

4. Diphenyl



2,4-Dinitrophenylhydrazones of aldehydes and ketones

1. Formaldehyde 2,4-DNPH2. Acetaldehyde 2,4-DNPH3. Acetone 2,4-DNPH4. Acrolein 2,4-DNPH5. Propionaldehyde 2,4-DNPH6. Crotonaldehyde 2,4-DNPH7. Methylethylketone 2,4-DNPH8. Isobutyraldehyde 2,4-DNPH9. Benzaldehyde 2,4-DNPH

10. n-Valeraldehyde 2,4-DNPH11. p-Tolualdehyde 2,4-DNPH12. Capronaldehyde 2,4-DNPH


Part number : BU12SO51546WTEluent : A)tetrahydrofuran/water (10/90)

B)acetonitrile35%B (0-7min), 35-65%B (7-18min, linear), 100%B (18-19min),35%B (19-35min)


(T920302A)

2,4-dinitrophenylhydrazones of aldehydes and ketones

1. Formaldehyde 2,4-DNPH2. Acetaldehyde 2,4-DNPH3. Acetone 2,4-DNPH4. Acrolein 2,4-DNPH5. Propionaldehyde 2,4-DNPH6. Crotonaldehyde 2,4-DNPH7. Methylethylketone 2,4-DNPH8. Isobutyraldehyde 2,4-DNPH9. Benzaldehyde 2,4-DNPH10. n-Valeraldehyde 2,4-DNPH11. p-Tolualdehyde 2,4-DNPH12. Capronaldehyde 2,4-DNPH


Part number : JH08S04L546WTEluent : A)tetrahydrofuran/water (20/80)

B)acetonitrile/methanol (90/10)30-67%B (0-15min, Linear), 30%B (15-25min)


(T931130D)

Polyaromatic hydrocarbons1. Benzene2. Naphthalene3. 7,12-Dimethylbenzo[a]anthracene4. Acenaphthylene5. Diphenyl6. Fluorene7. Naphthacene8. Acenaphthene9. Phenanthrene10. Anthrathene11. Fluoranthene12. Pyrene13. Triphenylene14. Chrysene15. Perylene16. Benzo[e]pyrene17. Benzo[b]fluoranthene18. Benzo[k]fluoranthene19. Benzo[a]pyrene20. Dibenzo[a,h]anthracene21. Benzo[g,h,i]perylene22. Coronene


Part number : JH08S042546WTEluent : acetonitrile/water (65/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 7 µL

(K930918A)

Polyaromatic hydrocarbons1. Benzene2. Naphthalene3. Acenaphthylene4. 7,12-Dimethylbenzo[a]anthracene5. Diphenyl6. Fluorene7. Acenaphthene8. Naphthacene9. Phenanthrene10. Anthrathene11. Fluoranthene12. Pyrene13. Triphenylene14. Chrysene15. Perylene16. Benzo[e]pyrene17. Benzo[b]fluoranthene18. Benzo[k]fluoranthene19. Benzo[a]pyrene20. Dibenzo[a,h]anthracene21. Benzo[g,h,i]perylene22. Coronene


Part number : JM08S042546WTEluent : acetonitrile/water (65/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 7 µL

(K930918B)



Polyaromatic hydrocarbons1. Benzene2. Naphthalene3. 7,12-Dimethylbenzo[a]anthracene4. Acenaphthylene5. Diphenyl6. Fluorene7. Naphthacene8. Acenaphthene9. Phenanthrene10. Anthrathene11. Fluoranthene12. Pyrene13. Triphenylene14. Chrysene15. Perylene16. Benzo[e]pyrene17. Benzo[b]fluoranthene18. Benzo[k]fluoranthene19. Benzo[a]pyrene20. Dibenzo[a,h]anthracene21. Benzo[g,h,i]perylene22. Coronene


Part number : JH08S041546WTEluent : A)acetonitrile/water (50/50)

B)acetonitrile30%B (0-5min), 30-100%B (5-40min), 100%B (40-50min)

Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 7 µL

(K930918C)


Miscellaneous 12

Benzoic acid derivatives


Part number : JL08S041546WTEluent : tetrahydrofuran/water/acetic acid (40/60/1)Flow rate : 0.5 mL/minTemperature : ambient (26 ˚C)Detection : UV at 260 nm, 0.32 AUFSInjection : 10 µL (0.04 ~ 0.2 mg/mL)

Methoxybenzoic acid isomers

1. o-Methoxybenzoic acid (o-Anisic acid)

2. p-Methoxybenzoic acid (p-Anisic acid)

3. m-Methoxybenzoic acid (m-Anisic acid)


Part number : JH08S04L546WTEluent : acetonitrile/water/acetic acid (20/80/1)Flow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 285 nm, 0.16 AUFSInjection : 10 µL (0.17 mg/mL

(O950511C) (O950508A)

1. p-Ethoxybenzoic acid

2. p-Propoxybenzoic acid

3. p-Isopropylbenzoic acid(Cuminic acid)

4. p-Buthoxybenzoic acid

5. p-tert -Butylbenzoic acid

Methoxybenzoic acid isomers

1. o-Methoxybenzoic acid(o-Anisic acid)

2. p-Methoxybenzoic acid(p-Anisic acid)

3. m-Methoxybenzoic acid(m-Anisic acid)


Part number : JM08S05L546WTEluent : acetonitrile/water/acetic acid (20/80/1)Flow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 285 nm, 0.16 AUFSInjection : 10 µL (0.17 mg/mL)

Chlorobenzoic acid isomers

1. o-Chlorobenzoic acid

2. m-Chlorobenzoic acid

3. p-Chlorobenzoic acid


Part number : JH08S041546WTEluent : acetonitrile/water/acetic acid (25/75/1)Flow rate : 1.0 mL/minTemperature : ambient (27 ˚C)Detection : UV at 270 nm, 0.04 AUFSInjection : 10 µL (0.17 mg/mL)

(O950509B)(O950508B)


Miscellaneous 12

Hydroxybenzoic acids

DHBA, Dihydroxybenzoic acidHBA, Hydroxybenzoic acid


Part number : JH08S041546WTEluent : acetonitrile/water/acetic acid (5/90/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 285 nm, 0.16 AUFSInjection : 5 µL (0.1 mg/mL)

Resorcylic acid isomers

1. α-Resorcylic acid

2. β-Resorcylic acid

3. Resorcinol

4. γ-Resorcylic acid


Part number : OC12S051546WTEluent : methanol/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 285 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.4 mg/mL)

(O940530D)(O940607C)

7. 2,3-DHBA

8. Benzoic acid

9. Salicylic acid

1. 3,5-DHBA

2. 3,4-DHBA

3. p-HBA

4. 2,5-DHBA

5. 2,4-DHBA

6. m-HBA

Resorcylic acid isomers

1. α-Resorcylic acid

2. β-Resorcylic acid

3. Resorcinol

4. γ-Resorcylic acid


Part number : PH12S051546WTEluent : methanol/100mM KH2PO4 (10/90)Flow rate : 0.8 mL/minTemperature : 37 ˚CDetection : UV at 285 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.4 mg/mL)

Benzoic acid derivatives

1. p-Ethoxybenzoic acid

2. p-Propoxybenzoic acid

3. p-Isopropylbenzoic acid(Cuminic acid)

4. p-Buthoxybenzoic acid

5. p-tert-Butylbenzoic acid


Part number : JM08S041546WTEluent : tetrahydrofuran/water/acetic acid (40/60/1)Flow rate : 0.5 mL/minTemperature : ambient (26 ˚C)Detection : UV at 260 nm, 0.32 AUFSInjection : 10 µL (0.04 ~ 0.2 mg/mL)

(O940606J) (O950511B)


Miscellaneous 12

Phenol derivatives


Part number : JH08S04L546WTEluent : 2-propanol/water/TFA (40/60/0.1)Flow rate : 0.4 mL/minTemperature : 37 ˚CDetection : UV at 230 nm, 0.13 AUFSInjection : 5 µL (0.04 mg/mL)

Phenol derivatives

1. o-Nitrophenol

2. o-Chlorophenol

3. m-Nitrophenol

4. p-Nitrophenol

5. m-Chlorophenol

6. p-Chlorophenol


Part number : JH08S041546WTEluent : tetrahydrofuran/water/acetic acid (35/65/1)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 240 nm, 0.13 AUFSInjection : 4 µL (0.08 mg/mL)

(O950616I) (O950614C)

1. 2,6-Dinitrophenol

2. 2,4,6-Trinitrophenol

3. 2,4-Dinitrophenol

4. 2,6-Dichlorophenol

5. 2,4-Dichlorophenol

6. 2,4,6-Trichlorophenol

Phenol derivatives

1. o-Nitrophenol

2. o-Chlorophenol

3. m-Nitrophenol

4. p-Nitrophenol

5. m-Chlorophenol

6. p-Chlorophenol

Column : YMC-Pack ODS-AM™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AM12S051546WTEluent : tetrahydrofuran/water/acetic acid (35/65/1)Flow rate : 0.5 mL/minTemperature : 37 ˚CDetection : UV at 240 nm, 0.13 AUFSInjection : 4 µL (0.08 mg/mL)

Cresol isomers

1. m-Cresol

2. p-Cresol

3. o-Cresol


Part number : JH08S041546WTEluent : acetonitrile/water (18/82)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 260 nm, 0.064 AUFSInjection : 10 µL (0.3 mg/mL)

(O951025B)(O950614F)


Miscellaneous 12

Chlorobenzoic acid isomers

1. o-Chlorobenzoic acid

2. m-Chlorobenzoic acid

3. p-Chlorobenzoic acid


Part number : AM12S051546WTEluent : acetonitrile/water/acetic acid (25/75/1)Flow rate : 1.0 mL/minTemperature : ambient (27 ˚C)Detection : UV at 270 nm, 0.04 AUFSInjection : 10 µL (0.17 mg/mL)

Polyphenols

1. Pyrogallol2. Hydroquinone3. Catechol4. Phenol


Part number : PH12S052546WTEluent : 5mM acetic acidFlow rate : 1.0 mL/minTemperature : 25 ˚CDetection : UV at 280 nm, 0.32 AUFSSample : reagentsInjection : 20 µL

(O950509D)(H890627A)

0 10 20min

1

2

3

4

Dimethylphenol isomers

1. 2,6-Dimethylphenol



Column : YMC-Pack Polyamine II™

250 x 4.6 mm I.D.Part number : PB12S052546WTEluent : 20% ethyl acetate in hexaneFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 20 µL (0.33 mg/mL)

Dimethylphenol isomers





Part number : NH12S052546WTEluent : 10% ethyl acetate in hexaneFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : UV at 254 nm, 0.08 AUFSInjection : 20 µL (0.33 mg/mL

(T921019B) (T921020C)








Miscellaneous 12

Aminoalcohols1. Ethanolamine2. Diethanolamine3. N-Methylethanolamine4. Triethanolamine5. N,N-Dimethylethanolamine

Column : YMC-Pack PolymerC18™

250 x 6.0 mm I.D.Part number : PC99S062506WTEluent : 100mM Na2HPO4/100mM NaOH (60/40, pH 12.0)Flow rate : 0.6 mL/minTemperature : 20 ˚CDetection : UV at 215 nm, 0.32 AUFSInjection : 50 µL (0.2 ~ 3.0 mg/mL)

Urea and related compounds1. Urea2. Propionamide3. Ethylurea4. 1,3-Diethylurea5. 1,1-Diethylurea

Column : YMC-Pack PolymerC18™

250 x 6.0 mm I.D.Part number : PC99S062506WTEluent : 0.4% HClO4 (pH 1.3)Flow rate : 0.5 mL/minTemperature : 25 ˚CDetection : UV at 210 nm, 0.32 AUFSInjection : 15 µL (0.4 ~ 7.5 mg/mL)

(M920124B) (M920108A)

A nonionic detergent1. Triton X-100


Part number : DL12S055008WTEluent : acetonitrile/water (10/90)Flow rate : 1.0 mL/minTemperature : ambient (23 ˚C)Detection : UV at 260 nm, 0.02 AUFSInjection : 15 µL (5.0 mg/mL)Sample : Triton X-100

Polyethyleneglycols1. PEG #20,000 (MW 20,000)2. PEG #6,000 (MW 8,400)3. PEG #4,000 (MW 3,350)4. PEG #1,000 (MW 1,000)5. PEG #300 (MW 300)6. Ethyleneglycol (MW 62)


Part number : DL12S055008WTEluent : acetonitrile/water(10/90)Flow rate : 1.0 mL/minTemperature : ambient (22 ˚C)Detection : RI, 64 x 10-6 RIU/FSInjection : 100 µL (1.67 mg/mL)

(G920123A)(G920109C)


Miscellaneous 12

Cresol isomers

1. m-Cresol

2. p-Cresol

3. o-Cresol



Metal-PAN chelates

1. Co (II)-1- (2-Pyridylazo)-2-naphthol2. Ni (II)-1- (2-Pyridylazo)-2-naphthol3. Fe (III)-1- (2-Pyridylazo)-2-naphthol4. Zn (II)-1- (2-Pyridylazo)-2-naphthol


Part number : AM12S051506WTEluent : acetonitrile/water (70/30) containig 0.01% PAN

and 10mM tetrabutylammonium bromideFlow rate : 1.0 mL/minTemperature : 30 ˚CDetection : VIS at 565 nm, 0.08 AUFSInjection : 12 µL (25 ~ 92 µg/mL)

(O951025C)(T910520A)

Coordination compounds1. Uracil2. Acetylacetone3. 8-Quinolinol


Part number : AM12S051546WTEluent : 20mM KH2PO4 - K2HPO4 (pH7.6)/methanol (40/60)Flow rate : 1.0 mL/minTemperature : 40 ˚CDetection : UV at 254 nm, 0.32 AUFS

Hinokitiol

1. Hinokitiol

2. 1-Naphthol(I.S.)


Part number : AM12S051546WTEluent : 20mM NH4H2PO4 containing 1mM EDTA•2Na/acetonitrile (65/35)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 320 nm, 0.16 AUFSInjection : 10 µL (0.08, 0.25 mg/mL

(M910604I) (O960507F)


Miscellaneous 12

Phthalic acid isomers

1. Phthalic acid

2. Terephthalic acid

3. Isophthalic acid

Column : YMC-Pack Pro C18™ (5µm, 120Å)150 x 3.0 mm I.D.

Part number : AS12S051503WTEluent : methanol/10mM H3PO4 (25/75)Flow rate : 0.4 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 4 µL (0.05 ~ 0.5 mg/mL)

Phthalic acid isomers

Column : YMC-Pack ODS-AQ™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AQ12S051546WTEluent : methanol/10mM H3PO4 (25/75)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.05 ~ 0.5 mg/mL)

(A971112B) (A971112A)

1. Phthalic acid

2. Terephthalic acid

3. Isophthalic acid

1

2

3

1.

2.

3.

10 200 min

m-Chlorophenol

OH

Cl

o-Chlorophenol

OHCl

OH

Clp-Chlorophenol

Chlorophenol isomers

Column : YMC-Pack Pro C18 RS™ (5µm, 80Å)150 x 4.6 mm I.D.

Part number : RS08S051546WTEluent : acetonitrile/water/acetic acid (30/70/1)Flow rate : 1.0 mL/minTemperature : 37 ˚CPressure : 8.8MPaDetection : UV at 230 nm, 0.31 AUFSInjection : 10 µL (0.1 ~ 0.2 mg/mL)

(J011113D)

1

2

3

1.

2.

3.

m-Chloroacetophenone

COCH3

Cl

o-Chloroacetophenone

COCH3Cl

COCH3

Clp-Chloroacetophenone

10 200 min

Chloracetophenone isomers

Column : YMC-Pack Pro C18 RS™ (5µm, 80Å)150 x 4.6 mm I.D.

Part number : RS08S051546WTEluent : acetonitrile/ water (40/60)Flow rate : 1.0 mL/minTemperature : 30 ˚CPressure : 9.7 MPaDetection : UV at 254 nm, 0.32 AUFSInjection : 8.0 µL (0.05 ~ 0.1 µl/mL)

(J011026B)


Miscellaneous 12

Fullerenes

1. Buckminsterfullerene(C60)

2. (5,6)-Fullerene(C70)

Column : YMC-Pack ODS-A™ (5µm, 120Å)150 x 6.0 mm I.D.

Part number : AA12S051506WTEluent : hexane/2-propanol (70/30)Flow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 350 nm, 0.08 AUFSInjection : 4 µL (0.125 mg/mL)

Fullerenes

1. Buckminsterfullerene(C60)

2. (5,6)-Fullerene(C70)


Part number : PH12S051506WTEluent : hexane/2-propanol (50/50)Flow rate : 1.0 mL/minTemperature : ambient (25 ˚C)Detection : UV at 350 nm, 0.08 AUFSInjection : 4 µL (0.125 mg/mL)

(S930119B) (S930128B)

Aromatic amines

1. p-Phenylenediamine

2. p-Aminophenol

3. m-Phenylenediamine

4. m-Aminophenol

5. o-Phenylenediamine

6. o-Aminophenol

Column : YMC-Pack Pro C18™ (5µm, 120Å)150 x 4.6 mm I.D.

Part number : AS12S051546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.7)/methanol (95/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.26 AUFSInjection : 5 µL (0.125 ~ 0.5 mg/mL)

Aromatic amines

1. p-Phenylenediamine

2. p-Aminophenol

3. m-Phenylenediamine

4. m-Aminophenol

5. o-Phenylenediamine

6. o-Aminophenol


Part number : AM12S051546WTEluent : 50mM NH4H2PO4 - (NH4)2HPO4 (pH 6.7)/methanol (95/5)Flow rate : 1.0 mL/minTemperature : 37 ˚CDetection : UV at 254 nm, 0.26 AUFSInjection : 5 µL (0.125 ~ 0.5 mg/mL)

(S961007C) (S961004E)


Miscellaneous 12

1

2

3

1.

2.

3.

10 200 min

m-Terphenyl

o-Terphenyl

p-Terphenyl

Terphenyl isomers

Column : YMC-Pack Pro C18™ RS (5µm, 80Å)150 x 4.6 mm I.D.

Part number : RS08S051546WTEluent : methanol/water (85/15)Flow rate : 1.0 mL/minTemperature : 37 ˚CPressure : 9.2 MPaDetection : UV at 254 nm, 0.16 AUFSInjection : 10 µL (0.02mg/mL)

(J020719E)


Acacetin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72Acenaphthene . . . . . . . . . . . . . . . . . . . . . . . .92,93,117,118Acenaphthylene . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Acetaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . . .117Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87,88Acetic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Acetoacetyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Acetone 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117Acetylacetone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124Acetyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31N -Acetylprocainamide . . . . . . . . . . . . . . . . . . . . . . . . . . .98Acid red . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Acrolein 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117Acyclovir . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99Adenine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,43Adenosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Adenylate kinase . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56-585'-ADP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45ADP-D-glucose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46,47Aflatoxin B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76Aflatoxin B2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76Aflatoxin G1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76Aflatoxin G2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76Alachlor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115Alanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49L-Alanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Albiflorin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69Aldicarb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Allantoic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102Allantoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29,102Allopurinol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99Amaranth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Ametryn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Amino Acids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49p -Aminobenzoic acid (PABA) . . . . . . . . . . . . . . . . . . . .27, 29o -Aminopehnol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126

p -Aminophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126Aminopterin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96Amitriptyline hydrochloride . . . . . . . . . . . . . . . . . . . . . . .92,93Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1115'-AMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45,46Ampicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105, 111Androsterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81trans -Androsterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81[Asn1,Val5] Angiotensin I . . . . . . . . . . . . . . . . . . . . . . . . . .49[Val5] Angiotensin I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49Angiotensin I . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49,50,51Angiotensin II . . . . . . . . . . . . . . . . . . . . . . . .49,50,52,55,56Angiotensin III . . . . . . . . . . . . . . . . . . . . . . . . . .49,50,52,53o -Anisic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .119m -Anisic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .119p -Anisic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .119Annatto extract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66Anthrathene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Antioxidants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63-65Apigenin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72

Apronalide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88Arabitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Arachidonic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Arbutin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69,75Arginine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Arginine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 49L-Ascorbic acid . . . . . . . . . . . . . . . . . . . . . . .25, 26, 28, 31L-Ascorbic acid 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . . .31Asparagine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Asparagine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49Aspartame . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66, 67Aspartic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Aspartic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 49Asulam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1135'-ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Atraton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Atrazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Atrazine-desethyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Atrazine-desisopropyl . . . . . . . . . . . . . . . . . . . . . . . . . . .114Atrazine-2-hydroxy . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Atropine sulfate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68AZT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100

Bacampicillin hydrochloride . . . . . . . . . . . . . . . . . . . . . . .111Baicalein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72Baicalin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69, 72BAM-12P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51Barbaloin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69Beclomethasone . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78,80Beclomethasone dipropionate . . . . . . . . . . . . . . . . . . . . . . .80Bendiocarb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Benfotiamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29, 30Bensulide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .113Benzaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . .117Benzalkonium chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . .89Benzene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77,117,118Benzethonium chloride . . . . . . . . . . . . . . . . . . . . . . . . .89, 90Benzo[a]pyrene . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Benzo[b]fluoranthene . . . . . . . . . . . . . . . . . . . . . . . .117,118Benzo[e]pyrene . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Benzo[g,h,i]perylene . . . . . . . . . . . . . . . . . . . . . . . .117,118Benzo[k]fluoranthene . . . . . . . . . . . . . . . . . . . . . . . .117,118Benzocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97Benzoic acid . . . . . . . . . . . . . . . . . . . . . . . . . .62,66,67,98Benzylpenicillin potassium . . . . . . . . . . . . . . . . . . . . . . . .111Bepridil HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94Betamethasone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78, 80Betamethasone valerate . . . . . . . . . . . . . . . . . . . . . . . . . . .80Bezafibrate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95BHA (Butyl hydroxyanisol) . . . . . . . . . . . . . . . . . . . . . . . . . .65BHT (Dibutyl hydroxytoluene) . . . . . . . . . . . . . . . . . . . . . . . .651,1,-Bi-2-naphthol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124Biotin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27Bisbentiamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30Bombesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51Bradykinin . . . . . . . . . . . . . . . . . . . . . . . . . . . .51-53, 58,59Brassicasterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84

A

B

Index of Analytes

Click anywhere on Index, Type desired Page #, Click OK


Brilliant Blue FCF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Bromovalerylurea . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87,90BSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49Bucetine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87, 88Bufalin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86Butacaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97Butachlor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115p -Buthoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . .119,120p -tert-Butylbenzoic acid . . . . . . . . . . . . . . . . . . . . . .119,120tert -Butylhydroquinone (TBHQ) . . . . . . . . . . . . . . . . . . .63, 64Butyl hydroxyanisol (BHA) . . . . . . . . . . . . . . . . . . . . . . . . . .64Butyl p-hydroxybenzoate . . . . . . . . . . . . . . . . .62, 63, 76, 91

Caffeine . . . . . . . . . . . . . . . . . . . . . . . . . .26,66,67,68, 87, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89,90,88,111,112Campesterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84Capronaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . .117Carbadox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Carbamazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92Carnitine chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99α−Carotene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21β−Carotene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,22Casein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56(+)-Catechin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73,74Catechol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .122Catecholamines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102CCK-Octapeptide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .525'-CDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45CDP-D-glucose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46,47Cefaclor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106, 108Cefadroxil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107,108Cefamandole sodium . . . . . . . . . . . . . . . . . . . . . . . .107,110Cefatrizine propylene glycol . . . . . . . . . . . . . . . . . . .107,108Cefazolin sodium . . . . . . . . . . . . . . . . . . . . . . . . . .106, 108Cefoperazone sodium . . . . . . . . . . . . . . . . . . . . . . .107,110Cefotaxime sodium . . . . . . . . . . . . . . . . . . . . .106, 108-110Cefoxitin sodium . . . . . . . . . . . . . . . . . . . .106,108,111,112Cefsulodin sodium . . . . . . . . . . . . . . . . . . . . . . . . . .106,108Ceftriaxone sodium . . . . . . . . . . . . . . . . . . . . . .109,110,112Cefuroxime sodium . . . . . . . . . . . . . . . . . . . . . . . . .106,108Cephalexin hydrate . . . . . . . . . . . . . . . . . . . . . . . . .105-108Cephaloglycin . . . . . . . . . . . . . . . . . . . . . . . . .106,108,109Cephaloridine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106-108Cephalosporin C potassium . . . . . . . . . . . . . . . .107,108,112Cephalothin sodium . . . . . . . . . . . . . . . . . . . . . . . . .107,110Cephapirin sodium . . . . . . . . . . . . . . . . . . . . . .106,108,109Cephradine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106,108Chenodeoxycholic acid (CDAC) . . . . . . . . . . . . . . . . . . . . .83Chloramphenichol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Chlorhexidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101o -Chlorobenzoic acid . . . . . . . . . . . . . . . . . . . . . . .119,122m -Chlorobenzoic acid . . . . . . . . . . . . . . . . . . . . . . .119,122p -Chlorobenzoic acid . . . . . . . . . . . . . . . . . . . . .87,119,122o -Chlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121m -Chlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121p -Chlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121Chlorophyll a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68

Chlorophyll b . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Chloropropham . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115Chlorotetracycline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Chloroheniramine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89Chlorpheniramine maleate . . . . . . . . . . . . . . . . . .87,88,90,91Chlorpromazine hydrochloride . . . . . . . . . . . . . . . . . . . . . .92Chlorthalidone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96,97Cholecalciferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,22Cholesterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84Cholic acid (CA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83Chondroitin, Na salt . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41Chondroitin sulfate A, Na salt . . . . . . . . . . . . . . . . . . . . . . .41Chondroitin sulfate B, Na salt . . . . . . . . . . . . . . . . . . . . . . .41Chondroitin sulfate C, Na salt . . . . . . . . . . . . . . . . . . . . . .42Chrysene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Chrysin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72Chrysoeriol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72Cinobufagin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86Cinchonine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68,97Cinoxacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105,106Citric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Clofibrate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95Cloxacillin sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1115'-CMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45, 46Codeine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90Coenzyme A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Coenzyme A glutathione disulfide . . . . . . . . . . . . . . . . . . . .31Coenzyme A oxidized . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Color additives (Acid red) . . . . . . . . . . . . . . . . . . . . . . . . .65Color additives (Amaranth) . . . . . . . . . . . . . . . . . . . . . . . . .65Color additives (Brilliant Blue FCF) . . . . . . . . . . . . . . . . . . . .65Color additives (Erythrosine) . . . . . . . . . . . . . . . . . . . . . . . .65Color additives (Fast Green FCF) . . . . . . . . . . . . . . . . . . . . .65Color additives (Indigo Carmine) . . . . . . . . . . . . . . . . . . . . .65Color additives (New Coccine) . . . . . . . . . . . . . . . . . . . . . .65Color additives (Phloxine) . . . . . . . . . . . . . . . . . . . . . . . . . .65Color additives (Rose Bengale) . . . . . . . . . . . . . . . . . . . . . .65Color additives (Sunset Yellow FCF) . . . . . . . . . . . . . . . . . . .65Color additives (Tartrazine) . . . . . . . . . . . . . . . . . . . . . . . . .65Copper 8-quinolinolate . . . . . . . . . . . . . . . . . . . . . . . . . .114Coronene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Corticosterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77-80Corticosterone acetate . . . . . . . . . . . . . . . . . . . . . . . . .77,80Cortisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77-80Cortisone acetate . . . . . . . . . . . . . . . . . . . . . . . . . . . .77,80o -Cresol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121,124m -Cresol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121,124p -Cresol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121,124Crimidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Crotonaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . .1175'-CTP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Cuminic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .119,120Cyanazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Cyanocobalamine . . . . . . . . . . . . . . . . . . . . . . . . .25,27,29Cyclodextrins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37,38α-Cyclodextrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37,38β-Cyclodextrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37,38γ-Cyclodextrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37,38L-Cystine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Cytidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Cytochrome c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55-58

C

Index of Analytes



Cytochrome c (dimer) . . . . . . . . . . . . . . . . . . . . . . . . . . . .55Cytochrome c (hexamer) . . . . . . . . . . . . . . . . . . . . . . . . . .55Cytochrome c (monomer) . . . . . . . . . . . . . . . . . . . . . . . . . .55Cytochrome c (tetramer) . . . . . . . . . . . . . . . . . . . . . . . . . . .55Cytochrome c (trimer) . . . . . . . . . . . . . . . . . . . . . . . . . . . .55Cytocine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43

D4T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100Daidzein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73Daidzin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .735'-dAMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .455'-dCMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45DDC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100DDI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100Dehydroacetic acid . . . . . . . . . . . . . . . . . . . . . . . . . . .62,67Dehydroisoandrosterone . . . . . . . . . . . . . . . . . . . . . . . . . . .81Deoxyadenosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Deoxycorticosterone . . . . . . . . . . . . . . . . . . . . . . . . . . .77-80Deoxycorticosterone acetate . . . . . . . . . . . . . . . . . . . . . . . .80Deoxycytidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Deoxyguanosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Deoxyinosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Deoxyuridine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96Desipramine hydrochloride . . . . . . . . . . . . . . . . . . . . . .92,93Dexamethasone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78,805'-dGMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45∆ Di-0S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33∆ Di-4S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33∆ Di-6S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33∆ Di-diSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33∆ Di-diSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33∆ Di-triS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Diaveridine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Dibenzo[a,h]anthracene . . . . . . . . . . . . . . . . . . . . . .117,118Dibutyl hydroxytoluene (BHT) . . . . . . . . . . . . . . . . . . . . . . . .64Dicethiamine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302,4-Dichlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1212,6-Dichlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121Dicloxacillin sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . .111Diethanolamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1231,1-Diethylurea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1231,3-Diethylurea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Digitoxigenin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Digitoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69,85Digoxigenin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Digoxigenin-bis-digitoxoside . . . . . . . . . . . . . . . . . . . . . . . .85Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .852,3-Dihydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .1202,4-Dihydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .1202,5-Dihydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .1203,4-Dihydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .1203,5-Dihydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .1203,4-Dihydroxyphenylacetic acid . . . . . . . . . . . . . . . . . . . .1023,4-Dihydroxyphenylalanine (DOPA) . . . . . . . . . . . . . . . . . .102Diltiazem HCl . . . . . . . . . . . . . . . . . . . . . . . . . . .94, 97,1017,12-Dimethylbenzo[a]anthracene . . . . . . . . . . . . . . .117,118

O -Dimethyl-β-cyclodextrin . . . . . . . . . . . . . . . . . . . . . . . . .38N,N -Dimethylethanolamine . . . . . . . . . . . . . . . . . . . . . . .1232,3-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1222,4-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1222,5-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1222,6-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1223,4-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1223,5-Dimethylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1222,4-Dinitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1212,6-Dinitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121Diphenhydramine hydrochloride . . . . . . . . . . . . . . . . . . . . .91Diphenyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83,116-118Disaccharides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32``Diuron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Docosahexaenoic acid . . . . . . . . . . . . . . . . . . . . . . . . . . .61n -Dodecyl gallate (DG) . . . . . . . . . . . . . . . . . . . . . . . .63,64DOPA (3,4-Dihydroxyphenylalanine) . . . . . . . . . . . . . . . . . .102Dopamine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . .102Doxepin hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . . . . .93Doxorubicin hydrochloride . . . . . . . . . . . . . . . . . . . . . . . .105Dynorphin A (Human,1-13) . . . . . . . . . . . . . . . . . . . . . . . .51

α-Ecdysone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84β-Ecdysone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84Cu (II)-EDTA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63Fe (III)-EDTA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63Eicosapentaenoic acid . . . . . . . . . . . . . . . . . . . . . . . . . . .61Eicosatrienoic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Eledoisin related peptide . . . . . . . . . . . . . . . . . . . . . . . . . .51α-Endorphin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51β-Endorphin (Human) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51γ-Endorphin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51[D-Ala2,Met5]-Enkephalin . . . . . . . . . . . . . . . . . . . . . . . . . .51Leu-Enkephalin . . . . . . . . . . . . . . . . . . . . . . .49,51-53,58,59Met-Enkephalin . . . . . . . . . . . . . . . . . . . . . . . . . . . .49,51-53[D-Ala2,Met5]-Enkephalinamide . . . . . . . . . . . . . . . . . . . . . .51Enolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56-58Enoxacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105(-)-Epicatechin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73,74(-)-Epicatechin gallate . . . . . . . . . . . . . . . . . . . . . . . . . .73,74(-)-Epigallocatechin . . . . . . . . . . . . . . . . . . . . . . . . . . . .73,74(-)-Epigallocatechin gallate . . . . . . . . . . . . . . . . . . . . . . .73,74Epinephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102Ergocalciferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,22Erythorbic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28,31Erythritol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .113Erythromycin estolate . . . . . . . . . . . . . . . . . . . . . . . . . . . .113Erythromycin ethylsuccinate . . . . . . . . . . . . . . . . . . . . . . . .113Erythrosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Esculine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69β-Estradiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82,83Estradiol benzoate . . . . . . . . . . . . . . . . . . . . . . . . . . . .82,83Estradiol dipropionate . . . . . . . . . . . . . . . . . . . . . . . . . .82,83Estriol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82Estrone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82

E

D

Index of Analytes



Ethanolamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Ethenzamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87,88,90Ethinylestradiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82,83Ethiofencarb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Ethopropazine hydrochloride . . . . . . . . . . . . . . . . . . . . . . .92Ethosuximide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92p -Ethoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .119,120Ethyl 4-aminobenzoate . . . . . . . . . . . . . . . . . . . . . . . . . . .97Ethylbenzene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80Ethyleneglycol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Ethyl p-hydroxybenzoate . . . . . . . . . . . . . . . . . . . . . . . .62,63Ethylurea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123

Fast Green FCF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Fenofibrate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95Fenoprofen calcium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93Flavin adenine dinucleotide disodium . . . . . . . . . . . . . . . . . .30Flavin mononucleotide sodium salt(Flavin sodium phosphate) . . . . . . . . . . . . . . . . . . . . . .26,30

Flavinoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71,72,73Fluocinolone acetonide . . . . . . . . . . . . . . . . . . . . . . . . .77-80Fluocinonide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78-80Fluoranthene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Fluorene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,1185-Fluorocytosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .435-Fluoro-2'-deoxyuridine . . . . . . . . . . . . . . . . . . . . . . . . . . .965-Fluoroorotic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .445-Fluorouracil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .44, 96Fluoxymesterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80,81Fluphenazine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . .92Flurbiprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93,101Folic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,96Formaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . . .1171-Fructofuranosyl-D-nystose . . . . . . . . . . . . . . . . . . . . . . . . .34Fructooligusaccharides . . . . . . . . . . . . . . . . . . . . . . . . . . . .34Fructose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Fucose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Fucosterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84Fullerene (C60) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126Fullerene (C70) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126Fumaric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Furazolidone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96,97

Galactose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Gallic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .755'-GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45GDP-D-mannose . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46,47Gemfibrozil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95Genistein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73Genistin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73Ginsenoside-Rb1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71

Ginsenoside-Rg1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71Glucose (G1) . . . . . . . . . . . . . . . . . . . . . . . .32,35,37,46,47Glutamate dehydrogenase . . . . . . . . . . . . . . . . . . . . . . .56-58Glutamic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Glutamic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Glutamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48Glutathione (GSH) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49Glutathione disulfide (GSSG) . . . . . . . . . . . . . . . . . . . . . . .49Glycerol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Glycine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49,55,56Glycolic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Glycosides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69Glycyrrhizic acid (Glycyrrhizin) . . . . . . . . . . . . . . . . .67,69,895'-GMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45,465'-GTP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Guanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Guanosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43

Heparan sulfate, Na salt . . . . . . . . . . . . . . . . . . . . . . . . . .42Heparin, Na salt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42Hesperidin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72,73Hexazinone, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114Hinokitiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124Hippuric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101,102Histidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Histidine,Hydrachloride . . . . . . . . . . . . . . . . . . . . .48,49,99Homovanilic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102Hordenine sulfate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Human IgA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53,54Human IgG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53,54Human IgM(κ),myeloma protein . . . . . . . . . . . . . . . . . . .53,54Hyaluronic acid, Na salt . . . . . . . . . . . . . . . . . . . . . . . . . .42Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . .96,97Hydrocortisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77-80Hydrocortisone acetate . . . . . . . . . . . . . . . . . . . . . . . . .77,80Hydrocortisone succinate . . . . . . . . . . . . . . . . . . . . . . . . . .79Hydroquinone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75,1224'-Hydroxyacetophenone . . . . . . . . . . . . . . . . . . . .69,98,113m -Hydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . . . .120p -Hydroxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . .87,1204-Hydroxy-3-methoxymandelic acid . . . . . . . . . . . . . . . . . .1024-Hydroxy-3-methoxyphenylglycol . . . . . . . . . . . . . . . . . . .1024-Hydroxymethyl-2,6-di-tert-butylphenol(HMBP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63,64

3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Hyodeoxycholic acid (HDCA) . . . . . . . . . . . . . . . . . . . . . . .83Hypoxanthine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43,99

Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90,93Imazalil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Imipramine hydrochloride . . . . . . . . . . . . . . . . . . . . . . .92,93

G

H

I

F

Index of Analytes



Immunoglobins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53,545'-IMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Indigo Carmine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Indomethacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86,87Inosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Inositol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49-52,55,56Insulin (Bovine) . . . . . . . . . . . . . . . . . . . . . . . . .50,51,55,56Insulin (Equine) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50Insulin (Human) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50,51Insulin (Porcine) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50,51Insulin (Sheep) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50,51Insulin Chain B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52Isobutyraldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . .117Isobutyl p-hydroxybenzoate . . . . . . . . . . . . . . . . . . . . . . . . .62Isoleucine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Isoleucine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Isonicotinic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . .98,100Isonicotinic acid hydrazide . . . . . . . . . . . . . . . . . . . . .98,100Isophthalic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .125p -Isopropylbenzoic acid . . . . . . . . . . . . . . . . . . . . . .119,120Isopropyl p-hydroxybenzoate . . . . . . . . . . . . . . . . . . . . . . .62Isoproturon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115

Kaempferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71Keratan polysulfate, Na salt . . . . . . . . . . . . . . . . . . . . . . . .43Keratan sulfate, Na salt . . . . . . . . . . . . . . . . . . . . . . . . . . .431-Kestose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33,34Ketoprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91,93

Lactate dehydrogenase . . . . . . . . . . . . . . . . . . . . . . . . .56-58Lactic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Lactose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Lactosyl fructoside . . . . . . . . . . . . . . . . . . . . . . . . . . . .34,35Lanatoside B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Lanatoside C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Leucine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Leucine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Leu-Enkephalin . . . . . . . . . . . . . . . . . . . . . . . . . . . .49,51-53Lidocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94,97,101Linoleic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61γ-Linolenic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Linuron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Lovastatin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95Luteolin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72Lysine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Lysine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Lysozyme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58

Maleic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60,89L-Malic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Malonic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Malonyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Maltitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Maltododecaose (G12) . . . . . . . . . . . . . . . . . . . . . . . . .35,36Maltoheptaose (G7) . . . . . . . . . . . . . . . . . . . . . . . . . . .35,37Maltohexaose (G6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35Maltooligosaccharides . . . . . . . . . . . . . . . . . . . . . . . . .35-37Maltopentadecaose (G15) . . . . . . . . . . . . . . . . . . . . . . .35-37Maltopentaose (G5) . . . . . . . . . . . . . . . . . . . . . . . . . . .35,37Maltose (G2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32,35Maltotetradecaose (G14) . . . . . . . . . . . . . . . . . . . . . . . .35,36Maltotetraose (G4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35Maltotridecaose (G13) . . . . . . . . . . . . . . . . . . . . . . . . . .35-37Maltotriose (G3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37Maltoundecaose (G11) . . . . . . . . . . . . . . . . . . . . . . . . .35-37Mandelic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . .101,102Mannitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Mannose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32,46,47α-Mating factor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49,51Medroxyprogesterone acetate . . . . . . . . . . . . . . . . . . . . . . .82Menadione . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Menaquinone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,25Mestranol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82Metazachlor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Methicillin sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .111Methionine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Methionine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Methotrexate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96o -Methoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . . . .119m -Methoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . . . .119p -Methoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . . . . .1193-Methoxytyramine hydrochloride . . . . . . . . . . . . . . . . . . .102Methoxyverapamil HCl . . . . . . . . . . . . . . . . . . . . . . . . . . .94Methyl Benzoate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101N -Methylethanolamine . . . . . . . . . . . . . . . . . . . . . . . . . .123Methylethylketone 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . .117o -Methylhippuric acid . . . . . . . . . . . . . . . . . . . . . . .101,102m -Methylhippuric acid . . . . . . . . . . . . . . . . . . . . . . .101,102p -Methylhippuric acid . . . . . . . . . . . . . . . . . . . . . . .101,102Methyl p-hydroxybenzoate . . . . . . . . . . . . . . . . . . . .62,63,72Methyl linoleate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Methyl linolenate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Methyl γ-linolenate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Methylmalonyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31N' -Methylnicotinamide . . . . . . . . . . . . . . . . . . . . . . . .98,100Methyl oleate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61Methylprednisolone . . . . . . . . . . . . . . . . . . . . . . . . .77,78,80Methyltestosterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81Metobromuron . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Metolachlor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Metoxuron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Monosaccharides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Myoglobin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55,58Myricetin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71

L

M

K

Index of Analytes



NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30NADH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30NADP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30NADPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30Nalidixic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104-106Naphazoline hydrochloride . . . . . . . . . . . . . . . . . . . . . . . .90Naphthacene . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Naphthalene . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,1181-Naphthol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124Naproxen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91Narcotine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68,87,88Naringin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72,73Narirutin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72,73Neohesperidin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72,73Neostigmine methylsulfate . . . . . . . . . . . . . . . . . . . . . . . . .89Neurotensin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51,55,56New Coccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Nicardipine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94,97Nicotinamide . . . . . . . . . . . . . . . . . . . . . . . . . .25,26,28,29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,98,100β-Nicotinamide adenine dinucleotide . . . . . . . . . . . . . . . . . .30Nicotinamide adenine dinucleotide phosphate oxidized form . . . . . . . . . . . . . . . . .30Nicotinamide adenine dinucleotide phosphate reduced form . . . . . . . . . . . . . . . . . . . . . . . . . .30β-Nicotinamide adenine dinucleotide reduced form . . . . . . . . . . . . . . . . . . . . . . . . .30Nicotinic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,28,30, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98,100

Nifedipine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94Niguldipine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94o -Nitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121m -Nitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121p -Nitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121Nordihydroguaiaretic acid (NDGA) . . . . . . . . . . . . . . . .63,64Norepinephrine hydrochloride . . . . . . . . . . . . . . . . . . . . . .102Norethisterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82Norfloxacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Norgestrel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83Nucleosides and bases . . . . . . . . . . . . . . . . . . . . . . . . . . .43Nucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43-47Nystose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33,34

n -Octyl gallate (OG) . . . . . . . . . . . . . . . . . . . . . . . . . . . .63Ofloxacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Olaquindox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Oligonucleotides (c-Ha-ras/12) . . . . . . . . . . . . . . . . . . . . . .46Oligosaccharides . . . . . . . . . . . . . . . . . . . . . . . . . .33,34,35Organic Acids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60-61Orotic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28,44Ouabain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69,85Ouabagenin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Ovalubmin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49

Oxamyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Oxipurinol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99Oxolinic acid . . . . . . . . . . . . . . . . . . . . . . . . . .104,105,106Oxytetracycline hydrochloride . . . . . . . . . . . . . . . . . .105,113Oxytocin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51,58,59

PABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27,29Paeoniflorin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69,70Paeonol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76Pantothenic acid (Na salt) . . . . . . . . . . . . . . . . . . . . . . . . .25Pantothenyl alcohol (Panthenol) . . . . . . . . . . . . . . . . . . . .26,30Papaverine chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68PA-Sugar Chain 001 . . . . . . . . . . . . . . . . . . . . . . . . . .38,39PA-Sugar Chain 002 . . . . . . . . . . . . . . . . . . . . . . . . . .38,39PA-Sugar Chain 014 . . . . . . . . . . . . . . . . . . . . . . . . . .38,39PEG #300 (MW 300) . . . . . . . . . . . . . . . . . . . . . . . . . .123PEG #1,000 (MW 1,000) . . . . . . . . . . . . . . . . . . . . . . .123PEG #4,000 (MW 3,350) . . . . . . . . . . . . . . . . . . . . . . .123PEG #6,000 (MW 8,400) . . . . . . . . . . . . . . . . . . . . . . .123PEG #20,000 (MW 20,000) . . . . . . . . . . . . . . . . . . . . .123Penicillin G potassium . . . . . . . . . . . . . . . . . . . . . . . . . . .111Penicillin V potassium . . . . . . . . . . . . . . . . . . . . . . . . . . .111Pentaglycine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56Peptides . . . . . . . . . . . . . . . . . . . . . . . . . . .49,51,52,53,55Perphenazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92Perylene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Phenanthrene . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Phenethicillin potassium . . . . . . . . . . . . . . . . . . . . . . . . . .111Phenobarbital sodium salt . . . . . . . . . . . . . . . . . . . . . . . . . .92Phenol . . . . . . . . . . . . . . . . . . . . . . . . .68,98,112,121,122Phenoxyethylpenicillin potassium . . . . . . . . . . . . . . . . . . . .111Phenoxymethylpenicillin potassium . . . . . . . . . . . . . . . . . . .111Phenylalanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Phenylalanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49o -Phenylenediamine . . . . . . . . . . . . . . . . . . . . . . . . . . . .126m -Phenylenediamine . . . . . . . . . . . . . . . . . . . . . . . . . . . .126p -Phenylenediamine . . . . . . . . . . . . . . . . . . . . . . . . . . . .126Phenylephrine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .892-Phenylethyl β-cellobioside . . . . . . . . . . . . . . . . . . . . . . . .742-Phenylethyl β-gentiobioside . . . . . . . . . . . . . . . . . . . . . . .742-Phenylethyl β-lactoside . . . . . . . . . . . . . . . . . . . . . . . . . .742-Phenylethyl β-maltoside . . . . . . . . . . . . . . . . . . . . . . . . . .742-Phenylethyl β-melibioside . . . . . . . . . . . . . . . . . . . . . . . . .742-Phenylethyl glycoside . . . . . . . . . . . . . . . . . . . . . . . . . . .74o -Phenylphenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Phenylpropanolamine HCl . . . . . . . . . . . . . . . . . . . . . . . . .89Phenytoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92Phloxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Phosphoenolpyruvic acid monopotassium salt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Phthalic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .125Phylloquinone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,25Pilocarpine chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Pipemidic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Pirimicarb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Piromidic acid . . . . . . . . . . . . . . . . . . . . . . . . .104,105,106Piroxicam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91

O

P

N

Index of Analytes



Plasmid pBR322 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47Poly (A) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46Polydextrose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40Prednisolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77-80Prednisolone acetate . . . . . . . . . . . . . . . . . . . . . . . . . . .78-80Prednisolone succinate . . . . . . . . . . . . . . . . . . . . . . . . . . . .79Prednisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77,78,80Prenylamine lactate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94Primidone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92Procainamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98Procaine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97Prochlorperazine maleate . . . . . . . . . . . . . . . . . . . . . . . . . .92Profenamine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . .92Progesterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77,82Proline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Proline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Promazine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . . .92Prometon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Prometryn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Propazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Propham . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Propicillin potassium . . . . . . . . . . . . . . . . . . . . . . . . . . . .111Propionaldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . .117Propionamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Propionic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Propionyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31p -Propoxybenzoic acid . . . . . . . . . . . . . . . . . . . . . .119,120Propranolol hydrochloride . . . . . . . . . . . . . . . . . . . . . . .94,97n -Propyl gallate (PG) . . . . . . . . . . . . . . . . . . . . . . . . . .63,64Propyl p-hydroxybenzoate . . . . . . . . . . . . . . . . . . . .62,63,67Proscillaridin A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85Pullulan P-5 (MW 10,700) . . . . . . . . . . . . . . . . . . . . . . . . .40Pullulan P-20 (MW 23,700) . . . . . . . . . . . . . . . . . . . . . . . .40Pullulan P-50 (MW 48,000) . . . . . . . . . . . . . . . . . . . . . . . .40Pullulan P-800 (MW 853,000) . . . . . . . . . . . . . . . . . . . . . .40Pyrene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Pyridoxal HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29Pyridoxine HCl . . . . . . . . . . . . . . . . . . . . . . .25,26,28,29,89Co (II)-1-(2-Pyridylazo)-2-naphthol . . . . . . . . . . . . . . . . . . . .124Fe (III)-1-(2-Pyridylazo)-2-naphthol . . . . . . . . . . . . . . . . . . . .124Ni (II)-1-(2-Pyridylazo)-2-naphthol . . . . . . . . . . . . . . . . . . . .124Zn (II)-1-(2-Pyridylazo)-2-naphthol . . . . . . . . . . . . . . . . . . . .124Pyrimethamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Pyrogallol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .122Pyrroloquinoline quinone (PQQ) . . . . . . . . . . . . . . . . . . . . .28Pyruvic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60

Quercetin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71Quinidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94,97Quinine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .688-Quinolinol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124

Raffinose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34

Rebaudioside A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67Resorcinol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,112,120α -Resorcylic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .120β -Resorcylic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .120γ -Resorcylic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .120Resibufogenin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86Retinol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Retinol acetate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Retinol palmitate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Rhamnose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32Ribitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Riboflavin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,27,29,30Ribonuclease A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58Rose Bengale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65

Saccharin sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62Saikosaponin a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70Saikosaponin b2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70Saikosaponin c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70Saikosaponin d . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70Salicin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69Salicylic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98,120Saponins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70Scopolamine bromide . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Sebuthylazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Sennoside A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74,75Sennoside B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74,75Serine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Serine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Simazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115β-Sitosterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84Sorbic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62,67Sorbitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Sparteine sulfate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Stachyose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34Stevioside . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67Stigmasterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84G-Strophanthin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69,85Substance P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51Succinic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Succinyl-CoA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31Sucrose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32,34Sugar Alcohols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Sulfachloropyridazine . . . . . . . . . . . . . . . . . . . . . . . . . . .103Sulfadiazine . . . . . . . . . . . . . . . . . . . . . . . . . .103,104,105Sulfadimethoxine . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfadimidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104,105Sulfadoxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103Sulfaguanidine . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfamerazine . . . . . . . . . . . . . . . . . . . . . . . . .103,104,105Sulfamethazine . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfamethizole . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfamethoxazole . . . . . . . . . . . . . . . . . . . . . . . . . . .103,105Sulfamethoxypyridazine . . . . . . . . . . . . . . . . . . . . . .103,104Sulfamonomethoxine . . . . . . . . . . . . . . . . . . . . .103,104,105Sulfanilamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfapyridine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104

R

S

Q

Index of Analytes



Sulfaquinoxaline sodium . . . . . . . . . . . . . . . . . . . . . . . . . .103Sulfathiazole . . . . . . . . . . . . . . . . . . . . . . . . . .103,104,105Sulfisomidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104Sulfisoxazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103Sulindac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91Sunset Yellow FCF53, . . . . . . . . . . . . . . . . . . . . . . . . . . .65Swep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115

Tartaric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60Tartrazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65Taurine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,495'-TDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Terbumeton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Terbuthylazine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Terbutryn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114,115Terephthalic acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .125o-Terphenyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .127m-Terphenyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .127p-Terphenyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .127Testosterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81,82Testosterone enanthate . . . . . . . . . . . . . . . . . . . . . . . . .81,82Testosterone propionate . . . . . . . . . . . . . . . . . . . . . . . .81,82Tetracaine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . . .97Tetracycline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105Tetracycline hydrochloride . . . . . . . . . . . . . . . . . . . . . . . .113Theobromine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68Theophylline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68,98Thiabendazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116Thiamine HCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,26,30Thiamphenicol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Threonine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Threonine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49∆-Threonine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48Thymidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Thymine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .435'-TMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45α-Tocopherol . . . . . . . . . . . . . . . . . . . . . . . . . . .21,23,24,25β-Tocopherol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23γ-Tocopherol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23,24δ¬-Tocopherol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,23α-Tocopherol acetate . . . . . . . . . . . . . . . . . . . . . . . .21,24,25Tolmetin sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91p -Tolualdehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . . .117Triamcinolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78-80Triamcinolone acetonide . . . . . . . . . . . . . . . . . . . . . . . .78-802,4,6-Trichlorophenol . . . . . . . . . . . . . . . . . . . . . . . . . . .121Triethanolamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Trifluoperazine hydrochloride . . . . . . . . . . . . . . . . . . . . . . .92Triglycine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56Trigonerlline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .682,4,5-Trihydroxy butyrophenone(THBP) . . . . . . . . . . . . . .63,64Trimethoprim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103,104O -Trimethyl-β-cyclodextrin . . . . . . . . . . . . . . . . . . . . . . . . .382,4,6-Trinitrophenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121Triphenylene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117,118Triton X-100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Tryptophan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48

L-Tryptophan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .485'-TTP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45Tyrosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Tyrosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49

5'-UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45UDP-D-glucose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47UDP-N-acetyl-D-glucosamine . . . . . . . . . . . . . . . . . . .115,1235'-UMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45,463Unsaturated chloro-disaccharides . . . . . . . . . . . . . . . . . . . . .33Uracil . . . . . . . . . . . . . . . . . . . . . . . . . . . .43,44,96,98,124Urea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123Uric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99,101Uridine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .435'-UTP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45

[Arg8]- Vasopressin . . . . . . . . . . . . . . . . . . . . . . . . . . . .58,59n -Valeraldehyde 2,4-DNPH . . . . . . . . . . . . . . . . . . . . . . .117Valine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48L-Valine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48,49Vancomycin hydrochloride . . . . . . . . . . . . . . . . . . . . . . . .113Verapamil HCl . . . . . . . . . . . . . . . . . . . . . . . . . . .94,97,101Vitamin A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Vitamin A palmitate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Vitamin B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,26Vitamin B2 (Flavin mononucleotide) . . . . . . . . . . . . . . . . .26,27Vitamin B2 (Riboflavin) . . . . . . . . . . . . . . . . . . . .25,26,27,29Vitamin B6 (Pyridoxal HCl) . . . . . . . . . . . . . . . . . . . . . . .29,30Vitamin B6 (Pyridoxine HCl) . . . . . . . . . . . . . .25,26,28,29,89Vitamin B12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,27Vitamin B13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28Vitamin C . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25,26,28,31Vitamin D2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,22Vitamin D3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,22Vitamin E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21Vitamin H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27Vitamin K1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,25Vitamin K2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21,25Vitamin K3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21

Xanthine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23,29,43,99Xanthosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43Xylitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33Xylose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32

U

V

X

T

Index of Analytes


Austria and European Export(Central South Eastern Europe, CISand Middle East) 43 1 877 18 07

Australia 61 2 9933 1777

Belgium 32 2 726 1000

Brazil 55 11 5094-3788

Canada 1 800 252 4752 x2205

China 86 10 8586 8899

CIS/Russia +7 495 3367000

Czech Republic 420 2 617 1 1384

Denmark 45 46 59 8080

Finland 09 5659 6288

France 33 1 30 48 72 00

Germany 49 6196 400600

Hong Kong 852 29 64 1800

Hungary 36 1 350 5086

India and India Subcontinent91 80 2837 1900

Ireland 353 1 448 1500

Italy 39 02 27 421 1

Japan 81 3 3471 7191

Korea 82 2 820 2700

Mexico 52 55 5200 1860

The Netherlands 31 76 508 7200

Norway 47 6 384 60 50

Poland 48 22 833 4400

Puerto Rico 1 787 747 8445

Singapore 65 6273 1221

Spain 34 93 600 9300

Sweden 46 8 555 11 500

Switzerland 41 62 889 2030

Taiwan 886 2 2543 1898

United Kingdom 44 208 238 6100

All other countries:Waters Corporation U.S.A.1 508 478 2000

1 800 252 4752

www.waters.com

Sales Offices

Waters, and The Science of What’s Possible are registered trademark of Waters CorporationCombiChrom, CombiPrep, CombiScreen, Hydrosphere, J’Sphere, N-Sure. ODS-A.

ODS-AL, ODS-AM, ODS-AQ, PA-gel, Polyamine II, PolymerC18, Pro C18, Pro C18 RS, Pro C8, Pro C4, Protein-RP, PVA-Sil, R&D Column Set, Carotenoid, YMC, YMC*Gel,

YMC30, YMCbasic, and YMC-Pack are registered trademarks of YMC, Co., Ltd.

720000565EN 2007 IH-??

http://www.waters.com

http://www.waters.com/watersdivision/Contentd.asp?ref=KGLY-5JY48V&WT.svl=2

ymc hplc columns applications notebook

Documents